data_2k2g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.548 0.213 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.427 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 121' ' ' TYR . 2.8 t30 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.463 ' N ' ' ND2' ' A' ' 120' ' ' ASN . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.596 ' NH2' ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.596 ' NZ ' ' NH2' ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 10.2 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.476 ' C ' ' HG ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.476 ' HG ' ' C ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.537 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 239' ' ' THR . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 260' ' ' SER . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.461 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.739 ' HE ' HD22 ' A' ' 119' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.739 HD22 ' HE ' ' A' ' 117' ' ' ARG . 18.9 m120 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.428 ' O ' ' OG1' ' A' ' 145' ' ' THR . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.667 ' H ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.63 ' CE1' ' HE2' ' A' ' 172' ' ' HIS . 73.2 t60 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.647 ' HE2' ' HE2' ' A' ' 222' ' ' HIS . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.647 ' HE2' ' HE2' ' A' ' 218' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 261' ' ' LEU . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 120' ' ' ASN . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.535 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.516 ' HG ' ' N ' ' A' ' 143' ' ' ASN . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.516 ' N ' ' HG ' ' A' ' 142' ' ' SER . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 155' ' ' GLY . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.518 ' N ' ' HG1' ' A' ' 154' ' ' THR . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.495 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 57.0 p-80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.555 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.438 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.4 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 220' ' ' ILE . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 226' ' ' LEU . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.407 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.435 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' TYR . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' ' HD1' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 114' ' ' ILE . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.416 ' OG1' ' OE1' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' ' CE1' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 16.2 m170 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.408 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.498 HH11 ' CG ' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.647 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.491 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.408 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 180' ' ' ILE . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.567 ' HD1' ' N ' ' A' ' 184' ' ' ALA . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.567 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 260' ' ' SER . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.509 ' C ' ' H ' ' A' ' 261' ' ' LEU . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.397 0.141 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.624 ' CD2' ' H ' ' A' ' 207' ' ' SER . 11.5 t-160 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.624 ' H ' ' CD2' ' A' ' 206' ' ' HIS . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.749 ' NE2' ' HE2' ' A' ' 228' ' ' HIS . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.749 ' HE2' ' NE2' ' A' ' 222' ' ' HIS . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 239' ' ' THR . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 18.5 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' A' ' 115' ' ' THR . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HE ' ' ND2' ' A' ' 119' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.474 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.663 ' ND2' ' HE ' ' A' ' 117' ' ' ARG . 5.3 m120 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.453 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.661 ' HE2' ' CD2' ' A' ' 183' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.554 ' CG ' ' O ' ' A' ' 171' ' ' PHE . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.661 ' CD2' ' HE2' ' A' ' 168' ' ' HIS . 2.4 t60 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 193' ' ' GLY . 8.9 tt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.363 0.125 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.592 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.592 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 231' ' ' ASP . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 230' ' ' SER . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.45 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.468 0.175 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.451 ' H ' ' HG1' ' A' ' 115' ' ' THR . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.608 ' NE ' HD22 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.608 HD22 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' OH ' ' NZ ' ' A' ' 136' ' ' LYS . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.497 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.697 ' HE2' ' HD1' ' A' ' 196' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.607 ' H ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 171' ' ' PHE . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.525 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.622 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.547 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.435 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.697 ' HD1' ' HE2' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.671 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.98 ' NE2' ' HE2' ' A' ' 228' ' ' HIS . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.98 ' HE2' ' NE2' ' A' ' 222' ' ' HIS . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.713 ' H ' ' HG ' ' A' ' 251' ' ' SER . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.661 ' NH1' HE22 ' A' ' 259' ' ' GLN . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.661 HE22 ' NH1' ' A' ' 256' ' ' ARG . 18.8 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.456 ' CG ' ' H ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 13.9 p-80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.622 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 201' ' ' GLU . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.423 ' NE2' ' HE2' ' A' ' 222' ' ' HIS . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.656 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.656 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.668 ' NH1' HD22 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.668 HD22 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.467 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.687 ' CG ' ' H ' ' A' ' 207' ' ' SER . 31.6 t60 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.687 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.438 ' O ' ' OG1' ' A' ' 215' ' ' THR . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.531 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.531 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.44 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.491 ' O ' ' NE ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.409 ' NE2' ' NH2' ' A' ' 135' ' ' ARG . 83.4 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 145' ' ' THR . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.631 ' H ' ' ND1' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.624 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 12.1 m170 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 261' ' ' LEU . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.63 ' HD1' ' N ' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.446 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.624 ' N ' HD21 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.62 ' H ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.647 ' HE2' ' HD1' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.647 ' HD1' ' HE2' ' A' ' 183' ' ' HIS . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 255' ' ' ILE . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 260' ' ' SER . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 262' ' ' TYR . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 259' ' ' GLN . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.773 0.321 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' A' ' 145' ' ' THR . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 153' ' ' ASN . 0.7 OUTLIER -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 115' ' ' THR . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 46.7 p-80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.696 ' HE2' ' H ' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 84.0 t80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.696 ' H ' ' HE2' ' A' ' 183' ' ' HIS . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 207' ' ' SER . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 211' ' ' ASN . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.607 ' HE2' ' HE2' ' A' ' 222' ' ' HIS . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.607 ' HE2' ' HE2' ' A' ' 218' ' ' HIS . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.492 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.577 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.577 ' H ' ' HG ' ' A' ' 251' ' ' SER . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 260' ' ' SER . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.482 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 16.5 mm100 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 7.1 t30 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.708 ' NE2' ' H ' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.708 ' H ' ' NE2' ' A' ' 183' ' ' HIS . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.462 ' ND1' ' HG ' ' A' ' 207' ' ' SER . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.462 ' HG ' ' ND1' ' A' ' 206' ' ' HIS . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.449 ' CG2' ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.47 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.411 ' O ' ' OG ' ' A' ' 223' ' ' SER . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 220' ' ' ILE . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.601 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 2.7 m170 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.601 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.523 0.202 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 114' ' ' ILE . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 115' ' ' THR . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.719 ' HE ' HD22 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.447 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.719 HD22 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.451 ' OH ' ' NZ ' ' A' ' 136' ' ' LYS . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.405 ' C ' ' HG1' ' A' ' 154' ' ' THR . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 153' ' ' ASN . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.466 ' H ' ' HG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 58.4 t60 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 21.4 tt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.434 ' O ' ' OG1' ' A' ' 215' ' ' THR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.674 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.674 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.481 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.71 ' H ' ' HG ' ' A' ' 251' ' ' SER . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.391 0.138 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.42 ' C ' ' HG1' ' A' ' 145' ' ' THR . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 193' ' ' GLY . 17.6 tt . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.443 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.854 ' NE2' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.854 ' HE2' ' NE2' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.422 ' H ' ' CG2' ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.467 ' HG1' ' CG ' ' A' ' 158' ' ' ASP . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.664 ' NE ' HD22 ' A' ' 119' ' ' ASN . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.664 HD22 ' NE ' ' A' ' 117' ' ' ARG . 10.9 m120 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.457 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' CG ' ' HG1' ' A' ' 115' ' ' THR . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.536 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 168' ' ' HIS . 5.5 p-80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 60.0 t60 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 8.0 tt . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.628 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.42 ' O ' ' OE2' ' A' ' 219' ' ' GLU . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 215' ' ' THR . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.66 ' NE2' ' HE2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.66 ' HE2' ' NE2' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.486 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 262' ' ' TYR . 16.5 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 39.8 mtm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.2 14.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.29 -24.47 66.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -49.32 132.76 20.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ttt -158.78 66.1 3.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.51 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.89 175.18 7.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.03 2.486 . . . . 0.0 112.22 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.04 128.69 1.78 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.73 -67.65 1.55 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 109' ' ' TRP . 56.8 Cg_endo -70.23 -179.88 3.45 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.733 2.289 . . . . 0.0 111.762 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 t -54.37 82.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' PRO . 1.8 t90 -111.25 117.58 33.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.085 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 112' ' ' HIS . 69.3 mtm180 -158.37 33.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp 61.8 -10.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.297 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.613 ' H ' ' C ' ' A' ' 110' ' ' ARG . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.427 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 121' ' ' TYR . 2.8 t30 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.463 ' N ' ' ND2' ' A' ' 120' ' ' ASN . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.596 ' NH2' ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.596 ' NZ ' ' NH2' ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 186' ' ' GLY . 10.2 t80 -93.15 159.91 15.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 185' ' ' PHE . . . -40.55 103.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.43 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.77 108.06 2.21 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.819 1.679 . . . . 0.0 112.457 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 162.96 -22.07 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 190' ' ' GLY . 5.6 m -94.25 156.96 16.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 189' ' ' SER . . . -38.95 -96.88 0.01 OUTLIER Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.84 54.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.476 ' C ' ' HG ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.476 ' HG ' ' C ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.537 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 239' ' ' THR . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 260' ' ' SER . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.461 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.7 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -172.66 9.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -78.23 5.24 10.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -164.86 144.16 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.683 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.6 tpp -161.56 63.97 1.74 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.593 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.17 101.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.757 2.305 . . . . 0.0 112.204 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.34 13.38 0.06 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.4 168.97 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.64 129.78 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.745 2.297 . . . . 0.0 111.801 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' CZ ' ' A' ' 110' ' ' ARG . 85.4 t -150.7 -48.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.579 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.48 121.01 14.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 43.4 mtm-85 -138.26 49.33 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.685 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -100.99 136.45 40.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.454 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.739 ' HE ' HD22 ' A' ' 119' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.739 HD22 ' HE ' ' A' ' 117' ' ' ARG . 18.9 m120 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.428 ' O ' ' OG1' ' A' ' 145' ' ' THR . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.667 ' H ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.63 ' CE1' ' HE2' ' A' ' 172' ' ' HIS . 73.2 t60 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -154.63 152.9 30.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -63.06 178.93 5.76 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 34.11 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.492 2.128 . . . . 0.0 111.609 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -49.16 127.34 20.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.7 m -59.22 140.9 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.616 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 79.87 -161.04 45.5 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt -51.5 -5.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.512 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 261' ' ' LEU . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.512 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -70.48 114.77 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -161.45 -16.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.582 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -160.46 -25.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.5 ttt 48.47 89.63 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.129 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.07 153.15 18.91 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.102 1.868 . . . . 0.0 112.341 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.91 -86.36 0.06 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.06 173.19 19.48 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.93 165.01 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.847 2.365 . . . . 0.0 111.834 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 109' ' ' TRP . 2.4 t -145.83 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.219 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -62.86 168.52 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.135 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 112' ' ' HIS . 4.4 mmm180 154.72 3.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.026 0.829 . . . . 0.0 111.021 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp 66.06 -42.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.553 ' H ' ' C ' ' A' ' 110' ' ' ARG . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 120' ' ' ASN . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.535 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.516 ' HG ' ' N ' ' A' ' 143' ' ' ASN . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.516 ' N ' ' HG ' ' A' ' 142' ' ' SER . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 155' ' ' GLY . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.518 ' N ' ' HG1' ' A' ' 154' ' ' THR . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.495 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 57.0 p-80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 -132.06 153.42 50.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.3 159.05 38.63 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.56 153.83 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.557 2.171 . . . . 0.0 112.013 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.96 -125.98 3.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 192' ' ' GLY . 70.1 m -42.77 132.18 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.751 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.13 -78.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.047 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.68 -30.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.162 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.555 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.438 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.4 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CD2' ' C5 ' ' A' ' 1' ' ' DSV . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 220' ' ' ILE . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 226' ' ' LEU . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.407 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.435 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' TYR . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 52.31 40.84 29.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -78.4 -1.13 32.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.537 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -166.42 158.92 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.592 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.0 ttt -168.75 64.19 0.57 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.459 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -42.77 169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.771 2.314 . . . . 0.0 112.242 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.18 -148.76 15.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.52 -175.74 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.09 99.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.738 2.292 . . . . 0.0 112.005 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.89 -173.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.531 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.7 117.97 7.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.301 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -132.41 49.32 2.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.324 0.583 . . . . 0.0 109.708 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -103.64 143.24 33.03 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' ' HD1' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 114' ' ' ILE . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.416 ' OG1' ' OE1' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' ' CE1' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -145.75 142.54 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -49.39 178.57 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.73 24.16 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.716 2.277 . . . . 0.0 111.888 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -60.05 146.34 45.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.7 m -77.85 167.25 21.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 72.02 -167.09 53.1 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt -44.07 -15.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.58 HD22 ' CY1' ' A' ' 1' ' ' DSV . 0.3 OUTLIER -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.516 ' ND1' ' C5 ' ' A' ' 1' ' ' DSV . 3.1 t-160 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 16.2 m170 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.58 ' CY1' HD22 ' A' ' 211' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 102' ' ' GLU . 64.1 m-85 54.38 35.27 22.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -62.39 -3.46 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 100' ' ' PHE . 11.3 pt-20 -171.76 -0.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.5 ttp 54.32 69.19 2.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.18 92.51 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.499 2.133 . . . . 0.0 111.934 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.13 -123.6 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.41 -175.53 29.15 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.3 -179.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.75 2.3 . . . . 0.0 112.07 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 109' ' ' TRP . 7.6 p -172.26 -45.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.47 ' N ' ' CG1' ' A' ' 108' ' ' VAL . 2.1 t90 -90.23 115.03 27.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -157.05 32.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp 51.82 34.94 14.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.085 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.408 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.498 HH11 ' CG ' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.647 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.491 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.408 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 180' ' ' ILE . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.567 ' HD1' ' N ' ' A' ' 184' ' ' ALA . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.567 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 -107.62 126.37 52.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.18 -67.02 1.63 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.477 ' O ' ' CE2' ' A' ' 185' ' ' PHE . 40.2 Cg_endo -65.27 -154.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.701 2.267 . . . . 0.0 111.93 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.62 70.25 0.25 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' GLY . 49.5 m -93.15 167.98 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.74 -46.46 0.6 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.77 70.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.416 ' CE1' ' O40' ' A' ' 1' ' ' DSV . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 260' ' ' SER . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.509 ' C ' ' H ' ' A' ' 261' ' ' LEU . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.456 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -174.99 3.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -50.55 -23.62 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.31 -152.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.751 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 13.3 ptt? -163.17 -12.0 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.751 ' CD ' ' H ' ' A' ' 103' ' ' MET . 88.7 Cg_exo -44.29 106.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 122.057 1.77 . . . . 0.0 112.257 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.23 120.87 0.99 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -83.49 -169.4 44.91 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' GLY . 50.8 Cg_exo -52.56 -160.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.877 2.384 . . . . 0.0 112.028 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.28 36.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.338 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -46.76 114.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.225 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 112' ' ' HIS . 58.7 mtp85 -159.17 32.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER 59.76 -9.45 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.191 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 110' ' ' ARG . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -110.72 130.42 55.58 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -74.17 -68.5 1.56 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 186' ' ' GLY . 15.4 Cg_endo -55.57 -152.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.718 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -156.92 70.43 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 54.5 m -100.39 166.58 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.437 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -38.96 -90.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.09 -29.66 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.624 ' CD2' ' H ' ' A' ' 207' ' ' SER . 11.5 t-160 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.624 ' H ' ' CD2' ' A' ' 206' ' ' HIS . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.593 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 239' ' ' THR . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 18.5 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.517 ' C5 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.413 ' C ' ' H ' ' A' ' 102' ' ' GLU . 49.7 t80 -170.66 -30.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -79.72 19.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 100' ' ' PHE . 8.0 tp10 -166.67 -53.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.783 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 44.2 ttp 53.52 92.83 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.546 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.18 140.67 5.33 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.098 1.865 . . . . 0.0 112.199 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.04 -159.35 1.82 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 -67.01 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.57 98.53 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.668 2.245 . . . . 0.0 111.868 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.13 158.19 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' CZ2' ' O ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -79.34 101.83 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.281 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -149.05 56.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.52 134.17 41.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' A' ' 115' ' ' THR . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HE ' ' ND2' ' A' ' 119' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.474 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.663 ' ND2' ' HE ' ' A' ' 117' ' ' ARG . 5.3 m120 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.453 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.661 ' HE2' ' CD2' ' A' ' 183' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.554 ' CG ' ' O ' ' A' ' 171' ' ' PHE . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.661 ' CD2' ' HE2' ' A' ' 168' ' ' HIS . 2.4 t60 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -87.83 162.26 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -75.34 169.59 54.65 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 28.18 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.882 2.388 . . . . 0.0 112.085 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -42.16 148.22 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -60.01 136.13 57.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.11 0.91 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 193' ' ' GLY . 8.9 tt -71.24 -32.66 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.666 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.583 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.583 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 231' ' ' ASP . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 230' ' ' SER . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.45 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.406 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 99' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' C ' ' N ' ' A' ' 102' ' ' GLU . 18.7 m-85 -58.33 -156.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.599 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.35 17.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.572 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 100' ' ' PHE . 6.4 tp10 -69.43 -22.09 63.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.51 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' PRO . 44.5 mtt 52.99 64.99 6.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 106' ' ' GLY . 79.7 Cg_exo -43.85 173.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.739 2.293 . . . . 0.0 112.2 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.26 -5.84 0.8 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . 83.21 174.63 50.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 109' ' ' TRP . 56.9 Cg_endo -69.65 101.23 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.11 46.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.69 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.496 ' H ' ' C ' ' A' ' 107' ' ' PRO . 2.1 t90 -60.02 115.26 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 112' ' ' HIS . 40.7 mtp180 -159.07 35.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt 63.81 -28.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.643 ' H ' ' C ' ' A' ' 110' ' ' ARG . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.451 ' H ' ' HG1' ' A' ' 115' ' ' THR . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.608 ' NE ' HD22 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.608 HD22 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' OH ' ' NZ ' ' A' ' 136' ' ' LYS . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.497 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' NE2' ' A' ' 183' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.607 ' H ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 171' ' ' PHE . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.525 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.615 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.547 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 -67.06 146.67 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -52.89 -179.68 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.58 34.93 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.577 2.185 . . . . 0.0 111.903 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -58.88 143.33 45.48 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 38.7 m -74.89 164.44 26.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 47.27 -131.0 14.47 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt -68.67 46.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.671 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.415 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.584 ' ND1' ' SD ' ' A' ' 236' ' ' MET . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.713 ' H ' ' HG ' ' A' ' 251' ' ' SER . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.661 ' NH1' HE22 ' A' ' 259' ' ' GLN . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.661 HE22 ' NH1' ' A' ' 256' ' ' ARG . 18.8 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.457 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -173.35 13.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.548 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.22 -2.96 14.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.65 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -152.88 116.52 4.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.447 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.3 66.39 1.35 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.521 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.78 86.28 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.0 2.467 . . . . 0.0 112.083 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.69 35.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.3 71.93 0.15 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.23 138.4 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.714 2.276 . . . . 0.0 112.135 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.44 142.35 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.297 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.44 118.11 12.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -132.68 50.31 2.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -105.73 138.77 41.36 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.456 ' CG ' ' H ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 13.9 p-80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.622 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -161.15 163.92 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -86.43 -164.28 39.46 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 186' ' ' GLY . 45.3 Cg_exo -55.42 -139.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.913 2.408 . . . . 0.0 112.255 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.38 118.83 3.21 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.8 m -46.27 119.55 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.56 -142.94 31.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt -54.89 140.11 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 201' ' ' GLU . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.656 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.656 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.452 ' H3 ' ' H ' ' A' ' 100' ' ' PHE . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.452 ' H ' ' H3 ' ' A' ' 99' ' ' MET . 34.9 m-85 -70.64 145.29 50.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.1 ptp180 34.24 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.484 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 100' ' ' PHE . 49.5 mt-10 56.2 171.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 57.4 mtt 54.32 67.37 3.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.689 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.77 38.46 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.971 2.447 . . . . 0.0 112.33 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.0 165.54 20.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -165.71 -168.69 28.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' TRP . 39.5 Cg_exo -55.61 -147.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.892 2.395 . . . . 0.0 112.257 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.8 m -37.89 -25.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' PRO . 2.1 t90 -68.91 114.76 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.915 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -156.14 41.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.027 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm 50.54 42.49 26.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.668 ' NH1' HD22 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.668 HD22 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.446 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.467 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 186' ' ' GLY . 28.9 t80 -143.1 159.31 42.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.415 ' N ' ' CD2' ' A' ' 185' ' ' PHE . . . -72.53 113.77 4.58 Favored Glycine 0 CA--C 1.54 1.603 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.33 167.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.854 1.703 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.96 -112.37 2.01 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 190' ' ' GLY . 58.6 m -44.01 137.49 3.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.634 0.254 . . . . 0.0 110.768 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -33.44 -85.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp -47.27 -35.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.687 ' CG ' ' H ' ' A' ' 207' ' ' SER . 31.6 t60 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.687 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.438 ' O ' ' OG1' ' A' ' 215' ' ' THR . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.531 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.531 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.44 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.515 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 60.1 mmm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 99' ' ' MET . 95.4 m-85 -159.35 120.01 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 54.68 7.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 100' ' ' PHE . 43.0 tt0 48.75 72.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.3 tpt -168.66 63.92 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.713 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.57 157.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.71 129.98 2.06 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.15 -72.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.14 178.56 5.28 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.73 2.287 . . . . 0.0 111.861 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.69 55.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 111' ' ' LYS . 1.4 t90 -57.27 104.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 110.155 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.676 ' C ' ' H ' ' A' ' 112' ' ' HIS . 55.9 mtp180 -65.28 61.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' TRP . 41.8 mtmt -55.62 14.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.676 ' H ' ' C ' ' A' ' 110' ' ' ARG . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.491 ' O ' ' NE ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.409 ' NE2' ' NH2' ' A' ' 135' ' ' ARG . 83.4 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 145' ' ' THR . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.631 ' H ' ' ND1' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -75.83 138.6 41.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.47 162.79 36.64 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.47 126.08 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.574 2.183 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.25 -93.86 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 192' ' ' GLY . 53.9 m -99.63 168.03 10.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.58 -89.45 0.01 OUTLIER Glycine 0 N--CA 1.471 1.005 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt -43.49 -27.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 189' ' ' SER . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.624 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 12.1 m170 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 261' ' ' LEU . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.443 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 60.29 12.58 3.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 102' ' ' GLU . 12.1 tpp180 -71.09 -21.44 62.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 101' ' ' ARG . 94.0 mt-10 -45.65 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.699 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.6 mmt 47.15 67.72 4.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.59 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.51 105.71 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.875 2.383 . . . . 0.0 112.028 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.37 143.99 6.2 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.43 175.67 43.01 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.67 -164.45 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.808 2.339 . . . . 0.0 111.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -176.23 126.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.543 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.32 124.36 44.36 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -143.52 51.11 1.36 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.612 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -99.43 145.82 27.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.6 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.63 ' HD1' ' N ' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.446 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.624 ' N ' HD21 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.62 ' H ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.3 131.39 44.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.88 -161.52 4.07 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.91 10.25 3.72 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.498 2.132 . . . . 0.0 112.191 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.68 146.71 8.98 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.3 m -78.89 143.91 35.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.14 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 96.45 93.76 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt 41.57 18.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 242' ' ' TYR . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 255' ' ' ILE . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 260' ' ' SER . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 262' ' ' TYR . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 259' ' ' GLN . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.561 ' C37' ' HE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.513 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 48.2 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.513 ' CG ' ' O ' ' A' ' 99' ' ' MET . 84.7 m-85 -160.13 57.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.395 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 103' ' ' MET . 74.0 mtp180 -79.49 26.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 100' ' ' PHE . 67.3 mm-40 -77.34 41.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.629 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 29.9 mtt -87.61 -27.42 0.35 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 103' ' ' MET . 66.6 Cg_endo -80.93 84.96 1.89 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.311 1.34 . . . . 0.0 112.008 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.56 25.43 0.02 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 170.97 60.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 35.61 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 106' ' ' GLY . 16.3 m -93.03 -155.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.51 ' CG ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -47.91 113.54 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.426 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 24.9 mmt180 -143.85 23.11 1.75 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.057 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm 54.72 29.97 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.271 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 110' ' ' ARG . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' O ' ' OG1' ' A' ' 145' ' ' THR . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 153' ' ' ASN . 0.7 OUTLIER -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD1' ' CG ' ' A' ' 109' ' ' TRP . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 46.7 p-80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.696 ' HE2' ' H ' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 186' ' ' GLY . 84.0 t80 -94.77 152.54 18.35 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -64.12 178.77 7.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 123.37 9.45 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.515 2.143 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -159.32 159.54 30.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.6 m -86.25 166.72 15.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -89.89 1.36 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt -128.18 1.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' GLY . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.696 ' H ' ' HE2' ' A' ' 183' ' ' HIS . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 207' ' ' SER . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 211' ' ' ASN . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.54 ' HG1' ' CY1' ' A' ' 1' ' ' DSV . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.401 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 225' ' ' GLY . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.492 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.577 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.577 ' H ' ' HG ' ' A' ' 251' ' ' SER . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 260' ' ' SER . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.482 ' N ' ' CG2' ' A' ' 258' ' ' ILE . 16.5 mm100 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.54 ' CY1' ' HG1' ' A' ' 215' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.508 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 22.8 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.533 ' H ' HH11 ' A' ' 101' ' ' ARG . 88.7 m-85 -160.48 32.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.533 HH11 ' H ' ' A' ' 100' ' ' PHE . 36.3 mmt-85 -79.26 7.92 6.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.862 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -150.75 179.66 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ttt 48.71 64.07 9.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.64 113.02 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.787 2.325 . . . . 0.0 112.154 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.55 50.12 2.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' VAL . . . -71.22 -168.96 9.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.69 50.96 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.174 2.583 . . . . 0.0 112.024 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 19.6 m -156.0 47.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.289 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' O ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -45.56 118.94 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.253 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.4 mtp-105 -137.44 51.87 1.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? -106.09 137.96 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 7.1 t30 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.472 ' N ' ' O22' ' A' ' 1' ' ' DSV . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.708 ' NE2' ' H ' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -64.04 140.41 58.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.64 -66.94 2.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 189' ' ' SER . 57.7 Cg_endo -70.21 93.53 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.657 2.238 . . . . 0.0 111.755 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -56.51 -2.8 0.51 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 187' ' ' PRO . 48.6 m -66.0 122.38 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 111.1 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 64.77 -169.04 26.75 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt -44.41 -15.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.708 ' H ' ' NE2' ' A' ' 183' ' ' HIS . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.462 ' ND1' ' HG ' ' A' ' 207' ' ' SER . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.462 ' HG ' ' ND1' ' A' ' 206' ' ' HIS . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.449 ' CG2' ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.47 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.548 ' HD1' ' C5 ' ' A' ' 1' ' ' DSV . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.411 ' O ' ' OG ' ' A' ' 223' ' ' SER . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.526 ' O ' ' CE3' ' A' ' 109' ' ' TRP . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.601 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 2.7 m170 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.601 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.548 ' C5 ' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.507 ' C ' ' H ' ' A' ' 102' ' ' GLU . 94.4 m-85 -73.25 155.88 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 53.48 6.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.155 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 100' ' ' PHE . 32.5 mm-40 47.19 54.18 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.665 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 71.3 mtp -100.8 -16.52 0.19 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 103' ' ' MET . 74.4 Cg_endo -80.32 176.2 9.47 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 CA-C-N 120.606 1.252 . . . . 0.0 112.012 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.58 62.46 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -50.81 175.3 0.07 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 140.61 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.863 2.376 . . . . 0.0 111.703 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -70.81 99.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -75.98 102.09 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.184 0.516 . . . . 0.0 110.419 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 112' ' ' HIS . 21.3 mmt180 -74.78 62.84 1.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.546 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -60.61 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.247 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 110' ' ' ARG . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 114' ' ' ILE . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 115' ' ' THR . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.719 ' HE ' HD22 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.447 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.719 HD22 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.451 ' OH ' ' NZ ' ' A' ' 136' ' ' LYS . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.405 ' C ' ' HG1' ' A' ' 154' ' ' THR . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 153' ' ' ASN . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.466 ' H ' ' HG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 58.4 t60 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 -149.99 144.56 25.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.5 162.96 51.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 140.97 31.44 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.663 2.242 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' SER . . . 177.79 -171.2 43.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 188' ' ' GLY . 48.0 m -40.64 169.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -27.87 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.467 0.746 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.26 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 21.4 tt -74.63 57.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.434 ' O ' ' OG1' ' A' ' 215' ' ' THR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.65 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.65 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.481 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 254' ' ' ASP . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.71 ' H ' ' HG ' ' A' ' 251' ' ' SER . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.471 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 100' ' ' PHE . 43.8 t80 -167.12 -9.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.81 40.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 100' ' ' PHE . 63.8 mm-40 -73.4 -31.34 63.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.488 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER 54.63 79.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.85 120.51 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.516 2.144 . . . . 0.0 112.113 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.02 104.28 0.26 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.25 56.98 0.06 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.79 87.98 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.625 2.216 . . . . 0.0 111.781 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 109' ' ' TRP . 15.4 m -75.26 -44.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.403 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.444 ' N ' ' CG2' ' A' ' 108' ' ' VAL . 3.3 t90 -57.92 102.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 112' ' ' HIS . 64.6 mtp180 -160.3 44.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp 59.61 -11.7 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.637 ' H ' ' C ' ' A' ' 110' ' ' ARG . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.42 ' C ' ' HG1' ' A' ' 145' ' ' THR . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.63 139.45 30.54 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.32 -77.21 1.2 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 189' ' ' SER . 81.4 Cg_exo -44.15 113.2 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.36 2.04 . . . . 0.0 112.17 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -63.74 67.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 187' ' ' PRO . 6.0 m -89.96 168.09 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -35.61 -48.37 0.94 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 193' ' ' GLY . 17.6 tt -107.42 -18.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.443 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CD2' ' C6 ' ' A' ' 1' ' ' DSV . 65.7 t60 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.562 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.562 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.422 ' H ' ' CG2' ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.498 ' C6 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.51 ' C ' ' H ' ' A' ' 101' ' ' ARG . 20.8 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 102' ' ' GLU . 17.7 m-85 -73.2 39.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.482 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.51 ' H ' ' C ' ' A' ' 99' ' ' MET . 13.9 mmm180 -68.65 46.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 100' ' ' PHE . 14.7 pt-20 -46.35 143.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.615 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 7.9 ttt -173.13 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.845 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.615 ' CD ' ' H ' ' A' ' 103' ' ' MET . 81.5 Cg_endo -92.88 38.33 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.343 2.028 . . . . 0.0 112.145 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.27 -126.26 0.77 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . 75.5 75.6 0.83 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' GLY . 54.4 Cg_exo -50.94 -167.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.856 2.371 . . . . 0.0 112.2 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -138.15 89.26 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.385 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -79.63 101.55 8.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -72.35 58.08 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm -57.44 99.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.467 ' HG1' ' CG ' ' A' ' 158' ' ' ASP . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.664 ' NE ' HD22 ' A' ' 119' ' ' ASN . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.664 HD22 ' NE ' ' A' ' 117' ' ' ARG . 10.9 m120 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.457 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' CG ' ' HG1' ' A' ' 115' ' ' THR . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.536 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 168' ' ' HIS . 5.5 p-80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 60.0 t60 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 -73.52 124.26 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 188' ' ' GLY . . . -84.98 -159.64 31.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.14 55.52 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.799 2.333 . . . . 0.0 111.885 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 186' ' ' GLY . . . -78.06 -154.58 7.19 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 192' ' ' GLY . 51.7 m -89.04 168.63 12.19 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.33 -57.36 0.71 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 8.0 tt -45.77 -43.01 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.628 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.42 ' O ' ' OE2' ' A' ' 219' ' ' GLU . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 215' ' ' THR . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.631 ' HE2' ' CD2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.631 ' CD2' ' HE2' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.486 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 260' ' ' SER . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 262' ' ' TYR . 16.5 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' DSV . . . . . 0.46 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.548 0.213 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 147' ' ' LEU . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.469 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.648 HG21 ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CE1' HG21 ' A' ' 118' ' ' ILE . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.602 HH22 ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.602 ' NZ ' HH22 ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 258' ' ' ILE . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 112' ' ' HIS . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 10.2 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 191' ' ' ILE . 20.8 tt . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 206' ' ' HIS . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 235' ' ' VAL . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.412 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 259' ' ' GLN . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 153' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 16.7 t-20 -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' H ' HG22 ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' VAL . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 145' ' ' THR . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.47 HG23 HG23 ' A' ' 144' ' ' VAL . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.416 ' N ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 30.5 t-80 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 215' ' ' THR . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.403 ' CB ' HG22 ' A' ' 245' ' ' ILE . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 211' ' ' ASN . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG1' HG21 ' A' ' 235' ' ' VAL . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.424 HG21 ' CG1' ' A' ' 217' ' ' VAL . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 241' ' ' LYS . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 213' ' ' PHE . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.649 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.649 ' H ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 144' ' ' VAL . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 159' ' ' ILE . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 14.3 p80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.456 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 205' ' ' THR . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 227' ' ' GLY . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 226' ' ' LEU . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.901 ' O ' HG22 ' A' ' 243' ' ' VAL . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 241' ' ' LYS . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 258' ' ' ILE . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 262' ' ' TYR . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.44 ' ND1' ' N ' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 158' ' ' ASP . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 115' ' ' THR . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.467 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.408 ' CB ' HG22 ' A' ' 245' ' ' ILE . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 235' ' ' VAL . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.475 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' TYR . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.624 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.624 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 2.0 m120 -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.576 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 145' ' ' THR . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.44 HG23 HG23 ' A' ' 144' ' ' VAL . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 112' ' ' HIS . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 152' ' ' ILE . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.539 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 191' ' ' ILE . 19.7 tt . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.405 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.413 ' O ' ' OG1' ' A' ' 215' ' ' THR . 1.9 m120 -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 226' ' ' LEU . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 225' ' ' GLY . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.483 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.406 HG22 ' OG1' ' A' ' 247' ' ' THR . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 245' ' ' ILE . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.406 ' OG1' HG22 ' A' ' 243' ' ' VAL . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 259' ' ' GLN . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.585 ' N ' HG23 ' A' ' 258' ' ' ILE . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.397 0.141 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.7 ' O ' HG22 ' A' ' 118' ' ' ILE . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 217' ' ' VAL . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.661 HD11 ' O ' ' A' ' 156' ' ' MET . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.487 HD11 ' SD ' ' A' ' 156' ' ' MET . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.541 ' CD2' ' N ' ' A' ' 168' ' ' HIS . 3.8 p80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ3' HG22 ' A' ' 210' ' ' THR . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 204' ' ' THR . 12.7 t60 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.443 ' HG ' ' HE2' ' A' ' 242' ' ' TYR . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.535 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.475 ' ND2' ' CD1' ' A' ' 242' ' ' TYR . 75.3 m-20 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.443 HD13 HD21 ' A' ' 211' ' ' ASN . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.434 ' HA ' ' HE1' ' A' ' 141' ' ' TRP . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.46 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.593 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 243' ' ' VAL . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 241' ' ' LYS . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 245' ' ' ILE . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 258' ' ' ILE . 76.8 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 153' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 3.4 m-80 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.42 HG23 HG23 ' A' ' 145' ' ' THR . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 144' ' ' VAL . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 159' ' ' ILE . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.577 ' HD1' ' CB ' ' A' ' 172' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.577 ' CB ' ' HD1' ' A' ' 168' ' ' HIS . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.437 HD23 ' OE2' ' A' ' 201' ' ' GLU . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 1.2 t-80 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.601 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 193' ' ' GLY . 8.9 tt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.363 0.125 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 235' ' ' VAL . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.592 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.592 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 229' ' ' SER . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.519 ' N ' HG23 ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.468 0.175 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 114' ' ' ILE . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.632 ' NE ' HD21 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.595 ' HB3' HG13 ' A' ' 162' ' ' VAL . 15.3 t-20 -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 130' ' ' VAL . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.446 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.44 ' C ' ' HG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 159' ' ' ILE . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 120' ' ' ASN . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 183' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 172' ' ' HIS . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.494 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.414 HD23 ' OE2' ' A' ' 201' ' ' GLU . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.622 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.435 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 214' ' ' LEU . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 235' ' ' VAL . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.653 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.413 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 207' ' ' SER . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 76.5 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 220' ' ' ILE . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 144' ' ' VAL . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 156' ' ' MET . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.447 ' CG ' ' N ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 13.6 p80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.509 HD13 ' CD1' ' A' ' 138' ' ' PHE . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 225' ' ' GLY . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 244' ' ' ASP . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.619 ' H ' HG22 ' A' ' 243' ' ' VAL . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.532 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD12 ' A' ' 114' ' ' ILE . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.694 ' NH1' HD21 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.694 HD21 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 t30 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 145' ' ' THR . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 210' ' ' THR . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 207' ' ' SER . 6.1 t-80 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.657 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 245' ' ' ILE . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 141' ' ' TRP . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.528 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 241' ' ' LYS . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.528 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 258' ' ' ILE . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 159' ' ' ILE . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.422 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.456 ' CG ' HG22 ' A' ' 245' ' ' ILE . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 1.1 m80 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.465 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 235' ' ' VAL . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.456 HG22 ' CG ' ' A' ' 213' ' ' PHE . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 145' ' ' THR . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.46 ' N ' HG23 ' A' ' 258' ' ' ILE . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 215' ' ' THR . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 211' ' ' ASN . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' A' ' 233' ' ' LYS . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.853 ' O ' HG22 ' A' ' 243' ' ' VAL . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 241' ' ' LYS . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 258' ' ' ILE . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 111' ' ' LYS . 21.0 mtmm . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.773 0.321 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 121' ' ' TYR . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 144' ' ' VAL . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 156' ' ' MET . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 115' ' ' THR . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 159' ' ' ILE . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.583 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 27.2 p80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.414 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.431 ' HB3' ' ND1' ' A' ' 222' ' ' HIS . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 84.0 t80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' CE1' ' A' ' 242' ' ' TYR . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.46 ' CG ' HG21 ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.431 ' ND1' ' HB3' ' A' ' 184' ' ' ALA . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.477 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.477 ' N ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CG ' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 259' ' ' GLN . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 258' ' ' ILE . 68.2 mm-40 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.468 ' C ' ' NE2' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 114' ' ' ILE . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 25.8 t-20 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 134' ' ' ILE . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 130' ' ' VAL . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.42 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 159' ' ' ILE . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 160' ' ' LEU . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 120' ' ' ASN . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.543 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.437 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.621 ' N ' HG22 ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.418 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.545 ' CG ' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.545 ' SD ' ' CG ' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 245' ' ' ILE . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.523 0.202 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.774 ' HE ' HD21 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.774 HD21 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.502 ' H ' HG22 ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 145' ' ' THR . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 159' ' ' ILE . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.579 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 191' ' ' ILE . 21.4 tt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 210' ' ' THR . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.431 ' ND2' ' CE1' ' A' ' 242' ' ' TYR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.444 ' CB ' HG22 ' A' ' 245' ' ' ILE . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.486 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 213' ' ' PHE . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 258' ' ' ILE . 52.5 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 261' ' ' LEU . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.391 0.138 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' ND2' HD21 ' A' ' 160' ' ' LEU . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 156' ' ' MET . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 154' ' ' THR . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.497 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 17.6 tt . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.711 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.711 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 235' ' ' VAL . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.596 HG23 ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.596 ' H ' HG23 ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 258' ' ' ILE . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.594 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 145' ' ' THR . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 144' ' ' VAL . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 156' ' ' MET . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.594 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 192' ' ' GLY . 8.0 tt . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.551 ' O ' HG23 ' A' ' 215' ' ' THR . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 211' ' ' ASN . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 217' ' ' VAL . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.675 ' HE2' ' CD2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.675 ' CD2' ' HE2' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.478 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 243' ' ' VAL . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.478 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 258' ' ' ILE . 71.2 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 39.8 mtm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.2 14.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.29 -24.47 66.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -49.32 132.76 20.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ttt -158.78 66.1 3.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.51 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.89 175.18 7.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.03 2.486 . . . . 0.0 112.22 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.04 128.69 1.78 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.73 -67.65 1.55 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 109' ' ' TRP . 56.8 Cg_endo -70.23 -179.88 3.45 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.733 2.289 . . . . 0.0 111.762 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 108' ' ' VAL . 5.0 t -54.37 82.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' PRO . 1.8 t90 -111.25 117.58 33.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.085 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 112' ' ' HIS . 69.3 mtm180 -158.37 33.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp 61.8 -10.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.297 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' A' ' 110' ' ' ARG . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.469 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.648 HG21 ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CE1' HG21 ' A' ' 118' ' ' ILE . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.602 HH22 ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.602 ' NZ ' HH22 ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 258' ' ' ILE . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 112' ' ' HIS . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 186' ' ' GLY . 10.2 t80 -93.15 159.91 15.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 185' ' ' PHE . . . -40.55 103.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.43 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.77 108.06 2.21 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.819 1.679 . . . . 0.0 112.457 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 162.96 -22.07 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 190' ' ' GLY . 5.6 m -94.25 156.96 16.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 189' ' ' SER . . . -38.95 -96.88 0.01 OUTLIER Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 191' ' ' ILE . 20.8 tt -81.84 54.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 206' ' ' HIS . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 235' ' ' VAL . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.412 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 259' ' ' GLN . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.403 ' H5 ' ' O ' ' A' ' 236' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.7 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -172.66 9.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -78.23 5.24 10.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -164.86 144.16 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.683 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.6 tpp -161.56 63.97 1.74 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.593 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.17 101.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.757 2.305 . . . . 0.0 112.204 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.34 13.38 0.06 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.4 168.97 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.64 129.78 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.745 2.297 . . . . 0.0 111.801 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' CZ ' ' A' ' 110' ' ' ARG . 85.4 t -150.7 -48.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.579 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.48 121.01 14.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 43.4 mtm-85 -138.26 49.33 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.685 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -100.99 136.45 40.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.454 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 153' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 16.7 t-20 -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' H ' HG22 ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' VAL . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 145' ' ' THR . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.47 HG23 HG23 ' A' ' 144' ' ' VAL . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.416 ' N ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 30.5 t-80 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -154.63 152.9 30.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -63.06 178.93 5.76 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 34.11 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.492 2.128 . . . . 0.0 111.609 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -49.16 127.34 20.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.7 m -59.22 140.9 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.616 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 79.87 -161.04 45.5 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt -51.5 -5.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 215' ' ' THR . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.403 ' CB ' HG22 ' A' ' 245' ' ' ILE . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 211' ' ' ASN . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG1' HG21 ' A' ' 235' ' ' VAL . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.512 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.424 HG21 ' CG1' ' A' ' 217' ' ' VAL . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 241' ' ' LYS . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 213' ' ' PHE . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.512 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -70.48 114.77 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -161.45 -16.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.582 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -160.46 -25.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.5 ttt 48.47 89.63 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.129 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.07 153.15 18.91 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.102 1.868 . . . . 0.0 112.341 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.91 -86.36 0.06 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.06 173.19 19.48 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.93 165.01 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.847 2.365 . . . . 0.0 111.834 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 109' ' ' TRP . 2.4 t -145.83 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.219 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -62.86 168.52 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.135 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 112' ' ' HIS . 4.4 mmm180 154.72 3.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.026 0.829 . . . . 0.0 111.021 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp 66.06 -42.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 110' ' ' ARG . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.649 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.649 ' H ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 144' ' ' VAL . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 159' ' ' ILE . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 57.0 p-80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 -132.06 153.42 50.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.3 159.05 38.63 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.56 153.83 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.557 2.171 . . . . 0.0 112.013 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.96 -125.98 3.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 192' ' ' GLY . 70.1 m -42.77 132.18 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.751 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.13 -78.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.047 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.68 -30.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.162 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.555 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.456 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 205' ' ' THR . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CD2' ' C5 ' ' A' ' 1' ' ' DSV . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 227' ' ' GLY . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 226' ' ' LEU . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.901 ' O ' HG22 ' A' ' 243' ' ' VAL . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 241' ' ' LYS . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 258' ' ' ILE . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 262' ' ' TYR . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 52.31 40.84 29.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -78.4 -1.13 32.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.537 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -166.42 158.92 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.592 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.0 ttt -168.75 64.19 0.57 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.459 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -42.77 169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.771 2.314 . . . . 0.0 112.242 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.18 -148.76 15.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.52 -175.74 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.09 99.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.738 2.292 . . . . 0.0 112.005 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.89 -173.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.531 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.7 117.97 7.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.301 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -132.41 49.32 2.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.324 0.583 . . . . 0.0 109.708 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -103.64 143.24 33.03 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.44 ' ND1' ' N ' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 158' ' ' ASP . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 115' ' ' THR . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' ' CE1' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -145.75 142.54 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -49.39 178.57 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.73 24.16 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.716 2.277 . . . . 0.0 111.888 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -60.05 146.34 45.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.7 m -77.85 167.25 21.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 72.02 -167.09 53.1 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt -44.07 -15.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.408 ' CB ' HG22 ' A' ' 245' ' ' ILE . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 235' ' ' VAL . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.516 ' ND1' ' C5 ' ' A' ' 1' ' ' DSV . 3.1 t-160 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 16.2 m170 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.475 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' TYR . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.516 ' C5 ' ' ND1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 54.38 35.27 22.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -62.39 -3.46 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -171.76 -0.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.5 ttp 54.32 69.19 2.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.18 92.51 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.499 2.133 . . . . 0.0 111.934 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.13 -123.6 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.41 -175.53 29.15 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.3 -179.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.75 2.3 . . . . 0.0 112.07 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 109' ' ' TRP . 7.6 p -172.26 -45.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.549 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.1 t90 -90.23 115.03 27.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -157.05 32.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp 51.82 34.94 14.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.085 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.402 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.624 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.624 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 2.0 m120 -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.576 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 145' ' ' THR . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.44 HG23 HG23 ' A' ' 144' ' ' VAL . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 112' ' ' HIS . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 152' ' ' ILE . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' OD1' HG22 ' A' ' 108' ' ' VAL . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.539 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 -107.62 126.37 52.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.18 -67.02 1.63 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.477 ' O ' ' CE2' ' A' ' 185' ' ' PHE . 40.2 Cg_endo -65.27 -154.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.701 2.267 . . . . 0.0 111.93 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.62 70.25 0.25 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' GLY . 49.5 m -93.15 167.98 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.74 -46.46 0.6 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 191' ' ' ILE . 19.7 tt -125.77 70.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.405 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.413 ' O ' ' OG1' ' A' ' 215' ' ' THR . 1.9 m120 -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.416 ' CE1' ' O40' ' A' ' 1' ' ' DSV . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 226' ' ' LEU . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 225' ' ' GLY . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.483 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.406 HG22 ' OG1' ' A' ' 247' ' ' THR . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 245' ' ' ILE . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.406 ' OG1' HG22 ' A' ' 243' ' ' VAL . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 259' ' ' GLN . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.585 ' N ' HG23 ' A' ' 258' ' ' ILE . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.456 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.454 ' H ' ' H ' ' A' ' 101' ' ' ARG . 41.0 p90 -174.99 3.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 100' ' ' PHE . 56.6 ttt85 -50.55 -23.62 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.31 -152.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.861 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 13.3 ptt? -163.17 -12.0 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.861 ' CD ' ' H ' ' A' ' 103' ' ' MET . 88.7 Cg_exo -44.29 106.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 122.057 1.77 . . . . 0.0 112.257 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.23 120.87 0.99 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -83.49 -169.4 44.91 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' GLY . 50.8 Cg_exo -52.56 -160.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.877 2.384 . . . . 0.0 112.028 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.28 36.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.338 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -46.76 114.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.225 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 112' ' ' HIS . 58.7 mtp85 -159.17 32.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER 59.76 -9.45 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.191 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.579 ' H ' ' C ' ' A' ' 110' ' ' ARG . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.7 ' O ' HG22 ' A' ' 118' ' ' ILE . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 217' ' ' VAL . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.661 HD11 ' O ' ' A' ' 156' ' ' MET . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.487 HD11 ' SD ' ' A' ' 156' ' ' MET . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.541 ' CD2' ' N ' ' A' ' 168' ' ' HIS . 3.8 p80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -110.72 130.42 55.58 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -74.17 -68.5 1.56 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 186' ' ' GLY . 15.4 Cg_endo -55.57 -152.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.718 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -156.92 70.43 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 54.5 m -100.39 166.58 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.437 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -38.96 -90.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.09 -29.66 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ3' HG22 ' A' ' 210' ' ' THR . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 204' ' ' THR . 12.7 t60 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.443 ' HG ' ' HE2' ' A' ' 242' ' ' TYR . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.535 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.475 ' ND2' ' CD1' ' A' ' 242' ' ' TYR . 75.3 m-20 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.443 HD13 HD21 ' A' ' 211' ' ' ASN . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.434 ' HA ' ' HE1' ' A' ' 141' ' ' TRP . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.593 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.447 ' H ' ' CZ2' ' A' ' 1' ' ' DSV . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 243' ' ' VAL . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 241' ' ' LYS . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 245' ' ' ILE . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 258' ' ' ILE . 76.8 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.517 ' C5 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -170.66 -30.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -79.72 19.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -166.67 -53.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.783 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 44.2 ttp 53.52 92.83 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.546 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.18 140.67 5.33 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.098 1.865 . . . . 0.0 112.199 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.04 -159.35 1.82 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 -67.01 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.57 98.53 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.668 2.245 . . . . 0.0 111.868 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.13 158.19 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' CZ2' ' O ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -79.34 101.83 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.281 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -149.05 56.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.52 134.17 41.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 153' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 3.4 m-80 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.42 HG23 HG23 ' A' ' 145' ' ' THR . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 144' ' ' VAL . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 159' ' ' ILE . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.577 ' HD1' ' CB ' ' A' ' 172' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.577 ' CB ' ' HD1' ' A' ' 168' ' ' HIS . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.437 HD23 ' OE2' ' A' ' 201' ' ' GLU . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 1.2 t-80 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.601 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -87.83 162.26 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.59 54.65 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 28.18 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.882 2.388 . . . . 0.0 112.085 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -42.16 148.22 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -60.01 136.13 57.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.11 0.91 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 193' ' ' GLY . 8.9 tt -71.24 -32.66 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.666 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 235' ' ' VAL . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.583 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.583 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.521 ' O ' ' CZ2' ' A' ' 109' ' ' TRP . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 229' ' ' SER . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.519 ' N ' HG23 ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.406 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 99' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' C ' ' N ' ' A' ' 102' ' ' GLU . 18.7 m-85 -58.33 -156.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.599 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.35 17.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.572 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 100' ' ' PHE . 6.4 tp10 -69.43 -22.09 63.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.51 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' PRO . 44.5 mtt 52.99 64.99 6.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 106' ' ' GLY . 79.7 Cg_exo -43.85 173.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.739 2.293 . . . . 0.0 112.2 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.26 -5.84 0.8 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . 83.21 174.63 50.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 109' ' ' TRP . 56.9 Cg_endo -69.65 101.23 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 108' ' ' VAL . 6.0 m -66.11 46.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.69 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' PRO . 2.1 t90 -60.02 115.26 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.614 ' C ' ' H ' ' A' ' 112' ' ' HIS . 40.7 mtp180 -159.07 35.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt 63.81 -28.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 110' ' ' ARG . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 114' ' ' ILE . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.632 ' NE ' HD21 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.595 ' HB3' HG13 ' A' ' 162' ' ' VAL . 15.3 t-20 -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 130' ' ' VAL . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.446 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.44 ' C ' ' HG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 159' ' ' ILE . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 120' ' ' ASN . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' NE2' ' A' ' 183' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 172' ' ' HIS . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.494 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.414 HD23 ' OE2' ' A' ' 201' ' ' GLU . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.615 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.567 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 -67.06 146.67 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -52.89 -179.68 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.58 34.93 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.577 2.185 . . . . 0.0 111.903 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -58.88 143.33 45.48 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 38.7 m -74.89 164.44 26.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 47.27 -131.0 14.47 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt -68.67 46.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 214' ' ' LEU . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.415 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 235' ' ' VAL . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.651 ' CE1' HN24 ' A' ' 1' ' ' DSV . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.584 ' ND1' ' SD ' ' A' ' 236' ' ' MET . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.413 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 207' ' ' SER . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 76.5 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.651 HN24 ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -173.35 13.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.548 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.22 -2.96 14.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.65 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -152.88 116.52 4.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.447 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.3 66.39 1.35 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.521 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.78 86.28 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.0 2.467 . . . . 0.0 112.083 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.69 35.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.3 71.93 0.15 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.23 138.4 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.714 2.276 . . . . 0.0 112.135 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.44 142.35 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.297 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.44 118.11 12.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -132.68 50.31 2.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -105.73 138.77 41.36 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 220' ' ' ILE . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 144' ' ' VAL . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 156' ' ' MET . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.447 ' CG ' ' N ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 13.9 p-80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.622 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -161.15 163.92 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -86.43 -164.28 39.46 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 186' ' ' GLY . 45.3 Cg_exo -55.42 -139.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.913 2.408 . . . . 0.0 112.255 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.38 118.83 3.21 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.8 m -46.27 119.55 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.56 -142.94 31.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt -54.89 140.11 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.509 HD13 ' CD1' ' A' ' 138' ' ' PHE . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 225' ' ' GLY . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 244' ' ' ASP . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.619 ' H ' HG22 ' A' ' 243' ' ' VAL . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.532 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 102' ' ' GLU . 34.9 m-85 -70.64 145.29 50.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.1 ptp180 34.24 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.484 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 100' ' ' PHE . 49.5 mt-10 56.2 171.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 57.4 mtt 54.32 67.37 3.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.689 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.77 38.46 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.971 2.447 . . . . 0.0 112.33 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.0 165.54 20.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -165.71 -168.69 28.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' TRP . 39.5 Cg_exo -55.61 -147.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.892 2.395 . . . . 0.0 112.257 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.8 m -37.89 -25.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' PRO . 2.1 t90 -68.91 114.76 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.915 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -156.14 41.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.027 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm 50.54 42.49 26.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD12 ' A' ' 114' ' ' ILE . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.694 ' NH1' HD21 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.694 HD21 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 t30 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 145' ' ' THR . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 186' ' ' GLY . 28.9 t80 -143.1 159.31 42.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.415 ' N ' ' CD2' ' A' ' 185' ' ' PHE . . . -72.53 113.77 4.58 Favored Glycine 0 CA--C 1.54 1.603 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.33 167.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.854 1.703 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.96 -112.37 2.01 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 190' ' ' GLY . 58.6 m -44.01 137.49 3.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.634 0.254 . . . . 0.0 110.768 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -33.44 -85.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp -47.27 -35.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 210' ' ' THR . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 207' ' ' SER . 6.1 t-80 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.657 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 245' ' ' ILE . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 141' ' ' TRP . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.528 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 241' ' ' LYS . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.528 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.515 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 60.1 mmm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 99' ' ' MET . 95.4 m-85 -159.35 120.01 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 54.68 7.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 100' ' ' PHE . 43.0 tt0 48.75 72.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.3 tpt -168.66 63.92 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.713 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.57 157.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.71 129.98 2.06 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.15 -72.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.14 178.56 5.28 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.73 2.287 . . . . 0.0 111.861 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.69 55.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 111' ' ' LYS . 1.4 t90 -57.27 104.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 110.155 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 112' ' ' HIS . 55.9 mtp180 -65.28 61.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' TRP . 41.8 mtmt -55.62 14.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.647 ' H ' ' C ' ' A' ' 110' ' ' ARG . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 258' ' ' ILE . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 159' ' ' ILE . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -75.83 138.6 41.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.47 162.79 36.64 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.47 126.08 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.574 2.183 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.25 -93.86 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 192' ' ' GLY . 53.9 m -99.63 168.03 10.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.58 -89.45 0.01 OUTLIER Glycine 0 N--CA 1.471 1.005 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt -43.49 -27.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 189' ' ' SER . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.422 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.456 ' CG ' HG22 ' A' ' 245' ' ' ILE . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 12.1 m170 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.465 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 235' ' ' VAL . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.456 HG22 ' CG ' ' A' ' 213' ' ' PHE . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 145' ' ' THR . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.46 ' N ' HG23 ' A' ' 258' ' ' ILE . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.443 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 60.29 12.58 3.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 102' ' ' GLU . 12.1 tpp180 -71.09 -21.44 62.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 101' ' ' ARG . 94.0 mt-10 -45.65 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.699 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.6 mmt 47.15 67.72 4.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.59 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.51 105.71 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.875 2.383 . . . . 0.0 112.028 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.37 143.99 6.2 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.43 175.67 43.01 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.67 -164.45 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.808 2.339 . . . . 0.0 111.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.6 p -176.23 126.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.543 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.32 124.36 44.36 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -143.52 51.11 1.36 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.612 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -99.43 145.82 27.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.6 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.3 131.39 44.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.88 -161.52 4.07 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.91 10.25 3.72 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.498 2.132 . . . . 0.0 112.191 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.68 146.71 8.98 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.3 m -78.89 143.91 35.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.14 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 96.45 93.76 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt 41.57 18.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 215' ' ' THR . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 211' ' ' ASN . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' A' ' 233' ' ' LYS . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.853 ' O ' HG22 ' A' ' 243' ' ' VAL . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 241' ' ' LYS . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 258' ' ' ILE . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.48 ' C37' ' NE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.513 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 48.2 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.513 ' CG ' ' O ' ' A' ' 99' ' ' MET . 84.7 m-85 -160.13 57.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.395 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' MET . 74.0 mtp180 -79.49 26.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -77.34 41.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.629 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 29.9 mtt -87.61 -27.42 0.35 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 103' ' ' MET . 66.6 Cg_endo -80.93 84.96 1.89 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.311 1.34 . . . . 0.0 112.008 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.56 25.43 0.02 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 170.97 60.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 35.61 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 106' ' ' GLY . 16.3 m -93.03 -155.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.51 ' CG ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -47.91 113.54 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.426 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 24.9 mmt180 -143.85 23.11 1.75 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.057 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 111' ' ' LYS . 21.0 mtmm 54.72 29.97 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 110' ' ' ARG . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 121' ' ' TYR . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 144' ' ' VAL . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 156' ' ' MET . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD1' ' CG ' ' A' ' 109' ' ' TRP . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 159' ' ' ILE . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 46.7 p-80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.431 ' HB3' ' ND1' ' A' ' 222' ' ' HIS . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 186' ' ' GLY . 84.0 t80 -94.77 152.54 18.35 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -64.12 178.77 7.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 123.37 9.45 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.515 2.143 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -159.32 159.54 30.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.6 m -86.25 166.72 15.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -89.89 1.36 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt -128.18 1.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' GLY . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' CE1' ' A' ' 242' ' ' TYR . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.46 ' CG ' HG21 ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.428 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.401 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.431 ' ND1' ' HB3' ' A' ' 184' ' ' ALA . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.477 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.477 ' N ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CG ' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 259' ' ' GLN . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 258' ' ' ILE . 68.2 mm-40 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.468 ' C ' ' NE2' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.546 HC2B ' O39' ' A' ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.508 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 22.8 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.583 ' H ' HH11 ' A' ' 101' ' ' ARG . 88.7 m-85 -160.48 32.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.583 HH11 ' H ' ' A' ' 100' ' ' PHE . 36.3 mmt-85 -79.26 7.92 6.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.862 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -150.75 179.66 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ttt 48.71 64.07 9.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.64 113.02 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.787 2.325 . . . . 0.0 112.154 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.55 50.12 2.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 108' ' ' VAL . . . -71.22 -168.96 9.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.4 Cg_exo -61.69 50.96 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.174 2.583 . . . . 0.0 112.024 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 106' ' ' GLY . 19.6 m -156.0 47.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.289 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' O ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -45.56 118.94 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.253 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.4 mtp-105 -137.44 51.87 1.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? -106.09 137.96 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 114' ' ' ILE . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 25.8 t-20 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 134' ' ' ILE . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 130' ' ' VAL . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.42 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 159' ' ' ILE . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 160' ' ' LEU . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 120' ' ' ASN . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.543 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.472 ' N ' ' O22' ' A' ' 1' ' ' DSV . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.437 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -64.04 140.41 58.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.64 -66.94 2.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 189' ' ' SER . 57.7 Cg_endo -70.21 93.53 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.657 2.238 . . . . 0.0 111.755 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -56.51 -2.8 0.51 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 187' ' ' PRO . 48.6 m -66.0 122.38 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 111.1 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 64.77 -169.04 26.75 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt -44.41 -15.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.621 ' N ' HG22 ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.423 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.573 ' HD1' ' C5 ' ' A' ' 1' ' ' DSV . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.526 ' O ' ' CE3' ' A' ' 109' ' ' TRP . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.601 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 2.7 m170 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.601 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 245' ' ' ILE . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.573 ' C5 ' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' GLU . 94.4 m-85 -73.25 155.88 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 53.48 6.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.155 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' PHE . 32.5 mm-40 47.19 54.18 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.665 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 71.3 mtp -100.8 -16.52 0.19 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 103' ' ' MET . 74.4 Cg_endo -80.32 176.2 9.47 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 CA-C-N 120.606 1.252 . . . . 0.0 112.012 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.58 62.46 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -50.81 175.3 0.07 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 140.61 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.863 2.376 . . . . 0.0 111.703 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -70.81 99.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -75.98 102.09 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.184 0.516 . . . . 0.0 110.419 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 112' ' ' HIS . 21.3 mmt180 -74.78 62.84 1.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.546 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -60.61 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.247 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.611 ' N ' ' O ' ' A' ' 110' ' ' ARG . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.774 ' HE ' HD21 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.774 HD21 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' H ' HG22 ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 145' ' ' THR . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 159' ' ' ILE . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.579 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 -149.99 144.56 25.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.5 162.96 51.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 140.97 31.44 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.663 2.242 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' SER . . . 177.79 -171.2 43.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 188' ' ' GLY . 48.0 m -40.64 169.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -27.87 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.467 0.746 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.26 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 191' ' ' ILE . 21.4 tt -74.63 57.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 210' ' ' THR . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.431 ' ND2' ' CE1' ' A' ' 242' ' ' TYR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.444 ' CB ' HG22 ' A' ' 245' ' ' ILE . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.486 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 213' ' ' PHE . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 258' ' ' ILE . 52.5 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 261' ' ' LEU . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.471 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 100' ' ' PHE . 43.8 t80 -167.12 -9.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.81 40.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -73.4 -31.34 63.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.608 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.488 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER 54.63 79.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.85 120.51 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.516 2.144 . . . . 0.0 112.113 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.02 104.28 0.26 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.25 56.98 0.06 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.79 87.98 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.625 2.216 . . . . 0.0 111.781 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 109' ' ' TRP . 15.4 m -75.26 -44.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.403 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.542 ' N ' HG23 ' A' ' 108' ' ' VAL . 3.3 t90 -57.92 102.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' C ' ' H ' ' A' ' 112' ' ' HIS . 64.6 mtp180 -160.3 44.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp 59.61 -11.7 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.63 ' H ' ' C ' ' A' ' 110' ' ' ARG . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' ND2' HD21 ' A' ' 160' ' ' LEU . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 156' ' ' MET . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 154' ' ' THR . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.497 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.63 139.45 30.54 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.32 -77.21 1.2 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 189' ' ' SER . 81.4 Cg_exo -44.15 113.2 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.36 2.04 . . . . 0.0 112.17 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -63.74 67.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 187' ' ' PRO . 6.0 m -89.96 168.09 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -35.61 -48.37 0.94 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 17.6 tt -107.42 -18.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.598 ' CE1' ' H6 ' ' A' ' 1' ' ' DSV . 19.5 t-80 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.579 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 235' ' ' VAL . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.596 HG23 ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.596 ' H ' HG23 ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 258' ' ' ILE . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.598 ' H6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 101' ' ' ARG . 20.8 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 102' ' ' GLU . 17.7 m-85 -73.2 39.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.482 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 99' ' ' MET . 13.9 mmm180 -68.65 46.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 100' ' ' PHE . 14.7 pt-20 -46.35 143.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.687 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 7.9 ttt -173.13 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.845 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.687 ' CD ' ' H ' ' A' ' 103' ' ' MET . 81.5 Cg_endo -92.88 38.33 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.343 2.028 . . . . 0.0 112.145 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.27 -126.26 0.77 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . 75.5 75.6 0.83 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' GLY . 54.4 Cg_exo -50.94 -167.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.856 2.371 . . . . 0.0 112.2 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -138.15 89.26 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.385 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -79.63 101.55 8.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -72.35 58.08 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm -57.44 99.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.594 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 145' ' ' THR . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 144' ' ' VAL . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 156' ' ' MET . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.594 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 168' ' ' HIS . 5.5 p-80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.485 ' O ' HC1A ' A' ' 1' ' ' DSV . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 -73.52 124.26 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 188' ' ' GLY . . . -84.98 -159.64 31.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.14 55.52 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.799 2.333 . . . . 0.0 111.885 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 186' ' ' GLY . . . -78.06 -154.58 7.19 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 192' ' ' GLY . 51.7 m -89.04 168.63 12.19 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.33 -57.36 0.71 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 192' ' ' GLY . 8.0 tt -45.77 -43.01 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.551 ' O ' HG23 ' A' ' 215' ' ' THR . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 211' ' ' ASN . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 217' ' ' VAL . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.547 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.547 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 243' ' ' VAL . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.478 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 258' ' ' ILE . 71.2 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' DSV . . . . . 0.581 HC2B ' O40' ' A' ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.548 0.213 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 147' ' ' LEU . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.469 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.648 HG21 ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 121' ' ' TYR . 2.8 t30 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CE1' HG21 ' A' ' 118' ' ' ILE . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.602 HH22 ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.602 ' NZ ' HH22 ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 258' ' ' ILE . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 112' ' ' HIS . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 10.2 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 191' ' ' ILE . 20.8 tt . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 206' ' ' HIS . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 235' ' ' VAL . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.412 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 259' ' ' GLN . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.795 ' HE ' HD21 ' A' ' 119' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.795 HD21 ' HE ' ' A' ' 117' ' ' ARG . 18.9 m120 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' H ' HG22 ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' VAL . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 145' ' ' THR . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.47 HG23 HG23 ' A' ' 144' ' ' VAL . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.416 ' N ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 73.2 t60 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 215' ' ' THR . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.403 ' CB ' HG22 ' A' ' 245' ' ' ILE . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 211' ' ' ASN . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG1' HG21 ' A' ' 235' ' ' VAL . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.424 HG21 ' CG1' ' A' ' 217' ' ' VAL . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 241' ' ' LYS . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 213' ' ' PHE . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.649 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.649 ' H ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 144' ' ' VAL . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 159' ' ' ILE . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 57.0 p-80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.555 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.456 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 205' ' ' THR . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 227' ' ' GLY . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 226' ' ' LEU . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.901 ' O ' HG22 ' A' ' 243' ' ' VAL . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 241' ' ' LYS . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 258' ' ' ILE . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 262' ' ' TYR . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.44 ' ND1' ' N ' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 158' ' ' ASP . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 115' ' ' THR . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.467 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.408 ' CB ' HG22 ' A' ' 245' ' ' ILE . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 235' ' ' VAL . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 16.2 m170 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.475 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' TYR . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.688 ' H ' HD22 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.576 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 145' ' ' THR . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.44 HG23 HG23 ' A' ' 144' ' ' VAL . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 112' ' ' HIS . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 152' ' ' ILE . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.539 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 191' ' ' ILE . 19.7 tt . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.405 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 226' ' ' LEU . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 225' ' ' GLY . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.483 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.406 HG22 ' OG1' ' A' ' 247' ' ' THR . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 245' ' ' ILE . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.406 ' OG1' HG22 ' A' ' 243' ' ' VAL . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 259' ' ' GLN . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.585 ' N ' HG23 ' A' ' 258' ' ' ILE . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.397 0.141 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.514 ' ND2' HD21 ' A' ' 160' ' ' LEU . 7.2 m-80 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.7 ' O ' HG22 ' A' ' 118' ' ' ILE . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 217' ' ' VAL . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.661 HD11 ' O ' ' A' ' 156' ' ' MET . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.514 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ3' HG22 ' A' ' 210' ' ' THR . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CD2' ' H ' ' A' ' 207' ' ' SER . 11.5 t-160 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.622 ' H ' ' CD2' ' A' ' 206' ' ' HIS . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.535 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.434 ' HA ' ' HE1' ' A' ' 141' ' ' TRP . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.46 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.593 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 243' ' ' VAL . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 241' ' ' LYS . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 245' ' ' ILE . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 258' ' ' ILE . 18.5 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HE ' ' ND2' ' A' ' 119' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.68 ' ND2' ' HE ' ' A' ' 117' ' ' ARG . 5.3 m120 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.42 HG23 HG23 ' A' ' 145' ' ' THR . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 144' ' ' VAL . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 159' ' ' ILE . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.577 ' HD1' ' CB ' ' A' ' 172' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.577 ' CB ' ' HD1' ' A' ' 168' ' ' HIS . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.437 HD23 ' OE2' ' A' ' 201' ' ' GLU . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 184' ' ' ALA . 2.4 t60 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 193' ' ' GLY . 8.9 tt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.363 0.125 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 235' ' ' VAL . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.592 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.592 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 225' ' ' GLY . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 229' ' ' SER . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.519 ' N ' HG23 ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.468 0.175 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 114' ' ' ILE . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.632 ' NE ' HD21 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.595 ' HB3' HG13 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 130' ' ' VAL . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.446 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.44 ' C ' ' HG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 159' ' ' ILE . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 120' ' ' ASN . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 183' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 172' ' ' HIS . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.494 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.414 HD23 ' OE2' ' A' ' 201' ' ' GLU . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.622 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.435 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 214' ' ' LEU . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 235' ' ' VAL . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.653 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.413 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 207' ' ' SER . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.693 ' NH1' HE22 ' A' ' 259' ' ' GLN . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.693 HE22 ' NH1' ' A' ' 256' ' ' ARG . 18.8 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 220' ' ' ILE . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 144' ' ' VAL . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 156' ' ' MET . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.447 ' CG ' ' N ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 13.9 p-80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.622 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.509 HD13 ' CD1' ' A' ' 138' ' ' PHE . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 225' ' ' GLY . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 244' ' ' ASP . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.619 ' H ' HG22 ' A' ' 243' ' ' VAL . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.532 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD12 ' A' ' 114' ' ' ILE . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.694 ' NH1' HD21 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.694 HD21 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 145' ' ' THR . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 210' ' ' THR . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 207' ' ' SER . 31.6 t60 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.657 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 245' ' ' ILE . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 141' ' ' TRP . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.528 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 241' ' ' LYS . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.528 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.409 ' NE2' ' NH2' ' A' ' 135' ' ' ARG . 83.4 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 258' ' ' ILE . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 159' ' ' ILE . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.422 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.456 ' CG ' HG22 ' A' ' 245' ' ' ILE . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 12.1 m170 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.465 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 235' ' ' VAL . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.456 HG22 ' CG ' ' A' ' 213' ' ' PHE . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 145' ' ' THR . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.46 ' N ' HG23 ' A' ' 258' ' ' ILE . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 215' ' ' THR . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 211' ' ' ASN . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' A' ' 233' ' ' LYS . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.853 ' O ' HG22 ' A' ' 243' ' ' VAL . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 241' ' ' LYS . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 258' ' ' ILE . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 111' ' ' LYS . 21.0 mtmm . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.773 0.321 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 121' ' ' TYR . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 144' ' ' VAL . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 156' ' ' MET . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.624 ' N ' HD22 ' A' ' 153' ' ' ASN . 0.7 OUTLIER -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 115' ' ' THR . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 159' ' ' ILE . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 46.7 p-80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.414 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.431 ' HB3' ' ND1' ' A' ' 222' ' ' HIS . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 84.0 t80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' CE1' ' A' ' 242' ' ' TYR . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.46 ' CG ' HG21 ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.431 ' ND1' ' HB3' ' A' ' 184' ' ' ALA . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.477 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.477 ' N ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CG ' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 259' ' ' GLN . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 258' ' ' ILE . 16.5 mm100 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 114' ' ' ILE . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 7.1 t30 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 134' ' ' ILE . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 130' ' ' VAL . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.42 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 159' ' ' ILE . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 160' ' ' LEU . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 120' ' ' ASN . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.437 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.621 ' N ' HG22 ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.418 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.601 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 2.7 m170 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.601 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 245' ' ' ILE . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.523 0.202 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.774 ' HE ' HD21 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.774 HD21 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.502 ' H ' HG22 ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 145' ' ' THR . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 159' ' ' ILE . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.579 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 58.4 t60 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 191' ' ' ILE . 21.4 tt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 210' ' ' THR . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.431 ' ND2' ' CE1' ' A' ' 242' ' ' TYR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.444 ' CB ' HG22 ' A' ' 245' ' ' ILE . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.486 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 213' ' ' PHE . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 258' ' ' ILE . 14.2 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 261' ' ' LEU . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.391 0.138 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' ND2' HD21 ' A' ' 160' ' ' LEU . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 156' ' ' MET . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 154' ' ' THR . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.497 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 17.6 tt . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.711 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.711 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 235' ' ' VAL . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.596 HG23 ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.596 ' H ' HG23 ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 258' ' ' ILE . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.688 ' NE ' HD21 ' A' ' 119' ' ' ASN . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.688 HD21 ' NE ' ' A' ' 117' ' ' ARG . 10.9 m120 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.594 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 145' ' ' THR . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 144' ' ' VAL . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 156' ' ' MET . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.594 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 168' ' ' HIS . 5.5 p-80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 60.0 t60 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 192' ' ' GLY . 8.0 tt . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.551 ' O ' HG23 ' A' ' 215' ' ' THR . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 211' ' ' ASN . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 217' ' ' VAL . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.594 ' NE2' ' NE2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.594 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.478 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 243' ' ' VAL . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.478 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 258' ' ' ILE . 16.5 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 39.8 mtm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.2 14.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.542 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.29 -24.47 66.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -49.32 132.76 20.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ttt -158.78 66.1 3.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.51 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.89 175.18 7.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.03 2.486 . . . . 0.0 112.22 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.04 128.69 1.78 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.73 -67.65 1.55 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 109' ' ' TRP . 56.8 Cg_endo -70.23 -179.88 3.45 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.733 2.289 . . . . 0.0 111.762 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 108' ' ' VAL . 5.0 t -54.37 82.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' PRO . 1.8 t90 -111.25 117.58 33.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.085 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 112' ' ' HIS . 69.3 mtm180 -158.37 33.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 mttp 61.8 -10.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.297 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' A' ' 110' ' ' ARG . 29.2 m-70 -93.09 -54.22 3.81 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.664 0.269 . . . . 0.0 111.611 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.38 128.57 56.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.6 mt -121.51 125.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.469 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 9.9 p -96.5 143.71 27.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.792 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.527 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 9.7 p90 -127.07 134.98 50.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' NH1' ' ND2' ' A' ' 119' ' ' ASN . 50.6 ttt-85 -131.76 135.65 46.96 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.56 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.648 HG21 ' CE1' ' A' ' 121' ' ' TYR . 53.4 mt -110.21 95.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.179 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' NH1' ' A' ' 117' ' ' ARG . 1.2 m120 -83.98 8.46 15.12 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.203 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 121' ' ' TYR . 2.8 t30 -172.91 160.61 4.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CE1' HG21 ' A' ' 118' ' ' ILE . 43.7 m-85 -133.3 -119.51 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.93 126.36 0.98 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 98.6 Cg_endo -76.89 91.45 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.507 . . . . 0.0 111.727 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 5.4 m-20 -168.83 -22.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.276 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.9 mtm -149.95 167.21 27.33 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -50.72 112.62 0.73 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.99 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 83.8 mtt180 -62.19 -29.7 70.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.47 -34.53 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.172 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.38 -16.67 63.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.76 -32.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.757 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -83.95 -46.33 12.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.696 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -53.16 -57.52 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.08 -26.61 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.248 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mm -76.15 -29.36 19.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.602 HH22 ' NZ ' ' A' ' 136' ' ' LYS . 53.6 ttp85 -78.02 -33.83 50.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.542 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.602 ' NZ ' HH22 ' A' ' 135' ' ' ARG . 22.5 mmtm -81.03 -15.72 55.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.398 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.95 -47.98 11.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 14.1 m-85 -62.69 -19.48 63.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -74.49 -38.27 62.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.368 . . . . 0.0 110.604 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.5 t -50.85 -29.48 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.511 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -83.41 -45.66 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -62.65 -30.44 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.369 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -57.55 -37.87 73.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.946 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -111.69 20.26 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.553 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 258' ' ' ILE . 78.3 p -149.59 135.52 10.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.304 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.6 33.54 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.476 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 112' ' ' HIS . 74.9 mt -95.82 -165.64 1.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.053 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -158.26 101.82 1.74 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.066 0.46 . . . . 0.0 111.012 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.61 121.11 41.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.999 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.2 p -133.65 156.01 48.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.86 0.362 . . . . 0.0 110.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -110.41 129.44 55.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.065 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -86.56 137.84 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -57.74 -38.78 75.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.52 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.2 t -152.98 150.59 29.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.489 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.29 -152.19 16.86 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.8 mmt -110.46 132.89 53.79 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.065 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.55 157.19 21.47 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 115' ' ' THR . 25.6 m-20 -46.56 -41.82 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.3 tt -139.92 135.07 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.047 0.451 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 132.4 47.98 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.53 131.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.061 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.01 132.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 5.8 m-85 -103.79 149.34 25.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 109.925 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.56 175.01 9.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.457 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 9.0 ptp180 -138.21 150.48 46.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.402 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.53 -73.2 2.27 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -162.21 169.04 21.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CE1' ' CZ ' ' A' ' 174' ' ' PHE . 6.3 p-80 -160.84 51.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.788 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.34 -75.8 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 168' ' ' HIS . 2.7 m-20 -45.38 158.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.549 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 183' ' ' HIS . 57.0 m-85 54.49 165.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 14.9 p80 -74.96 26.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.46 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 171' ' ' PHE . . . 66.55 141.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.611 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.3 m-85 -64.89 147.09 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.8 -24.51 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.433 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 131.65 -157.8 22.53 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -73.48 124.8 26.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.71 -171.09 13.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.69 -107.44 0.92 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.8 mt -84.55 151.3 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.93 -18.17 11.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.36 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.254 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 171' ' ' PHE . 8.1 p80 -143.27 160.23 40.87 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.45 119.72 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.639 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 186' ' ' GLY . 10.2 t80 -93.15 159.91 15.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 185' ' ' PHE . . . -40.55 103.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.43 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.77 108.06 2.21 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.819 1.679 . . . . 0.0 112.457 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 162.96 -22.07 0.18 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 190' ' ' GLY . 5.6 m -94.25 156.96 16.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 189' ' ' SER . . . -38.95 -96.88 0.01 OUTLIER Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 191' ' ' ILE . 20.8 tt -81.84 54.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.663 0.744 . . . . 0.0 110.189 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.9 -46.89 0.21 Allowed Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -69.35 -29.98 71.61 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.52 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 7.9 m-20 -60.38 54.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.891 0.377 . . . . 0.0 110.919 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.46 178.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.513 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 0.2 OUTLIER -147.99 145.79 28.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.359 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -95.15 147.24 23.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.9 OUTLIER -88.65 109.43 20.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.2 tt0 -93.84 -6.56 45.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -44.49 -17.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.089 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 199' ' ' GLU . 26.1 mp0 -94.81 176.62 6.2 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.71 114.11 25.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.326 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 210' ' ' THR . 93.7 m95 -100.15 160.31 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 206' ' ' HIS . 5.5 m -160.29 116.91 2.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.0 p -54.72 -22.58 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.89 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 207' ' ' SER . 54.7 t-80 -79.65 1.64 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.2 m 84.88 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.605 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.26 -85.31 0.32 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.9 -117.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.498 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 87.6 m -102.35 108.54 19.93 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 211' ' ' ASN . 0.8 OUTLIER -67.04 123.5 20.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.358 0.599 . . . . 0.0 111.585 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.62 -24.26 39.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.604 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -70.72 -61.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.149 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.9 mp -51.95 -38.15 55.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.0 m -68.59 -34.31 75.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.779 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.61 9.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.86 -33.02 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.558 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.76 -50.06 59.17 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.773 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -55.97 -48.01 76.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.584 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.41 -29.05 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.931 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.23 -45.6 52.05 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 222' ' ' HIS . 3.5 m170 -68.16 -33.06 73.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.406 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.9 t -52.95 -48.42 67.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.98 39.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 35.47 41.68 0.38 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 tp -89.31 101.2 13.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.939 0.4 . . . . 0.0 111.591 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -50.74 -179.02 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.98 150.34 22.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.011 0.406 . . . . 0.0 109.958 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 230' ' ' SER . 47.2 t -97.57 -170.75 2.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' A' ' 229' ' ' SER . 20.4 t -80.58 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 232' ' ' PRO . 29.1 t70 -175.49 55.36 0.14 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.399 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 42.5 Cg_endo -86.52 43.93 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.652 2.235 . . . . 0.0 112.6 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 39.24 45.78 1.19 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -87.72 153.09 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.597 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 235' ' ' VAL . 2.1 p -48.76 -10.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.547 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ALA . 11.0 tmm? -67.34 -52.97 33.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.42 ' N ' ' SD ' ' A' ' 236' ' ' MET . 30.9 t80 -39.41 141.48 0.68 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.24 113.18 1.33 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.435 1.424 . . . . 0.0 112.175 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.0 p 50.18 52.68 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.57 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.8 p90 -45.3 -48.12 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.0 110.245 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.59 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 20.1 tptt -142.15 71.46 1.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.989 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -51.84 111.39 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.69 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.6 m -157.69 164.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.968 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 245' ' ' ILE . 22.7 t70 -52.89 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.049 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.412 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 12.3 pt -83.3 -32.52 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -82.22 -13.03 57.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.434 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 p -99.56 -1.81 37.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.501 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 48.1 t80 -54.66 127.73 29.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.944 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.79 137.28 21.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 48.4 mt -85.71 165.72 16.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.023 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.8 m -107.22 168.77 8.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.33 63.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.05 -41.0 44.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.769 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -68.31 -23.85 64.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.8 -22.59 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.694 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -78.32 -10.86 59.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.494 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.88 -50.46 3.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 259' ' ' GLN . 6.6 tt -69.69 -44.95 78.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 258' ' ' ILE . 10.5 mm100 -42.88 -20.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.731 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.6 p -50.48 -13.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.631 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 259' ' ' GLN . 13.9 mt -92.34 -16.73 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.106 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 259' ' ' GLN . 13.6 t80 74.31 18.89 2.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.759 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.984 -1.454 . . . . 0.0 110.965 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.403 ' H5 ' ' O ' ' A' ' 236' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.7 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -172.66 9.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -78.23 5.24 10.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -164.86 144.16 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.683 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.6 tpp -161.56 63.97 1.74 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.593 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.17 101.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.757 2.305 . . . . 0.0 112.204 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.34 13.38 0.06 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.4 168.97 0.03 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.64 129.78 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.745 2.297 . . . . 0.0 111.801 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' CZ ' ' A' ' 110' ' ' ARG . 85.4 t -150.7 -48.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.579 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.48 121.01 14.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' CZ ' ' O ' ' A' ' 108' ' ' VAL . 43.4 mtm-85 -138.26 49.33 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.685 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -100.99 136.45 40.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.454 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -78.48 -51.39 10.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.462 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.467 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 47.3 p90 -113.04 130.08 56.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -121.24 126.98 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 4.4 p -99.02 144.13 28.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 0.0 110.736 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 15.8 p90 -127.01 136.26 51.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.795 ' HE ' HD21 ' A' ' 119' ' ' ASN . 39.0 ttt85 -136.05 137.65 41.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.123 0.487 . . . . 0.0 110.656 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.2 mt -110.79 98.95 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.149 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.795 HD21 ' HE ' ' A' ' 117' ' ' ARG . 18.9 m120 -97.9 7.66 46.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.575 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -125.69 -19.07 5.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' H ' HG22 ' A' ' 118' ' ' ILE . 92.2 m-85 35.61 -151.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.658 0.265 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.5 115.7 0.32 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.98 -0.87 11.13 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.695 1.597 . . . . 0.0 112.418 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -24.13 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.403 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.2 mmm -140.91 160.56 39.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -51.32 108.27 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.8 mtt85 -53.36 -24.22 11.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.64 -44.42 28.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.8 m-20 -66.68 -15.71 63.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 83.7 t -86.22 -36.13 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.931 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.2 -41.87 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.983 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.28 -59.66 4.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.318 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -26.68 62.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.209 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' VAL . 57.2 mt -77.03 -29.07 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -76.93 -34.13 57.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.437 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -79.1 -15.55 58.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.2 -47.92 13.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.68 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -58.27 -21.4 48.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.12 -38.19 61.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -53.38 -37.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.267 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -80.87 -50.44 9.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.383 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -29.23 69.58 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.142 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -57.08 -39.08 74.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 145' ' ' THR . 5.2 m -114.65 20.08 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.012 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.47 HG23 HG23 ' A' ' 144' ' ' VAL . 60.5 p -147.48 139.46 13.95 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.55 31.52 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.339 2.026 . . . . 0.0 113.434 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 36.6 mt -95.53 -169.76 2.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -158.36 103.33 1.79 Allowed 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.063 0.459 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.36 120.88 41.23 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.282 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -135.78 156.42 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.75 0.309 . . . . 0.0 110.838 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -109.97 127.31 54.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.423 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.2 pt -84.64 137.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.07 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.491 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.0 m-20 -51.6 -43.86 62.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.68 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -154.58 152.19 29.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.646 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.1 -155.96 18.12 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 10.5 tpt -102.0 129.89 48.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.38 153.1 24.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.45 -43.45 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.355 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.8 tt -135.62 123.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.364 0.602 . . . . 0.0 110.539 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.68 127.8 35.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.691 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.38 133.08 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.685 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.22 123.23 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -100.73 142.69 31.85 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 110.417 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.92 177.35 6.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -135.29 144.57 46.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.328 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.86 -68.33 3.05 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.32 -179.96 6.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 174' ' ' PHE . 46.9 p-80 -171.6 175.42 4.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.688 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.84 -133.43 3.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -142.78 158.02 44.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 43.4 t80 46.11 26.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 3.8 t60 -158.06 157.52 33.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.581 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.416 ' N ' ' ND1' ' A' ' 172' ' ' HIS . . . -174.61 141.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.628 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.615 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 26.9 m-85 -63.83 148.66 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.419 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -70.54 -19.81 62.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.659 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.69 -155.51 16.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -83.11 127.16 33.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.65 16.26 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.48 -94.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.81 151.05 4.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 0.0 110.817 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.29 -18.94 9.79 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.3 146.99 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 73.2 t60 -105.81 170.66 7.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.182 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.611 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -169.9 159.52 7.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -154.63 152.9 30.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.45 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -63.06 178.93 5.76 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 34.11 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.492 2.128 . . . . 0.0 111.609 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -49.16 127.34 20.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.7 m -59.22 140.9 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.616 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 79.87 -161.04 45.5 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.0 tt -51.5 -5.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.62 0.248 . . . . 0.0 111.341 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -56.49 -62.23 6.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -63.96 -52.69 42.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 3.6 m-20 -19.32 83.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 O-C-N 124.144 0.555 . . . . 0.0 111.412 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -41.41 120.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.6 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 11.3 m80 -107.53 119.09 38.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -93.44 137.62 32.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.038 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.3 127.16 46.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 12.8 tt0 -107.9 6.64 27.5 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.079 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -42.5 -17.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 39.2 mp0 -100.37 -176.77 3.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -108.5 120.99 44.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.835 0.35 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 87.1 m95 -91.54 156.1 17.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.005 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.5 m -160.18 109.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.459 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.7 p -72.88 55.34 0.39 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.756 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 207' ' ' SER . 66.3 t60 -150.29 -5.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.298 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER 87.16 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.13 -93.66 0.1 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.96 -112.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 m -87.11 147.84 25.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.365 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 215' ' ' THR . 5.9 m120 -101.92 110.71 22.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.929 0.395 . . . . 0.0 110.002 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.97 -34.48 69.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.403 ' CB ' HG22 ' A' ' 245' ' ' ILE . 25.0 t80 -67.62 -58.23 5.04 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.556 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.12 -36.11 67.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.202 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 211' ' ' ASN . 31.1 p -73.61 -34.43 65.05 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.108 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.07 -37.5 64.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG1' HG21 ' A' ' 235' ' ' VAL . 94.4 t -66.61 -34.24 68.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.999 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.512 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 22.9 t-80 -69.8 -57.15 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.134 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -44.02 -54.99 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.4 -33.68 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -48.81 -49.84 27.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 77.1 m-70 -62.77 -34.77 77.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.355 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.2 t -55.81 -42.85 76.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.213 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.1 mt -79.24 36.61 0.3 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.31 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 39.35 27.1 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 224' ' ' LEU . 3.3 tp -79.01 97.15 5.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.011 0.434 . . . . 0.0 111.157 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -70.07 148.09 45.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 5.8 m-70 -72.2 160.74 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.777 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -117.01 -145.14 0.38 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -79.42 -64.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 171.43 59.75 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.724 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -86.77 51.97 2.56 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.729 2.286 . . . . 0.0 112.397 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 40.36 43.83 1.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.161 0.505 . . . . 0.0 110.655 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.41 146.08 27.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.424 HG21 ' CG1' ' A' ' 217' ' ' VAL . 3.3 p -50.52 -12.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.739 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.6 tmt? -62.1 -59.85 4.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.593 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.73 143.89 0.87 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.613 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 237' ' ' PHE . 40.2 Cg_exo -38.78 -121.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.93 2.42 . . . . 0.0 113.832 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 239' ' ' THR . 0.1 OUTLIER -74.05 69.83 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.175 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 18.8 p90 -68.16 -40.57 82.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.474 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 12.8 ttmm -141.62 60.07 1.49 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.215 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -49.9 105.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.79 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 241' ' ' LYS . 26.2 m -157.73 167.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -56.34 -178.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 213' ' ' PHE . 14.4 pt -86.59 -36.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.05 -15.57 60.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 110.608 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.0 p -101.37 3.84 40.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.621 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.427 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.7 t80 -59.22 127.23 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.268 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -148.43 138.53 22.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.12 161.42 20.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.926 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.2 m -100.8 164.33 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.44 -24.24 65.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.62 -37.77 59.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.436 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.83 -25.61 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.774 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -78.72 -22.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -69.22 -46.01 68.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.628 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -45.69 95.59 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.665 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.24 -49.65 59.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.253 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 258' ' ' ILE . 59.7 mm-40 -44.38 -15.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.2 t -48.69 -11.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 259' ' ' GLN . 6.4 mp -91.3 -13.05 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 16.0 t80 73.05 19.45 3.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 117.967 -1.463 . . . . 0.0 111.055 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.512 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -70.48 114.77 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -161.45 -16.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.582 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -160.46 -25.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.5 ttt 48.47 89.63 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.129 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.07 153.15 18.91 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.102 1.868 . . . . 0.0 112.341 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.91 -86.36 0.06 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.06 173.19 19.48 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.93 165.01 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.847 2.365 . . . . 0.0 111.834 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 109' ' ' TRP . 2.4 t -145.83 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.219 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -62.86 168.52 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.135 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 112' ' ' HIS . 4.4 mmm180 154.72 3.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.026 0.829 . . . . 0.0 111.021 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.9 tttp 66.06 -42.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 110' ' ' ARG . 47.9 m170 -78.91 -37.28 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.747 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.74 132.0 56.53 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.36 130.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 3.2 p -100.88 143.0 31.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.321 0.581 . . . . 0.0 111.471 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.3 p90 -126.37 135.96 52.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.958 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -132.16 135.15 46.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.649 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.43 100.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' ILE . 58.5 m-20 -32.97 -36.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 121' ' ' TYR . 1.6 p30 168.61 44.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.649 ' H ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER 34.63 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.737 0.303 . . . . 0.0 111.264 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.59 140.43 13.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.44 -5.37 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.904 1.736 . . . . 0.0 112.102 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 165' ' ' ARG . 1.2 m-20 -53.33 -31.12 42.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.66 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 78.3 mtp -149.78 173.54 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.373 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -51.01 109.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.41 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 68.9 mtp180 -55.92 -23.92 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.135 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 28.3 mp0 -77.47 -43.72 31.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.698 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.66 -16.65 57.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 91.6 t -86.09 -32.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.617 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.2 m-20 -83.51 -46.43 12.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.37 -55.25 30.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.14 -28.07 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.588 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.7 mm -76.04 -29.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -78.08 -32.78 50.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.264 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -78.53 -15.59 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.52 -48.8 12.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.457 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -55.43 -21.01 14.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -75.78 -35.48 60.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.37 . . . . 0.0 110.415 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.58 -40.22 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.427 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.41 -46.83 14.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.224 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 p -61.65 -30.52 70.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.054 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.6 -37.11 70.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.757 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.29 21.37 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.969 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 144' ' ' VAL . 77.1 p -149.6 141.05 14.65 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.491 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.73 33.31 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.215 1.943 . . . . 0.0 111.965 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.08 -176.23 4.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -157.9 100.85 1.76 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.002 0.43 . . . . 0.0 110.347 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 1.4 m-85 -96.72 120.56 37.27 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -133.56 155.18 50.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.742 0.306 . . . . 0.0 110.619 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -109.93 126.28 53.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.172 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.4 pt -83.95 136.17 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -48.01 -48.0 33.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.0 0.429 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -153.53 152.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.24 -153.59 18.1 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.0 tpt -106.62 132.36 52.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.03 156.33 21.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.19 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.7 m-20 -47.55 -40.79 19.81 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.098 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 159' ' ' ILE . 3.7 tt -140.14 135.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.61 130.9 46.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.133 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.87 130.97 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.164 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.97 132.65 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.744 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 26.1 m-85 -101.28 146.23 27.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.77 8.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.163 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 124' ' ' ASP . 10.2 ptp180 -130.43 139.59 50.58 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 72.59 -146.85 39.42 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.03 162.1 14.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 110.432 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.49 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 21.9 p-80 -157.24 -40.89 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.23 -82.27 0.04 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD2' ' CE1' ' A' ' 168' ' ' HIS . 2.3 p30 -45.27 134.69 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 52.5 t80 -57.37 137.6 55.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.686 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 1.6 t-80 86.38 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.249 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.77 171.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.087 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 166' ' ' GLY . 16.1 m-85 -63.61 158.12 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.365 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -55.27 -31.87 61.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.887 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.46 -159.84 15.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -50.8 110.46 0.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.72 -165.9 13.51 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.62 -109.7 0.88 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.83 150.85 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.876 0.369 . . . . 0.0 111.068 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.0 mt -118.59 -22.08 7.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.3 174.58 3.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.116 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 57.0 p-80 -165.01 99.21 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.3 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.97 172.06 11.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.244 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.3 t80 -132.06 153.42 50.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.3 159.05 38.63 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.56 153.83 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.557 2.171 . . . . 0.0 112.013 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.96 -125.98 3.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 192' ' ' GLY . 70.1 m -42.77 132.18 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.751 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.13 -78.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.047 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.68 -30.33 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.162 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -51.31 -70.07 0.97 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 194' ' ' ASP . . . -43.95 -50.11 7.53 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 193' ' ' GLY . 21.2 t0 -36.82 129.96 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.55 141.72 50.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.555 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 1.6 m80 -125.63 128.12 47.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.16 142.26 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.912 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.25 101.12 12.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.665 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' GLU . 23.6 tt0 -86.07 -7.05 58.88 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.23 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -44.94 -17.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 36.7 mm-40 -93.79 174.4 7.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.495 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -97.46 118.09 33.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.456 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 96.0 m95 -99.63 151.9 20.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 206' ' ' HIS . 7.1 m -160.17 117.76 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.163 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 205' ' ' THR . 16.6 p -49.42 -16.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.755 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 204' ' ' THR . 85.1 t60 -84.2 152.83 24.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -72.26 102.06 3.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.451 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . -167.33 -84.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -58.26 -123.35 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.438 ' O ' ' CZ3' ' A' ' 203' ' ' TRP . 88.3 m -103.58 110.04 21.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.666 0.269 . . . . 0.0 110.746 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -65.28 121.2 14.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.51 -26.78 63.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.112 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.33 -57.52 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.36 -34.58 66.79 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 52.7 m -74.45 -40.81 61.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.86 3.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.6 t -48.03 -35.55 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CD2' ' C5 ' ' A' ' 1' ' ' DSV . 62.7 t60 -69.21 -57.23 5.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.625 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -48.97 -50.77 34.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.01 -32.5 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.722 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.38 -48.57 11.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -54.22 -43.37 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.2 t -56.26 -34.67 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.295 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.67 25.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 61.4 2.41 3.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 227' ' ' GLY . 0.8 OUTLIER -76.57 136.42 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 110.422 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 226' ' ' LEU . . . -133.9 -178.25 15.48 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -73.38 158.57 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -137.86 -134.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.306 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.9 t -78.94 -72.98 0.36 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.464 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.7 p30 175.32 57.33 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.769 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.06 48.74 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.743 2.295 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp 38.96 46.4 1.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.39 146.78 26.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.614 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.9 p -48.36 -11.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 234' ' ' ALA . 10.8 tmm? -60.97 -56.52 20.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.488 ' N ' ' SD ' ' A' ' 236' ' ' MET . 31.1 t80 -40.96 139.22 1.24 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.917 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -42.5 107.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 112.581 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.3 p 43.44 61.27 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 3.5 p90 -40.68 -43.29 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.563 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.901 ' O ' HG22 ' A' ' 243' ' ' VAL . 26.0 tttp -131.6 64.34 1.59 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.054 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 243' ' ' VAL . 62.9 t80 -44.76 102.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.853 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 241' ' ' LYS . 19.7 m -161.0 172.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.87 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 245' ' ' ILE . 49.8 t0 -52.29 177.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.151 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 11.2 pt -85.8 -30.78 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.03 -12.35 60.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.011 0.434 . . . . 0.0 110.395 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 p -101.52 3.09 39.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.763 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 32.0 t80 -58.4 126.97 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -147.9 136.51 21.71 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -82.19 163.28 22.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.111 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.0 t -107.65 164.76 11.96 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.5 -19.91 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.31 -42.7 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.511 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -67.31 -26.1 66.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 79.1 mt -81.76 -22.78 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -78.98 -10.84 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 110.574 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.24 -51.32 3.37 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.9 tt -68.6 -45.47 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.651 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 258' ' ' ILE . 48.0 mm-40 -40.46 -22.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.72 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 258' ' ' ILE . 56.7 m -48.71 -14.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.782 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 262' ' ' TYR . 18.2 mt -84.97 -21.91 29.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.903 0.382 . . . . 0.0 110.012 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' GLN . 7.8 t80 84.99 14.52 0.19 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.196 -179.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 52.31 40.84 29.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.533 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -78.4 -1.13 32.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.537 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -166.42 158.92 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.592 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.0 ttt -168.75 64.19 0.57 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.459 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -42.77 169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.771 2.314 . . . . 0.0 112.242 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.18 -148.76 15.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.52 -175.74 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.09 99.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.738 2.292 . . . . 0.0 112.005 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.89 -173.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.531 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.7 117.97 7.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.301 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -132.41 49.32 2.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.324 0.583 . . . . 0.0 109.708 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -103.64 143.24 33.03 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.44 ' ND1' ' N ' ' A' ' 112' ' ' HIS . 5.2 m80 -77.63 -44.04 29.51 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.295 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 43.6 p90 -116.84 136.94 52.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.647 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.9 127.62 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 158' ' ' ASP . 0.8 OUTLIER -100.19 140.47 34.39 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.131 0.491 . . . . 0.0 111.046 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.76 137.6 52.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.174 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -130.5 134.07 46.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.137 0.494 . . . . 0.0 110.295 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mt -109.89 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.745 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -48.75 -42.89 36.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 121' ' ' TYR . 18.1 t-20 -171.77 170.18 5.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' CE2' ' OD1' ' A' ' 131' ' ' ASP . 9.0 m-85 -108.62 -126.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 3.0 t -153.18 141.49 13.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.94 91.31 1.19 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.678 1.585 . . . . 0.0 111.733 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -166.27 -27.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.053 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 28.5 mtm -141.26 160.06 40.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.737 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -54.25 108.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.046 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 64.8 mtp180 -52.36 -27.29 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 20.8 mp0 -74.01 -41.98 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.627 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -63.42 -16.82 61.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.812 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.1 t -86.3 -31.15 6.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.665 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' ' CE2' ' A' ' 121' ' ' TYR . 1.4 m-20 -83.6 -46.97 11.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.98 -58.15 7.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.75 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.341 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.9 mm -73.54 -29.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -74.64 -36.91 62.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.07 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -76.65 -15.24 59.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.471 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.23 -50.82 9.1 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.53 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -55.18 -21.95 15.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -75.08 -34.72 61.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.45 -42.3 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.15 -45.49 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -62.61 -32.14 73.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 0.0 110.004 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -55.4 -34.93 64.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.802 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.77 21.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 82.5 p -151.82 138.08 11.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.616 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 33.34 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.118 1.879 . . . . 0.0 112.031 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.04 -171.15 3.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.482 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -157.79 100.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.262 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 2.6 m-85 -96.86 119.85 36.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.449 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.4 m -136.11 155.21 50.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.518 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -107.82 126.35 52.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.7 pt -89.36 140.61 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -54.37 -42.03 69.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.67 158.69 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.394 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 101.62 127.88 6.22 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 155' ' ' GLY . 7.5 ttt -34.97 141.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 111.431 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.5 178.55 4.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 115' ' ' THR . 62.6 m-20 -70.91 -39.05 72.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.421 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 9.7 tt -137.7 114.97 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.44 0.638 . . . . 0.0 110.517 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.14 126.13 34.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.45 124.3 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.5 t -142.43 132.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.254 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.8 m-85 -101.41 143.38 31.5 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.051 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.97 171.06 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.135 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -129.8 140.63 50.99 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.29 -149.81 31.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.26 167.49 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.654 0.264 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.616 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 2.7 p-80 -154.57 -133.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.616 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -77.42 -97.21 0.2 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' ' CE1' ' A' ' 168' ' ' HIS . 2.6 p30 -45.13 157.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.348 . . . . 0.0 110.842 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.08 82.44 3.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.95 36.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.402 . . . . 0.0 110.417 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -47.45 136.46 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.4 138.8 58.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.35 -21.6 65.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.336 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' OD2' ' A' ' 200' ' ' ASP . . . 115.72 -157.26 15.13 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -62.83 112.56 2.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.695 0.283 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.7 -171.38 13.79 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.22 -107.64 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.9 mt -79.11 150.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.629 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 36.0 mt -115.29 -22.39 9.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.328 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.23 151.59 34.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.868 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 184' ' ' ALA . 1.7 t-80 -103.06 157.58 16.89 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.626 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -162.63 167.31 23.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.311 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -145.75 142.54 29.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -49.39 178.57 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.73 24.16 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.716 2.277 . . . . 0.0 111.888 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -60.05 146.34 45.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.7 m -77.85 167.25 21.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 72.02 -167.09 53.1 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 19.5 tt -44.07 -15.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -67.5 58.16 0.3 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -172.84 -51.61 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 8.5 m-20 -21.18 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.2 0.588 . . . . 0.0 111.723 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.16 115.33 0.74 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.269 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 23.2 m80 -110.45 124.47 51.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.88 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.78 131.66 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 31.6 p-10 -89.35 113.25 24.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLU . 28.0 tt0 -92.54 -8.43 44.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.653 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 176' ' ' GLY . 11.6 p-10 -39.59 -21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' GLU . 31.3 mt-10 -98.67 -177.29 3.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.756 0.313 . . . . 0.0 110.529 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -98.63 113.64 25.79 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.0 m95 -95.81 149.11 21.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.175 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' HIS . 22.5 m -160.85 117.29 2.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 59.1 p -65.09 52.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.772 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' THR . 44.3 t-80 -151.19 151.55 32.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.8 t -65.11 83.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.39 -95.0 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.74 -120.78 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.9 m -89.12 147.18 24.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 110.358 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.621 HD21 ' CY1' ' A' ' 1' ' ' DSV . 0.3 OUTLIER -102.88 112.78 25.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 110.146 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.2 tp -71.86 -28.68 63.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.408 ' CB ' HG22 ' A' ' 245' ' ' ILE . 24.1 t80 -66.39 -58.6 4.94 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.772 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.16 -41.21 78.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 94.1 m -63.72 -40.66 97.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.13 -62.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.508 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 235' ' ' VAL . 86.3 t -42.21 -30.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.516 ' ND1' ' C5 ' ' A' ' 1' ' ' DSV . 3.1 t-160 -71.38 -58.83 3.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -62.91 -24.01 67.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 110.616 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.3 mt -81.92 -40.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.876 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.82 83.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -65.69 -19.21 65.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.2 p -43.21 -48.8 6.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.518 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.5 mt -79.51 -58.27 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 53.07 0.07 OUTLIER Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tp -79.44 102.26 8.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 110.707 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.07 149.27 48.92 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 16.2 m170 -73.05 160.07 32.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.593 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.3 m -124.85 -138.75 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.53 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 25.8 t -78.95 -66.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.31 58.73 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.438 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.71 47.28 2.1 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.719 2.279 . . . . 0.0 112.657 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 70.6 mttt 40.18 45.18 1.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.095 0.474 . . . . 0.0 110.722 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.475 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.16 140.89 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.821 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.5 p -50.57 -12.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.916 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 14.5 tmm? -63.99 -59.75 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -42.6 140.65 1.71 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.009 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 237' ' ' PHE . 19.1 Cg_exo -34.06 -115.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.928 2.419 . . . . 0.0 114.091 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 p -78.22 59.71 2.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.841 -0.537 . . . . 0.0 110.603 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 24.1 p90 -54.04 -40.92 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.18 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 75.5 tttt -151.38 75.64 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.6 t80 -60.66 112.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.418 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' TYR . 30.4 m -160.05 165.13 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.135 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -56.63 178.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.239 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.2 pt -82.26 -38.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -75.44 -13.23 60.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 79.7 p -103.48 3.53 34.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.45 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 33.9 t80 -57.69 123.04 14.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -146.43 133.12 19.93 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.384 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.8 mt -79.73 161.73 25.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.2 m -101.32 163.27 12.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.24 67.09 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.3 -37.41 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.851 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -75.59 -24.68 56.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.901 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.8 mt -79.32 -22.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -69.33 -46.76 66.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.51 -43.76 85.52 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.151 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.5 tt -67.48 -49.09 74.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.419 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -41.17 -24.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 258' ' ' ILE . 13.5 m -68.35 -28.07 66.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 258' ' ' ILE . 26.5 mt -74.96 -46.69 33.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.563 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -174.03 -28.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.097 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.77 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.944 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.621 ' CY1' HD21 ' A' ' 211' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 54.38 35.27 22.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -62.39 -3.46 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -171.76 -0.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.688 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.5 ttp 54.32 69.19 2.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.591 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.18 92.51 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.499 2.133 . . . . 0.0 111.934 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.13 -123.6 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.41 -175.53 29.15 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.3 -179.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.75 2.3 . . . . 0.0 112.07 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 109' ' ' TRP . 7.6 p -172.26 -45.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.549 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.1 t90 -90.23 115.03 27.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -157.05 32.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 53.0 mttp 51.82 34.94 14.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.085 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 5.1 m-70 -144.29 -55.81 0.36 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.563 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -110.65 128.89 55.88 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.76 124.32 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.402 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 7.9 p -96.92 145.88 25.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.437 ' CG ' ' CE2' ' A' ' 138' ' ' PHE . 14.4 p90 -128.47 135.72 49.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 119' ' ' ASN . 52.3 ttt-85 -131.38 136.11 47.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.738 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.95 95.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.331 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.688 ' H ' HD22 ' A' ' 119' ' ' ASN . 0.3 OUTLIER -87.13 6.54 32.28 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.468 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.54 142.12 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.664 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.1 m-85 -132.68 98.32 4.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.332 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -36.73 100.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.28 -2.93 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.676 1.584 . . . . 0.0 112.663 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 122' ' ' THR . 4.2 m-20 -66.38 -23.91 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.52 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 36.2 mtp -139.3 159.84 41.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.941 0.401 . . . . 0.0 110.674 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -50.66 105.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.576 ' H ' ' CD ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -44.55 -27.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.923 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -76.51 -40.61 49.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.598 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.61 -15.95 63.24 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.832 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.88 -36.72 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.666 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -58.03 -52.35 65.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.168 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 213' ' ' PHE . . . -61.54 -35.06 76.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.21 -25.49 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 139' ' ' GLN . 48.7 ttp85 -77.61 -35.55 52.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.455 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.7 mtpp -77.39 -15.38 59.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.21 -50.9 9.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.831 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' CE2' ' CG ' ' A' ' 116' ' ' TYR . 31.6 m-85 -57.73 -21.05 38.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.581 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 135' ' ' ARG . 23.5 mt-30 -75.2 -38.77 60.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.57 -37.22 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 145' ' ' THR . 96.4 m95 -76.32 -48.62 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.346 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.0 t -60.01 -31.33 69.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.104 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.15 -41.48 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.853 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 145' ' ' THR . 4.4 m -112.07 22.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.923 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.44 HG23 HG23 ' A' ' 144' ' ' VAL . 76.8 p -149.06 131.96 8.08 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.63 38.73 0.73 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.186 1.924 . . . . 0.0 112.617 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 112' ' ' HIS . 68.1 mt -98.69 -163.82 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.91 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -157.38 103.76 1.99 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.259 0.552 . . . . 0.0 111.009 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.82 120.57 40.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.122 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.8 t -134.57 156.0 49.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.646 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -107.4 125.55 51.36 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.204 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 152' ' ' ILE . 16.1 pt -82.92 136.92 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.224 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER -54.3 -44.39 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.596 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.2 t -151.49 148.72 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.403 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.47 -149.7 17.96 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -111.77 132.56 54.57 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.596 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -111.18 160.79 16.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' OD1' HG22 ' A' ' 108' ' ' VAL . 1.7 m-20 -55.89 -40.89 73.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.701 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.9 tt -137.57 128.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.254 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 133.91 42.24 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.18 127.43 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.303 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.18 133.14 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.8 OUTLIER -108.57 150.18 27.85 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.238 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.91 175.01 9.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.567 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 166' ' ' GLY . 37.2 ttp180 -141.62 156.35 45.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 165' ' ' ARG . . . 77.23 -81.62 1.18 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.5 ' O ' ' CE2' ' A' ' 174' ' ' PHE . . . -84.17 -148.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.884 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.565 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 2.7 t60 -171.08 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 154.14 -88.54 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.55 77.55 9.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.094 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 38.24 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.175 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.565 ' CD2' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -174.78 48.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.0 133.08 44.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 110.617 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.5 ' CE2' ' O ' ' A' ' 167' ' ' ALA . 5.0 m-85 -66.52 139.6 57.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.585 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.84 -18.81 58.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.569 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.32 21.51 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -71.31 121.52 18.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.43 -169.37 13.44 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.69 -115.49 7.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.82 151.09 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.716 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.63 -22.46 9.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.451 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.2 176.58 2.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.164 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 3.1 p80 -139.15 -174.15 3.78 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.579 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.539 ' N ' ' ND1' ' A' ' 183' ' ' HIS . . . -164.12 159.9 20.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.536 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 2.1 p90 -107.62 126.37 52.48 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.18 -67.02 1.63 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.477 ' O ' ' CE2' ' A' ' 185' ' ' PHE . 40.2 Cg_endo -65.27 -154.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.701 2.267 . . . . 0.0 111.93 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.62 70.25 0.25 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' GLY . 49.5 m -93.15 167.98 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.74 -46.46 0.6 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 191' ' ' ILE . 19.7 tt -125.77 70.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.477 0.656 . . . . 0.0 109.927 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 185' ' ' PHE . . . -137.12 -34.9 0.2 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.05 -36.17 57.09 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 18.3 p-10 -59.16 50.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.632 0.253 . . . . 0.0 111.473 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -49.67 162.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.088 0.471 . . . . 0.0 111.418 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.539 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 2.6 m80 -140.46 139.99 35.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.019 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.52 ' CE2' ' OE1' ' A' ' 219' ' ' GLU . 13.5 m-85 -100.87 146.38 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.133 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' CG ' ' CD1' ' A' ' 174' ' ' PHE . 61.1 t0 -93.86 121.58 35.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 14.6 tp10 -100.24 -6.13 26.49 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.892 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 13.5 t0 -47.33 -20.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.62 177.4 6.12 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.503 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.74 105.98 17.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.405 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -90.56 154.43 19.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.118 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 206' ' ' HIS . 7.2 m -160.04 107.93 1.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.4 p -46.36 -20.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 207' ' ' SER . 84.3 t60 -83.48 162.07 21.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 14.5 m -78.95 108.53 12.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.8 -90.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.29 -114.25 0.06 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 60.9 m -81.26 140.9 34.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.421 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.475 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.3 OUTLIER -101.59 112.15 24.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.886 0.374 . . . . 0.0 110.239 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.15 -31.25 65.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 133' ' ' ALA . 64.5 m-85 -68.62 -59.6 3.01 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.498 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.14 -35.33 75.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 51.7 m -70.96 -40.07 72.18 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.0 -52.9 47.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.612 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.81 -32.01 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.31 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.416 ' CE1' ' O40' ' A' ' 1' ' ' DSV . 20.6 t-160 -72.1 -58.17 3.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE1' ' CE2' ' A' ' 197' ' ' PHE . 46.5 mt-10 -52.32 -49.39 64.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.719 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 223' ' ' SER . 5.4 mm -61.82 -29.58 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.423 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.38 -44.23 35.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -68.07 -19.99 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 220' ' ' ILE . 19.1 p -56.42 -43.51 79.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.94 -76.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 226' ' ' LEU . . . 166.47 17.74 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 225' ' ' GLY . 10.8 mp -79.11 141.29 37.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.14 170.31 14.21 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -73.55 160.1 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.396 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 20.9 t -139.69 -129.35 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.48 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 55.6 m -78.62 -81.19 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -176.06 60.66 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.231 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 233' ' ' LYS . 69.9 Cg_endo -82.72 45.46 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.869 2.38 . . . . 0.0 112.773 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 232' ' ' PRO . 53.5 mtpt 35.8 47.03 0.36 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.716 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.483 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -81.21 141.95 33.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.895 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.2 p -49.33 -13.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 9.8 tmm? -59.64 -57.58 12.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 34.7 t80 -45.22 139.86 4.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.945 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 24.6 Cg_exo -35.38 -116.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.967 2.445 . . . . 0.0 113.859 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.7 p -74.76 56.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.047 0.451 . . . . 0.0 110.361 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.3 p90 -54.13 -37.74 64.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -152.1 72.96 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.232 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -57.46 108.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.775 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.406 HG22 ' OG1' ' A' ' 247' ' ' THR . 2.5 p -163.41 159.78 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.368 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.74 176.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 245' ' ' ILE . 9.3 pt -84.88 -39.22 14.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.452 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.23 -13.01 62.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.775 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.406 ' OG1' HG22 ' A' ' 243' ' ' VAL . 13.9 p -104.69 7.69 34.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.563 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -52.74 120.43 5.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -146.52 125.87 13.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.1 mt -74.54 164.05 27.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.92 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.8 m -102.58 158.27 16.34 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.98 -21.97 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -77.34 -41.49 40.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.987 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.04 -24.85 61.61 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.071 0.463 . . . . 0.0 109.834 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.34 -25.96 11.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.669 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -77.32 -12.12 59.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.49 -49.53 3.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 259' ' ' GLN . 8.5 tp -69.0 -51.12 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.764 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.585 ' N ' HG23 ' A' ' 258' ' ' ILE . 89.1 mt-30 -43.75 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 258' ' ' ILE . 25.8 t -49.58 -11.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 110.643 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 259' ' ' GLN . 18.0 mt -93.22 -19.97 20.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 109.919 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' GLN . 2.0 m-85 75.94 20.07 1.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.566 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 117.852 -1.527 . . . . 0.0 110.964 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.456 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.454 ' H ' ' H ' ' A' ' 101' ' ' ARG . 41.0 p90 -174.99 3.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 100' ' ' PHE . 56.6 ttt85 -50.55 -23.62 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.31 -152.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.861 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 13.3 ptt? -163.17 -12.0 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.861 ' CD ' ' H ' ' A' ' 103' ' ' MET . 88.7 Cg_exo -44.29 106.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 122.057 1.77 . . . . 0.0 112.257 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.23 120.87 0.99 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -83.49 -169.4 44.91 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' GLY . 50.8 Cg_exo -52.56 -160.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.877 2.384 . . . . 0.0 112.028 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.28 36.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.338 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -46.76 114.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.225 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 112' ' ' HIS . 58.7 mtp85 -159.17 32.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.1 OUTLIER 59.76 -9.45 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.191 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.579 ' H ' ' C ' ' A' ' 110' ' ' ARG . 22.0 m170 -88.41 -54.87 3.98 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 1.5 m-85 -119.43 141.21 49.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.078 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -127.79 128.4 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 158' ' ' ASP . 7.3 p -94.4 143.14 26.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.95 139.31 51.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -141.75 140.77 33.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.623 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.5 mt -111.81 100.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.309 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.514 ' ND2' HD21 ' A' ' 160' ' ' LEU . 7.2 m-80 -76.97 11.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.504 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.7 ' O ' HG22 ' A' ' 118' ' ' ILE . 53.2 t30 -172.01 161.12 5.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -145.33 108.58 4.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.074 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.36 132.65 3.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.18 5.1 4.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.719 1.613 . . . . 0.0 111.79 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.31 -24.95 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.807 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 29.1 mtp -143.14 158.48 43.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 0.0 110.411 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER -50.98 110.7 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -44.17 -32.25 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.52 -41.31 63.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.582 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 8.8 t70 -66.09 -15.53 63.16 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.888 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.48 -34.35 7.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.3 m-20 -83.91 -44.45 14.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -54.69 -58.47 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.36 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.353 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -76.33 -30.67 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -35.22 59.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -78.79 -15.73 58.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.526 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.95 -46.63 17.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.367 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -59.99 -20.73 59.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.42 -38.39 63.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.371 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.84 -39.33 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.983 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 217' ' ' VAL . 88.5 m95 -78.9 -46.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -62.3 -30.38 71.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 0.0 110.248 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.08 -36.22 70.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.934 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.62 20.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 71.1 p -150.98 143.09 15.95 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.545 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.82 30.75 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.215 1.943 . . . . 0.0 112.194 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.3 mt -83.79 -176.99 6.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -158.76 102.96 1.7 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.916 0.389 . . . . 0.0 110.338 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.1 m-85 -101.07 119.29 38.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.773 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 p -138.45 155.82 48.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.414 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 3.1 ttmp? -107.46 122.24 46.23 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.661 HD11 ' O ' ' A' ' 156' ' ' MET . 3.1 pt -100.13 158.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -103.54 2.03 32.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.3 p -115.9 177.15 4.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 39.78 -99.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -170.82 -178.49 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.26 153.54 23.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.1 m-20 -55.92 -36.58 67.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.277 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.93 137.68 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.069 0.462 . . . . 0.0 110.165 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.514 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -104.71 131.72 51.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.189 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.24 128.05 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.598 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.95 132.64 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.783 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.25 146.2 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 109.953 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.07 172.06 13.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -131.62 141.9 49.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.228 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . 74.15 -145.2 34.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.25 155.57 24.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -156.21 -0.61 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.51 -69.86 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 22.0 p-10 -46.4 125.31 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -49.52 -47.61 48.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.477 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -74.23 64.62 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.96 161.17 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.536 ' CE1' ' CE1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -61.5 141.23 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.15 -22.96 61.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.17 -155.67 16.0 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.85 112.87 2.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.04 -171.8 14.69 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.68 -111.38 3.21 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.32 150.98 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.966 0.412 . . . . 0.0 110.912 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 mt -112.86 -18.64 12.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.53 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.073 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 54.6 p-80 -149.35 88.44 1.58 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -90.09 169.79 10.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -110.72 130.42 55.58 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 110.554 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -74.17 -68.5 1.56 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 186' ' ' GLY . 15.4 Cg_endo -55.57 -152.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.718 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -156.92 70.43 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 54.5 m -100.39 166.58 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.437 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -38.96 -90.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.09 -29.66 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 110.239 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.76 -60.47 8.63 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -47.47 -49.23 20.98 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 5.4 m-20 -59.22 54.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -61.04 174.81 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.656 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -146.98 144.69 29.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.838 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 219' ' ' GLU . 6.9 m-85 -89.69 146.97 24.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 174' ' ' PHE . 45.9 t0 -85.34 106.24 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 0.0 110.664 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . 63.0 tt0 -90.63 -7.11 53.58 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.272 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -40.36 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.645 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' OE2' ' N ' ' A' ' 178' ' ' GLY . 24.1 mm-40 -98.35 -178.93 4.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.225 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -106.36 117.62 34.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.207 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ3' HG22 ' A' ' 210' ' ' THR . 89.7 m95 -89.34 154.65 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 206' ' ' HIS . 21.2 m -153.81 106.61 2.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.977 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.5 p -65.76 50.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.004 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CD2' ' H ' ' A' ' 207' ' ' SER . 11.5 t-160 -163.89 158.55 20.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.094 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.622 ' H ' ' CD2' ' A' ' 206' ' ' HIS . 29.0 t -64.03 77.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.534 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 176.55 52.6 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 156.03 -153.06 24.44 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.535 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.8 m -79.89 141.91 35.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.46 109.34 20.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.899 0.381 . . . . 0.0 110.991 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.88 -34.88 72.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.164 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -65.06 -56.06 15.21 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.91 -41.34 77.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 82.3 m -62.93 -38.62 91.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.866 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.26 -61.68 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.434 ' HA ' ' HE1' ' A' ' 141' ' ' TRP . 95.9 t -53.31 -34.11 21.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.393 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 7.4 t60 -68.19 -51.78 41.87 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 197' ' ' PHE . 40.3 mt-10 -62.67 -44.47 96.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.78 -28.51 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.01 -39.15 89.12 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -75.07 -23.72 58.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.718 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 52.4 p -43.65 -53.1 5.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.4 -60.26 2.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.902 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.96 51.02 0.05 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tp -89.69 105.04 17.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 110.706 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -53.83 -175.95 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.593 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 57.1 m170 -111.69 159.85 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 t -115.5 -151.02 0.47 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.841 0.353 . . . . 0.0 110.903 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 95.7 p -79.52 -65.34 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.53 56.2 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -79.31 42.58 1.32 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.016 2.478 . . . . 0.0 112.952 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 40.4 41.88 1.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.489 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.44 155.58 19.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.683 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.86 -11.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.11 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.593 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 41.9 ttp -65.21 -62.22 1.67 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -40.04 138.79 1.06 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.327 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -43.1 113.98 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.841 1.694 . . . . 0.0 112.092 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.447 ' H ' ' CZ2' ' A' ' 1' ' ' DSV . 5.2 p 42.43 61.45 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.1 p90 -41.02 -50.46 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 243' ' ' VAL . 16.4 tptp -127.69 62.66 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.534 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 58.1 t80 -40.48 106.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.224 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 241' ' ' LYS . 20.9 m -160.95 172.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.077 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -54.31 -178.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.164 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 245' ' ' ILE . 10.2 pt -86.75 -40.11 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.672 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -74.53 -15.57 60.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.96 0.41 . . . . 0.0 110.4 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.9 p -97.42 1.9 49.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.708 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 36.5 t80 -58.14 128.25 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -150.99 135.55 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.405 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.28 165.18 21.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.896 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.7 t -106.2 173.21 6.41 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.39 -24.13 62.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.74 -37.48 65.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.005 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -72.96 -24.19 60.76 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.62 -21.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.679 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -67.84 -46.57 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.36 -44.76 97.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.903 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 259' ' ' GLN . 2.8 tp -67.63 -50.09 64.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.382 0.591 . . . . 0.0 110.54 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 258' ' ' ILE . 18.5 mt-30 -43.82 -19.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.6 m -71.34 -24.77 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.745 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.78 -46.03 39.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 110.588 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -173.67 -27.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.285 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.983 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.517 ' C5 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -170.66 -30.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -79.72 19.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -166.67 -53.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.783 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 44.2 ttp 53.52 92.83 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.546 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.18 140.67 5.33 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.098 1.865 . . . . 0.0 112.199 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.04 -159.35 1.82 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 -67.01 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.57 98.53 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.668 2.245 . . . . 0.0 111.868 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.13 158.19 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' CZ2' ' O ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -79.34 101.83 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.281 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -149.05 56.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.52 134.17 41.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -78.43 -55.01 5.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 110.578 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 50.9 p90 -116.24 131.77 56.85 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.8 mt -122.33 128.36 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 1.1 p -101.98 145.68 28.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 111.153 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 15.5 p90 -129.75 141.07 50.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.094 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HE ' ' ND2' ' A' ' 119' ' ' ASN . 40.3 ttt85 -138.02 139.38 39.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.23 0.538 . . . . 0.0 110.703 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 121' ' ' TYR . 1.6 mt -110.37 99.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.268 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.68 ' ND2' ' HE ' ' A' ' 117' ' ' ARG . 5.3 m120 -98.05 6.17 47.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.484 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' TYR . 14.4 t-20 -124.82 -16.76 6.07 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.377 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 118' ' ' ILE . 70.4 m-85 37.01 -134.85 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 99.66 0.17 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.169 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 92.3 Cg_endo -81.24 90.84 1.16 Allowed 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 121.697 1.598 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 19.8 m-20 -169.3 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.119 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mmm -140.71 167.67 21.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.02 109.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.192 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.05 -24.43 67.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -74.88 -37.52 62.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.37 -16.57 64.32 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.499 -0.481 . . . . 0.0 109.791 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 88.0 t -85.7 -38.64 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.048 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -80.78 -40.84 24.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.641 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -57.3 -60.48 3.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.67 67.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.424 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 5.5 mm -74.1 -28.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -77.99 -33.48 51.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.4 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -78.0 -15.82 58.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.22 -44.5 25.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.334 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -63.9 -19.07 64.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.767 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -74.65 -38.61 62.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.348 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.82 -37.43 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.384 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 145' ' ' THR . 84.6 m95 -80.09 -50.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -59.16 -30.85 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.237 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -55.2 -38.29 68.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.919 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.42 HG23 HG23 ' A' ' 145' ' ' THR . 6.8 m -119.25 23.16 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.005 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 144' ' ' VAL . 58.9 p -149.16 141.25 14.94 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.408 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.57 29.69 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.121 1.881 . . . . 0.0 112.036 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.53 -178.19 5.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.554 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -158.18 101.17 1.73 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 110.452 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -99.06 120.92 40.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m -133.96 155.85 49.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.632 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -109.14 126.08 52.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.85 135.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.168 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.511 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 73.6 m-20 -50.99 -45.47 61.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 t -152.49 147.22 25.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.31 -156.64 21.37 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.33 132.96 50.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.5 169.73 8.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.018 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.8 m-20 -73.72 -36.47 65.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 159' ' ' ILE . 19.6 tt -135.05 105.82 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.606 0.717 . . . . 0.0 110.669 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.46 123.48 26.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.131 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 1.7 t -102.81 131.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.898 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.18 124.72 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.189 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 17.1 m-85 -106.77 142.36 36.54 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -168.01 -178.77 3.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.08 136.22 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.128 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 174' ' ' PHE . . . 92.19 -65.85 2.17 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.16 -141.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.577 ' HD1' ' CB ' ' A' ' 172' ' ' HIS . 10.7 t-160 -171.76 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.483 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -159.85 -70.04 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.45 150.44 21.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.0 110.776 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 172' ' ' HIS . 47.2 t80 45.29 48.13 10.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.577 ' CB ' ' HD1' ' A' ' 168' ' ' HIS . 1.8 m80 172.97 -177.28 0.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -178.14 58.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.421 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 95.8 m-85 -50.04 145.06 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -179.6 50.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.447 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.41 106.37 0.5 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -52.54 124.66 14.16 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.46 -164.82 13.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.93 -102.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 180' ' ' ILE . 1.8 mp -77.81 150.63 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.076 0.465 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.437 HD23 ' OE2' ' A' ' 201' ' ' GLU . 72.1 mt -119.09 -21.24 7.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.578 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.54 164.02 32.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.273 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 184' ' ' ALA . 2.4 t60 -126.82 168.23 14.73 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 109.947 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' A' ' 183' ' ' HIS . . . -173.77 106.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.162 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -87.83 162.26 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.966 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.59 54.65 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 28.18 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.882 2.388 . . . . 0.0 112.085 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -42.16 148.22 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.0 m -60.01 136.13 57.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.11 0.91 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 193' ' ' GLY . 8.9 tt -71.24 -32.66 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.666 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.09 5.5 7.92 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 89.43 13.33 61.69 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 16.0 t0 -26.54 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.032 0.489 . . . . 0.0 111.966 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -32.13 146.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.948 0.404 . . . . 0.0 111.197 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 30.7 m170 -145.89 112.53 5.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.769 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -100.77 132.79 45.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 110.265 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.44 133.38 46.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.615 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 14.9 tt0 -103.56 3.59 34.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -40.44 -23.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.042 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 15.7 mt-10 -99.8 -179.75 4.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.766 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -103.94 118.16 36.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.0 m95 -89.21 156.59 18.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 206' ' ' HIS . 25.0 m -158.12 106.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.169 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.5 p -65.25 45.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 204' ' ' THR . 23.6 t60 -160.59 164.62 31.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.8 p -67.7 76.84 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.725 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.519 ' N ' ' OH ' ' A' ' 242' ' ' TYR . . . 179.87 56.87 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 154.58 -149.4 20.72 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -82.17 142.85 31.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.26 109.78 21.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.38 -32.14 66.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.134 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.73 -57.44 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.891 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.3 -44.96 72.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.1 m -63.27 -38.49 91.36 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.099 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.53 -46.14 66.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.816 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 235' ' ' VAL . 59.7 t -64.5 -33.93 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.583 ' CE1' ' NE2' ' A' ' 222' ' ' HIS . 32.7 t-80 -65.57 -49.57 68.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.335 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.21 -51.71 41.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.475 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.22 -36.18 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.968 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.55 -52.11 34.82 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.583 ' NE2' ' CE1' ' A' ' 218' ' ' HIS . 12.5 m-70 -59.56 -41.73 90.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.33 . . . . 0.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.521 ' O ' ' CZ2' ' A' ' 109' ' ' TRP . 5.7 t -47.51 -52.12 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.191 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' GLY . 11.6 mt -75.9 32.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 32.54 47.7 0.31 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.064 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.7 100.62 12.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -48.84 175.3 0.03 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.588 ' NE2' ' SD ' ' A' ' 236' ' ' MET . 1.4 m-70 -100.74 151.97 21.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 230' ' ' SER . 25.4 t -103.02 -164.98 1.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.541 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 229' ' ' SER . 61.2 p -80.11 -55.1 5.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.61 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 p30 176.93 57.18 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.595 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.77 28.18 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.901 2.401 . . . . 0.0 113.012 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 42.46 47.63 4.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.213 0.53 . . . . 0.0 110.182 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -86.0 148.48 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 235' ' ' VAL . 3.1 p -49.25 -12.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.588 ' SD ' ' NE2' ' A' ' 228' ' ' HIS . 38.8 ttm -80.99 -51.19 8.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -40.21 138.23 1.17 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.142 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -43.08 119.65 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.907 1.738 . . . . 0.0 112.628 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.4 p 37.18 48.69 0.79 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.867 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 1.4 p90 -43.71 -40.86 4.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.598 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 51.9 tttm -149.12 68.64 1.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.251 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 208' ' ' GLY . 67.1 t80 -53.59 109.95 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.5 m -162.65 177.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -57.7 179.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.2 pt -84.94 -24.67 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -84.05 -14.62 50.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.894 0.378 . . . . 0.0 110.575 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 13.2 p -99.18 0.7 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.752 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 248' ' ' PHE . 28.5 t80 -58.9 125.2 22.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -142.86 143.37 32.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.465 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.67 158.43 16.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 53.7 p -99.53 146.71 26.1 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.8 -23.62 44.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.629 -0.428 . . . . 0.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.25 -32.01 64.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.574 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.36 -23.87 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.03 -22.06 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.9 mmm-85 -69.02 -45.62 70.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.577 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.75 -47.76 89.37 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.766 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.0 tp -66.86 -47.06 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.969 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.519 ' N ' HG23 ' A' ' 258' ' ' ILE . 67.1 mt-30 -44.73 -27.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.354 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.7 t -66.04 -25.47 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -76.24 -45.21 33.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.59 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -175.56 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.938 -1.479 . . . . 0.0 110.999 -179.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.406 ' C5 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 99' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' C ' ' N ' ' A' ' 102' ' ' GLU . 18.7 m-85 -58.33 -156.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.599 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.35 17.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.572 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 100' ' ' PHE . 6.4 tp10 -69.43 -22.09 63.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.51 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' PRO . 44.5 mtt 52.99 64.99 6.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 106' ' ' GLY . 79.7 Cg_exo -43.85 173.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.739 2.293 . . . . 0.0 112.2 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.26 -5.84 0.8 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . 83.21 174.63 50.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 109' ' ' TRP . 56.9 Cg_endo -69.65 101.23 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.683 2.255 . . . . 0.0 111.717 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 108' ' ' VAL . 6.0 m -66.11 46.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.69 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' PRO . 2.1 t90 -60.02 115.26 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.614 ' C ' ' H ' ' A' ' 112' ' ' HIS . 40.7 mtp180 -159.07 35.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.7 mttt 63.81 -28.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 110' ' ' ARG . 17.9 m170 -79.86 -46.47 16.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.746 0.307 . . . . 0.0 111.103 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.63 137.31 53.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.313 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 114' ' ' ILE . 31.5 mt -129.95 129.01 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 10.2 p -98.78 146.94 25.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.6 p90 -126.85 137.14 53.13 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.989 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.632 ' NE ' HD21 ' A' ' 119' ' ' ASN . 45.1 ttt85 -138.18 138.9 39.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.25 0.548 . . . . 0.0 110.851 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mt -111.59 99.99 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.38 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' NE ' ' A' ' 117' ' ' ARG . 66.4 m-20 -104.26 2.38 31.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.965 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.595 ' HB3' HG13 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -123.34 -20.0 5.76 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.623 0.249 . . . . 0.0 111.055 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 38.5 -139.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.93 111.32 0.17 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.29 89.39 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.462 1.441 . . . . 0.0 111.835 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -163.84 -23.58 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.379 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 67.9 mtp -147.68 165.36 30.69 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.228 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -51.19 110.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -61.12 -24.09 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -76.3 -39.96 52.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.645 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.27 -16.71 63.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.496 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 97.5 t -85.63 -35.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.99 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.84 -41.53 17.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.934 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.2 t80 -56.57 -63.38 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 111.412 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -49.75 -31.69 12.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.02 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 130' ' ' VAL . 77.3 mt -74.5 -25.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 132' ' ' TYR . 38.5 ttt-85 -78.24 -34.14 49.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.282 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.446 ' NZ ' ' OH ' ' A' ' 132' ' ' TYR . 21.3 mmtp -79.71 -15.87 56.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.28 11.21 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 23.8 m-85 -59.33 -21.1 59.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.551 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -74.26 -37.26 63.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.309 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.08 -39.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.274 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.44 ' C ' ' HG1' ' A' ' 145' ' ' THR . 91.0 m95 -78.81 -46.94 17.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -62.2 -30.98 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -36.76 69.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.864 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.47 19.88 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 141' ' ' TRP . 52.4 p -152.28 147.56 19.81 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.03 34.42 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.255 1.97 . . . . 0.0 112.386 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.14 175.98 7.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.358 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -158.4 105.29 1.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.08 0.467 . . . . 0.0 110.079 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.564 ' CD2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 m-85 -102.33 121.09 41.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 t -132.55 154.96 49.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.115 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -108.98 121.93 46.17 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -84.2 142.94 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.408 . . . . 0.0 110.06 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 153' ' ' ASN . 2.8 m-20 -66.54 -34.65 78.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -149.09 141.91 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.086 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' MET . . . 108.63 120.21 4.38 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 155' ' ' GLY . 16.6 ttt -33.89 148.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.687 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -113.5 163.81 14.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.877 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.1 m-20 -48.44 -42.09 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.006 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 159' ' ' ILE . 5.3 tt -140.22 140.9 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.48 130.37 49.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.886 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.46 127.24 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 120' ' ' ASN . 66.5 t -142.46 130.11 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.621 0.248 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 2.2 m-85 -99.29 147.45 25.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.65 173.99 10.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.117 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.64 153.87 46.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.86 -74.68 1.86 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 174' ' ' PHE . . . -99.01 -138.43 0.31 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.615 ' CE1' ' NE2' ' A' ' 183' ' ' HIS . 18.3 t-160 -172.38 -111.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.662 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -148.81 -87.77 0.07 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 172' ' ' HIS . 19.9 t0 -76.25 -169.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.494 ' H ' ' CG ' ' A' ' 170' ' ' ASP . 89.4 m-85 -61.03 73.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.551 ' O ' ' ND1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -175.03 79.67 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.033 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.18 139.75 30.31 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.345 . . . . 0.0 110.409 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.16 -16.04 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.38 -153.88 16.67 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.96 116.0 8.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.68 -172.27 14.29 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 56.89 -110.09 1.98 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.75 150.54 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.772 0.32 . . . . 0.0 110.443 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.414 HD23 ' OE2' ' A' ' 201' ' ' GLU . 23.7 mt -116.06 -23.13 8.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.554 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.24 169.6 12.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.965 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.615 ' NE2' ' CE1' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -147.03 175.25 10.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.832 0.348 . . . . 0.0 110.327 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.567 ' N ' ' HD1' ' A' ' 183' ' ' HIS . . . -166.52 106.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 192' ' ' GLY . 25.9 t80 -67.06 146.67 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.73 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' GLY . . . -52.89 -179.68 0.08 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.58 34.93 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.577 2.185 . . . . 0.0 111.903 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' GLY . . . -58.88 143.33 45.48 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 38.7 m -74.89 164.44 26.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 192' ' ' GLY . . . 47.27 -131.0 14.47 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tt -68.67 46.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.564 0.697 . . . . 0.0 110.035 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 190' ' ' GLY . . . -116.35 -58.36 0.32 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -73.99 -24.41 73.94 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.533 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 59.5 t0 -58.69 55.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 111.128 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -63.29 -178.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 111.551 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -146.66 144.03 29.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.243 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.528 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.8 m-85 -88.02 143.27 27.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.98 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.6 m-20 -82.31 99.85 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 201' ' ' GLU . 49.0 tt0 -87.42 -11.61 48.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.99 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 22.3 p-10 -42.62 -18.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.212 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 199' ' ' GLU . 16.2 mt-10 -99.16 -179.69 4.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -96.0 112.87 24.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.798 0.333 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.1 m95 -96.02 151.92 19.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' HIS . 7.6 m -156.63 114.17 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.474 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.8 p -41.51 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.103 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.623 ' CG ' ' H ' ' A' ' 207' ' ' SER . 41.0 t-80 -103.56 -179.53 3.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.255 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.623 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 41.3 t -61.25 -132.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . 74.2 -107.75 2.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.39 -117.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 22.8 m -95.41 152.45 18.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.637 0.256 . . . . 0.0 110.668 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -102.07 111.66 24.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.18 -28.45 60.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 133' ' ' ALA . 72.0 m-85 -68.36 -58.29 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.464 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 214' ' ' LEU . 7.8 mp -64.15 -38.44 91.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.004 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.415 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 86.6 m -66.97 -41.38 86.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.36 19.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.281 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 235' ' ' VAL . 41.6 t -56.58 -29.15 28.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.637 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.651 ' CE1' HN24 ' A' ' 1' ' ' DSV . 36.9 t-80 -74.83 -63.33 1.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.739 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 28.1 mt-10 -45.92 -54.52 8.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 220' ' ' ILE . 1.3 mp -62.7 -32.27 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -44.49 -47.74 8.74 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 225' ' ' GLY . 74.7 m-70 -60.76 -40.89 94.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.478 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.2 t -43.27 -36.26 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.531 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 225' ' ' GLY . 12.4 mt -95.41 31.16 2.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.378 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 33.86 41.3 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.0 tp -87.43 106.7 18.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.673 0.273 . . . . 0.0 111.347 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -43.32 169.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.584 ' ND1' ' SD ' ' A' ' 236' ' ' MET . 50.6 m-70 -114.96 161.74 17.9 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 m -148.63 174.47 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.161 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.5 m -154.61 91.79 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.6 OUTLIER 158.41 -36.88 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 92.0 Cg_endo -86.38 37.59 0.54 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.773 1.649 . . . . 0.0 112.335 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' PRO . 50.8 mttp 38.8 52.52 1.91 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -89.2 140.28 29.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.41 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.413 HG21 ' CG1' ' A' ' 217' ' ' VAL . 2.2 p -49.22 -14.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.667 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.584 ' SD ' ' ND1' ' A' ' 228' ' ' HIS . 4.5 tpt -54.77 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 238' ' ' PRO . 49.1 t80 -46.36 138.48 6.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.841 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 237' ' ' PHE . 23.1 Cg_exo -36.74 -116.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.052 2.501 . . . . 0.0 114.068 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 239' ' ' THR . 0.4 OUTLIER -70.08 53.18 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.002 -0.436 . . . . 0.0 110.424 -179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 13.8 p90 -51.07 -41.25 59.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.271 0.558 . . . . 0.0 109.944 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.491 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 56.8 tttm -149.21 73.5 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.913 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 207' ' ' SER . 1.6 t80 -62.56 110.78 1.8 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.843 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -158.5 161.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.936 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.45 171.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.429 ' CG2' ' CG ' ' A' ' 213' ' ' PHE . 11.3 pt -79.41 -37.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.67 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.09 0.471 . . . . 0.0 110.333 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.7 p -105.61 3.32 29.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.689 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.487 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 34.9 t80 -54.44 125.56 19.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.787 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 13.0 mmp_? -146.05 137.24 24.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.13 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.9 mt -85.33 165.38 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.652 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 67.8 p -101.34 160.69 14.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.98 -23.49 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.58 -38.89 47.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.693 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.98 -23.48 62.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 72.7 mt -81.69 -22.88 10.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.693 ' NH1' HE22 ' A' ' 259' ' ' GLN . 47.2 mmt-85 -77.45 -10.69 59.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.582 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.21 4.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.6 tp -67.59 -45.87 84.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.693 HE22 ' NH1' ' A' ' 256' ' ' ARG . 18.8 mt-30 -42.14 -21.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.871 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 258' ' ' ILE . 65.0 p -63.4 -21.69 66.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.81 -46.76 18.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -173.51 -24.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.569 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 118.003 -1.443 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.651 HN24 ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -173.35 13.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.548 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.22 -2.96 14.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.65 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -152.88 116.52 4.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.447 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.3 66.39 1.35 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.521 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.78 86.28 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.0 2.467 . . . . 0.0 112.083 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.69 35.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.3 71.93 0.15 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.23 138.4 29.18 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.714 2.276 . . . . 0.0 112.135 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -124.44 142.35 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.297 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.44 118.11 12.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -132.68 50.31 2.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -105.73 138.77 41.36 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -78.11 -39.19 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.728 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 113' ' ' TYR . 51.5 p90 -116.1 131.57 56.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.851 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mm -116.44 126.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -99.09 142.97 29.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.082 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -131.36 140.16 49.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.756 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -137.67 139.71 40.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.352 0.596 . . . . 0.0 110.538 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.43 98.25 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.767 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -87.66 7.95 27.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.618 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -162.18 141.51 9.55 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.749 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.6 m-85 -131.66 117.67 18.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.416 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -43.51 115.2 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.53 94.06 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.783 1.656 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -174.29 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.335 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.3 mtm -138.58 163.62 31.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -52.44 106.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.07 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -49.69 -24.34 2.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.384 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -74.73 -39.39 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.67 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -70.98 -15.5 62.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.9 t -85.95 -43.85 16.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.144 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -79.23 -36.75 39.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.62 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 89.9 t80 -59.65 -59.36 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.335 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.84 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.527 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mm -75.47 -31.72 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -76.72 -33.75 58.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.509 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.62 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 8.4 mmtp -78.72 -15.27 58.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.98 -49.09 12.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.425 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 220' ' ' ILE . 35.8 m-85 -57.49 -19.26 23.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -77.55 -34.77 53.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 110.449 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.7 -36.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.35 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -80.64 -47.74 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.181 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -60.6 -30.03 69.57 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.171 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -55.68 -41.82 74.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -111.91 20.81 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 144' ' ' VAL . 80.6 p -147.44 137.11 12.02 Favored Pre-proline 0 N--CA 1.47 0.555 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.322 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.91 33.28 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.161 1.907 . . . . 0.0 112.184 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.27 -168.9 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.476 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -158.19 100.86 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.54 118.22 32.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -138.24 154.97 49.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.34 120.92 41.7 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.776 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 156' ' ' MET . 3.4 pt -99.52 155.45 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -110.36 60.48 0.6 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.1 t -176.64 175.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 38.2 -102.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.453 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.447 ' CG ' ' N ' ' A' ' 157' ' ' ALA . 12.7 ttt -161.85 171.37 17.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -106.95 161.43 14.73 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.32 -32.21 69.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.4 tp -139.77 117.38 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.291 0.567 . . . . 0.0 110.571 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -89.84 128.39 36.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.609 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.35 125.73 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.0 t -141.17 128.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -97.53 140.45 31.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 111.224 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.26 16.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.568 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 166' ' ' GLY . 28.8 ptt-85 -129.75 137.79 50.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 55.25 109.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 59.9 138.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.963 0.411 . . . . 0.0 111.108 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.622 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 13.9 p-80 -162.22 -51.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.557 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.622 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -91.62 -171.84 42.48 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 172' ' ' HIS . 39.8 t0 -95.68 139.26 32.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.726 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 173' ' ' ALA . 38.1 t80 59.46 -75.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ASP . 11.6 p80 -64.9 59.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.591 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.65 160.42 21.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.47 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -138.54 139.9 38.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.14 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -172.81 46.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 177' ' ' LYS . . . -133.52 92.71 0.26 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 ptpt -40.01 120.26 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 112.04 -169.4 13.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.29 -92.6 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 178' ' ' GLY . 6.5 mm -72.4 148.51 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.58 -26.38 3.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.37 154.15 36.13 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CG ' ' N ' ' A' ' 184' ' ' ALA . 28.9 t60 -103.6 164.46 11.65 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.285 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.533 ' N ' ' CG ' ' A' ' 183' ' ' HIS . . . -172.56 158.24 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.36 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -161.15 163.92 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . -86.43 -164.28 39.46 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 186' ' ' GLY . 45.3 Cg_exo -55.42 -139.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.913 2.408 . . . . 0.0 112.255 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.38 118.83 3.21 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.8 m -46.27 119.55 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.332 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.56 -142.94 31.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.8 tt -54.89 140.11 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.086 0.47 . . . . 0.0 110.349 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.88 -48.17 0.52 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -84.4 -39.69 8.89 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.537 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 1.5 m-20 -19.69 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.169 0.57 . . . . 0.0 111.659 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -43.78 113.01 0.45 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.527 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 23.3 m80 -112.56 123.47 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -85.43 126.99 34.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.09 127.21 41.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.937 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 201' ' ' GLU . 42.3 tt0 -89.49 -76.53 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.401 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' GLU . 48.6 m-20 29.12 38.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.572 0.545 . . . . 0.0 110.976 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 199' ' ' GLU . 29.9 mt-10 -165.37 173.02 11.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -97.89 116.13 29.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 95.8 m95 -94.57 150.55 20.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.93 0.395 . . . . 0.0 110.974 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 206' ' ' HIS . 6.3 m -160.3 113.54 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.28 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -61.75 0.11 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 204' ' ' THR . 1.5 t60 -79.98 -17.93 51.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.463 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 207' ' ' SER . 4.8 p 81.85 64.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -122.79 -77.86 0.41 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.39 -111.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.7 m -86.63 146.98 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.85 110.88 22.96 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.374 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.59 -33.61 75.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.172 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -67.16 -56.77 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.545 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.5 -32.08 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 98.1 m -73.61 -41.99 62.09 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.18 -52.17 37.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.69 -34.89 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.775 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.505 ' CE1' ' C6 ' ' A' ' 1' ' ' DSV . 50.3 t-80 -70.29 -58.18 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.536 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -45.86 -53.55 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.509 HD13 ' CD1' ' A' ' 138' ' ' PHE . 63.1 mt -60.91 -34.99 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.28 -48.68 20.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 225' ' ' GLY . 14.7 m-70 -59.0 -45.89 89.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.9 t -43.95 -30.91 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.575 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.38 31.7 3.32 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.401 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' HIS . . . 34.41 45.56 0.49 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 227' ' ' GLY . 2.8 tp -89.18 104.94 17.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 111.421 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 226' ' ' LEU . . . -41.04 166.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -93.3 150.34 20.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.181 0.49 . . . . 0.0 110.477 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.46 ' OG ' ' CB ' ' A' ' 234' ' ' ALA . 16.0 p -128.99 136.41 50.29 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 73.6 m -137.63 83.55 1.99 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.0 OUTLIER 162.98 -40.09 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.848 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 80.9 Cg_endo -88.63 41.63 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.188 1.925 . . . . 0.0 112.627 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 37.69 55.04 1.53 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 236' ' ' MET . . . -85.56 139.61 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.107 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -49.11 -11.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 234' ' ' ALA . 1.9 tmt? -66.45 -51.56 55.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.419 ' N ' ' SD ' ' A' ' 236' ' ' MET . 36.2 t80 -44.41 139.18 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.902 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -40.34 107.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.075 1.85 . . . . 0.0 112.649 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.4 p 41.15 62.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 2.8 p90 -42.62 -45.39 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.635 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 18.6 tptm -123.77 58.92 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.121 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -44.95 101.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.641 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 244' ' ' ASP . 5.3 p -165.3 175.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.865 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.619 ' H ' HG22 ' A' ' 243' ' ' VAL . 5.3 m-20 -47.66 169.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.174 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 18.7 pt -87.05 -32.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -75.48 -16.58 60.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.895 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.474 ' O ' ' NH1' ' A' ' 249' ' ' ARG . 61.2 p -102.33 7.49 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 248' ' ' PHE . 30.4 t80 -53.01 125.52 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.993 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 247' ' ' THR . 82.7 mtm-85 -143.06 143.83 32.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.2 mt -90.41 158.99 16.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 73.2 m -100.34 143.85 30.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.07 -25.43 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.03 -36.02 64.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.694 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -74.37 -27.49 60.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.248 0.547 . . . . 0.0 109.705 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.5 mm -77.21 -23.03 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.705 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -72.73 -43.93 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.393 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.19 96.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.072 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.532 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -67.71 -48.3 76.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.783 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 262' ' ' TYR . 12.3 mm100 -43.59 -18.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.579 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 258' ' ' ILE . 35.7 t -48.06 -12.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 259' ' ' GLN . 37.0 mt -93.29 -25.43 17.76 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 259' ' ' GLN . 8.7 t80 82.47 21.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.982 -1.455 . . . . 0.0 110.947 179.845 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.505 ' C6 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 102' ' ' GLU . 34.9 m-85 -70.64 145.29 50.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.1 ptp180 34.24 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.484 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 100' ' ' PHE . 49.5 mt-10 56.2 171.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 57.4 mtt 54.32 67.37 3.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.689 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.77 38.46 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.971 2.447 . . . . 0.0 112.33 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 163.0 165.54 20.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . -165.71 -168.69 28.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' TRP . 39.5 Cg_exo -55.61 -147.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.892 2.395 . . . . 0.0 112.257 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.8 m -37.89 -25.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' PRO . 2.1 t90 -68.91 114.76 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.915 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -156.14 41.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.027 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 60.5 mttm 50.54 42.49 26.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 111' ' ' LYS . 26.2 m-70 -146.49 -48.38 0.2 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' C ' HD12 ' A' ' 114' ' ' ILE . 7.8 m-85 -111.34 128.76 56.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 114' ' ' ILE . 2.7 mp -117.55 125.1 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.0 p -96.46 142.7 28.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.924 0.392 . . . . 0.0 111.099 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 18.4 p90 -127.49 136.37 51.66 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.694 ' NH1' HD21 ' A' ' 119' ' ' ASN . 27.0 ttp85 -136.01 137.36 41.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.315 0.579 . . . . 0.0 110.661 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mt -110.64 97.41 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.542 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.694 HD21 ' NH1' ' A' ' 117' ' ' ARG . 56.9 m-80 -83.39 4.44 27.51 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.488 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 179.11 125.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 1.5 m-85 -92.22 -130.99 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.352 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.99 87.11 8.15 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' O ' ' OD2' ' A' ' 124' ' ' ASP . 76.3 Cg_exo -46.98 86.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.66 1.573 . . . . 0.0 111.995 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 122' ' ' THR . 5.8 m-20 -164.19 -20.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.52 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.4 mtm -154.41 173.82 15.71 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -50.9 112.49 0.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -65.72 -26.35 67.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.177 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 3.5 mp0 -71.25 -35.7 71.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.106 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -67.38 -16.34 64.19 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.887 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.04 -34.89 8.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.876 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 3.3 m-20 -83.96 -42.77 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -53.95 -62.26 1.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -28.15 33.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.199 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -76.08 -29.21 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.6 ttm-85 -77.58 -33.86 53.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.31 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -77.68 -16.14 58.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.9 -44.76 22.03 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 32.3 m-85 -61.2 -22.77 65.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.742 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.11 -40.77 71.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.839 0.352 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.92 -38.9 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.986 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.436 ' O ' ' OG1' ' A' ' 145' ' ' THR . 93.2 m95 -74.07 -50.05 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.383 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -58.82 -30.79 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.227 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -56.51 -36.55 69.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 145' ' ' THR . 4.9 m -122.89 22.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 56.8 p -149.38 134.57 9.54 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.4 32.7 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.143 1.895 . . . . 0.0 113.017 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.32 -169.27 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -158.46 101.24 1.69 Allowed 'General case' 0 N--CA 1.457 -0.077 0 CA-C-O 121.067 0.46 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -98.15 120.33 38.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.878 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.0 m -135.78 156.0 49.49 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.9 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -107.42 128.09 54.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.035 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 pt -86.95 138.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -59.55 -37.59 78.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 110.496 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.8 m -153.61 150.61 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.528 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 124.25 -152.33 17.34 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.1 tpt -107.21 130.16 54.77 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.31 159.43 16.13 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 5.3 m-20 -63.78 -38.96 93.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.631 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tt -137.95 124.51 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 110.332 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.42 126.7 37.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.02 125.38 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.87 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -142.08 130.96 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.447 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 21.1 m-85 -100.38 145.25 28.42 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.93 174.69 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -129.67 138.38 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.067 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 84.88 -147.78 23.01 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.26 170.0 17.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.546 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 29.7 p-80 -158.33 -136.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.593 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.546 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -69.01 -86.09 0.11 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 171' ' ' PHE . 36.5 t0 -45.24 137.23 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.665 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 173' ' ' ALA . 34.4 t80 -53.81 -35.08 61.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.637 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -60.95 71.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.286 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -77.03 151.32 35.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CE1' ' OD1' ' A' ' 198' ' ' ASP . 4.9 m-85 -67.04 136.53 55.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.587 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -69.03 -15.03 63.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.36 -155.32 16.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -60.21 116.37 4.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.4 -169.55 14.31 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.62 -115.72 8.4 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.49 151.27 4.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.981 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.08 -20.17 11.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.07 170.8 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 10.7 p80 -145.46 153.12 40.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.893 0.378 . . . . 0.0 110.461 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.81 171.9 14.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 186' ' ' GLY . 28.9 t80 -143.1 159.31 42.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.415 ' N ' ' CD2' ' A' ' 185' ' ' PHE . . . -72.53 113.77 4.58 Favored Glycine 0 CA--C 1.54 1.603 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.33 167.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.854 1.703 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.96 -112.37 2.01 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 190' ' ' GLY . 58.6 m -44.01 137.49 3.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.634 0.254 . . . . 0.0 110.768 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -33.44 -85.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 193' ' ' GLY . 8.9 tp -47.27 -35.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.84 58.28 0.14 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 191' ' ' ILE . . . -170.5 -51.6 0.04 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -29.64 127.37 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.723 0.308 . . . . 0.0 110.69 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -127.46 139.41 52.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.769 0.318 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 183' ' ' HIS . 1.5 m80 -139.23 138.75 37.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.135 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 14.3 m-85 -94.83 145.49 24.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 1.9 m-20 -85.24 107.71 17.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 201' ' ' GLU . 37.5 tt0 -86.07 -10.04 55.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -41.36 -21.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.239 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 199' ' ' GLU . 34.6 mt-10 -101.62 -178.0 3.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.568 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.28 112.6 24.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.315 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 210' ' ' THR . 87.8 m95 -87.76 144.8 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.2 m -158.76 107.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.15 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 63.7 p -51.44 -41.03 60.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 207' ' ' SER . 31.6 t60 -88.27 -157.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.657 ' H ' ' CG ' ' A' ' 206' ' ' HIS . 6.0 p 70.43 -138.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 207' ' ' SER . . . -158.23 18.06 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.31 -125.52 2.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 7.1 m -60.37 116.66 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.129 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.02 110.08 21.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.475 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.0 -31.01 61.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.459 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 245' ' ' ILE . 20.8 t80 -69.77 -60.16 2.49 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.85 -32.79 63.94 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.592 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 64.8 m -74.95 -35.59 62.13 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.926 0.394 . . . . 0.0 110.697 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.33 -49.31 70.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.023 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.99 -32.87 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -67.22 -48.4 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.792 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 55.7 mt-10 -62.84 -42.22 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 141' ' ' TRP . 85.8 mt -65.54 -34.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.738 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.24 99.03 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.66 -15.59 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.419 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 m -76.7 -36.32 57.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.5 mt -78.86 -85.31 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.602 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -165.25 16.8 0.1 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.641 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 226' ' ' LEU . 3.2 mm? -57.68 -105.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.353 0.597 . . . . 0.0 110.287 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 85.28 165.63 40.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.9 m170 -73.06 159.11 34.13 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.299 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.8 t -153.01 -132.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 84.5 p -78.66 -74.2 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.417 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 230' ' ' SER . 0.8 OUTLIER 175.21 58.78 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.065 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 233' ' ' LYS . 58.3 Cg_endo -83.75 41.18 1.0 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.948 2.432 . . . . 0.0 112.8 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 232' ' ' PRO . 62.2 mttm 37.07 46.11 0.51 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.202 0.525 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 236' ' ' MET . . . -87.61 150.54 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.47 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.1 p -48.21 -11.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.458 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 234' ' ' ALA . 1.4 tmt? -62.04 -53.8 50.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' N ' ' SD ' ' A' ' 236' ' ' MET . 29.9 t80 -39.33 141.91 0.63 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 239' ' ' THR . 15.9 Cg_endo -56.7 110.92 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.36 1.373 . . . . 0.0 112.062 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 238' ' ' PRO . 5.9 p 50.88 55.42 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.528 ' OH ' ' CE2' ' A' ' 248' ' ' PHE . 4.7 p90 -45.78 -43.84 13.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.501 ' N ' ' CG ' ' A' ' 240' ' ' TYR . 29.5 mmtm -142.85 70.75 1.33 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.299 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.437 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.7 OUTLIER -51.12 107.61 0.19 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 241' ' ' LYS . 32.8 m -156.04 161.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.7 m-20 -50.18 175.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.99 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 213' ' ' PHE . 15.7 pt -81.82 -29.91 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.448 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -82.2 -13.43 57.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.425 . . . . 0.0 110.289 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.1 p -104.22 4.13 33.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.538 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.528 ' CE2' ' OH ' ' A' ' 240' ' ' TYR . 30.9 t80 -60.15 132.23 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.062 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -150.9 143.89 24.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.463 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.64 165.57 15.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.013 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.6 t -104.93 163.48 12.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.13 -21.33 65.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.8 OUTLIER -78.94 -42.2 27.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.662 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -67.56 -25.11 65.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 71.0 mt -81.71 -22.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.29 -11.13 59.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.446 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -88.09 -50.95 3.31 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.7 tp -69.63 -48.01 68.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.794 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 258' ' ' ILE . 78.3 mt-30 -43.61 -17.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.582 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 258' ' ' ILE . 40.5 t -55.21 -13.2 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.67 -49.31 11.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 110.608 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -174.39 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.017 -1.435 . . . . 0.0 111.259 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.515 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 60.1 mmm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 99' ' ' MET . 95.4 m-85 -159.35 120.01 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 54.68 7.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 100' ' ' PHE . 43.0 tt0 48.75 72.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.3 tpt -168.66 63.92 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.713 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.57 157.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 112.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.71 129.98 2.06 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.15 -72.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.14 178.56 5.28 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.73 2.287 . . . . 0.0 111.861 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.69 55.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 111' ' ' LYS . 1.4 t90 -57.27 104.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 110.155 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 112' ' ' HIS . 55.9 mtp180 -65.28 61.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 109' ' ' TRP . 41.8 mtmt -55.62 14.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.647 ' H ' ' C ' ' A' ' 110' ' ' ARG . 38.6 m80 -78.08 -60.93 2.17 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.26 118.69 34.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -125.58 128.71 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 3.7 p -97.6 145.54 26.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.904 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -128.26 135.28 49.44 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.267 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 152' ' ' ILE . 47.0 ttt85 -137.15 139.07 40.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' ASN . 1.8 mt -112.07 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.94 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -39.78 -30.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.384 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 121' ' ' TYR . 36.3 t30 -164.28 -156.46 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.51 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -154.43 111.14 3.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -41.62 130.01 2.35 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.97 2.93 6.56 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.746 1.631 . . . . 0.0 112.162 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -67.65 -24.91 65.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.555 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 23.9 mtp -140.19 160.14 40.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.667 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -50.76 106.75 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -47.73 -27.69 2.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.65 -39.95 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.772 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 10.1 t70 -67.16 -15.64 63.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.3 t -85.51 -38.48 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.04 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.82 -39.73 19.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.275 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -56.58 -62.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.535 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.32 -26.25 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.165 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mm -75.69 -29.27 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -77.41 -35.43 54.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.557 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 13.3 mtpp -78.98 -15.15 58.66 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.02 19.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.307 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -58.25 -19.45 34.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.409 ' NE2' ' NH2' ' A' ' 135' ' ' ARG . 83.4 mt-30 -79.74 -34.79 39.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.18 -37.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.467 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -85.42 -46.65 10.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.976 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -62.76 -28.85 70.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.291 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.23 -38.67 80.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.971 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.76 17.6 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.073 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 258' ' ' ILE . 69.7 p -150.76 143.21 16.13 Favored Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.516 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.82 33.91 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.366 2.044 . . . . 0.0 112.357 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -87.56 -174.99 5.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -158.91 106.91 1.85 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.093 0.473 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.6 120.31 41.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.771 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -132.95 154.77 50.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -112.42 125.59 54.38 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.345 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.444 ' O ' ' NH1' ' A' ' 117' ' ' ARG . 15.5 pt -83.28 137.85 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -61.21 -39.66 91.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.6 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -150.45 139.36 20.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.597 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.46 -153.69 20.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -110.13 150.46 28.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.745 0.307 . . . . 0.0 110.289 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.8 m-20 -46.63 -43.48 17.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.602 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 159' ' ' ILE . 5.6 tt -138.57 137.12 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.032 0.444 . . . . 0.0 110.491 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.55 132.78 48.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.371 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.46 130.15 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.4 133.01 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 10.7 m-85 -103.7 145.83 29.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 109.993 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.05 173.96 10.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.843 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' GLY . 9.6 ptp180 -139.27 151.66 46.64 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.603 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' ARG . . . 45.34 98.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 53.75 110.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 111.194 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.425 ' ND1' ' N ' ' A' ' 168' ' ' HIS . 10.7 p-80 -103.28 -35.03 8.57 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.441 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.82 -74.57 0.18 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.32 163.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 110.749 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -74.16 70.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -165.36 57.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.588 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.2 131.28 49.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -59.43 136.33 57.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.638 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.75 -22.24 66.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.528 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.58 -158.02 14.71 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.8 118.94 11.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.72 -169.73 13.13 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.34 -105.27 0.23 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 70.5 mt -78.02 150.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.0 110.713 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.7 mt -120.12 -25.04 5.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.5 142.53 33.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.842 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 0.5 OUTLIER -133.17 62.89 1.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.07 127.66 35.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.362 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -75.83 138.6 41.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.536 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.47 162.79 36.64 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.47 126.08 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.574 2.183 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.25 -93.86 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 192' ' ' GLY . 53.9 m -99.63 168.03 10.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -29.58 -89.45 0.01 OUTLIER Glycine 0 N--CA 1.471 1.005 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 193' ' ' GLY . 12.4 tt -43.49 -27.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 189' ' ' SER . . . -62.22 56.6 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -156.09 -49.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.43 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 1.1 m-20 -57.46 57.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.778 0.323 . . . . 0.0 111.221 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -50.34 160.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.29 0.567 . . . . 0.0 111.904 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 1.4 m80 -129.67 133.63 47.2 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.181 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 5.5 m-85 -94.83 138.02 33.15 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 198' ' ' ASP . 26.3 p-10 -92.12 112.49 24.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.422 ' HA ' ' HE1' ' A' ' 203' ' ' TRP . 27.3 tt0 -97.62 -4.6 37.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.825 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.49 -16.4 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.156 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.36 176.74 6.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.534 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -90.4 107.01 18.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 110.562 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.6 m95 -96.99 162.61 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.7 p -150.74 164.8 35.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.09 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -130.99 63.89 1.59 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.499 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.2 t60 -159.21 -51.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.6 t 154.03 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.352 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.47 41.78 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 44.94 -128.58 7.71 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 49.3 m -100.38 107.88 19.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.485 0.183 . . . . 0.0 110.781 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.482 ' CG ' ' CD1' ' A' ' 242' ' ' TYR . 5.4 m120 -67.6 123.16 19.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.399 0.618 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.35 -26.26 51.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.658 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.456 ' CG ' HG22 ' A' ' 245' ' ' ILE . 26.7 t80 -68.04 -60.05 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.192 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -54.49 -42.58 70.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 31.5 m -60.15 -36.68 78.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.611 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.82 -60.99 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.705 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.8 t -45.24 -36.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -71.19 -60.75 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.023 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 48.8 mt-10 -48.03 -51.92 22.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.803 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.31 -31.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.29 -44.4 44.05 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -55.28 -46.16 76.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 225' ' ' GLY . 4.5 m -52.0 -41.88 62.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.0 mt -74.27 38.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.449 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 46.61 12.1 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' LEU . 4.4 tp -82.05 140.44 33.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -131.88 -179.07 15.89 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 229' ' ' SER . 12.1 m170 -72.8 150.39 42.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.491 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 228' ' ' HIS . 1.9 p 149.42 16.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.612 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 56.6 m -152.32 76.32 1.16 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.023 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 41.4 t0 -80.56 -30.28 0.57 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 12.8 Cg_exo -37.9 96.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.75 1.634 . . . . 0.0 113.141 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 42.11 35.75 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.456 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.465 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -87.27 137.2 32.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 235' ' ' VAL . 6.7 p -49.28 -13.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.846 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.558 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 7.0 tmm? -55.47 -57.2 12.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.656 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.3 t80 -40.78 145.07 0.56 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.435 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 237' ' ' PHE . 75.8 Cg_exo -41.19 -127.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 122.881 2.388 . . . . 0.0 114.382 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -120.55 18.14 12.05 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.983 0.42 . . . . 0.0 110.607 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -40.44 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.668 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.562 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 5.5 tmtm? -146.29 66.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.962 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 6.2 t80 -59.29 168.4 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.935 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.628 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 4.0 p -163.15 143.42 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.919 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.8 157.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.283 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.456 HG22 ' CG ' ' A' ' 213' ' ' PHE . 15.2 pt -79.17 -29.94 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.36 -20.02 57.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.522 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 27.5 p -103.96 6.3 36.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -47.38 122.69 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.758 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -150.63 100.49 2.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 41.0 mt -53.37 165.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.042 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 28.7 t -101.27 154.27 18.91 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -19.31 26.62 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.77 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 253' ' ' ASP . 0.9 OUTLIER -77.56 -40.04 43.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.989 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -72.12 -22.48 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.883 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.6 mt -75.14 -21.73 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.786 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -65.02 -52.86 53.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.836 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -52.51 -47.28 57.52 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.501 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 145' ' ' THR . 7.0 tt -65.86 -52.05 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.465 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.46 ' N ' HG23 ' A' ' 258' ' ' ILE . 11.5 mm100 -39.65 -28.86 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.347 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 257' ' ' GLY . 80.2 p -66.28 -28.68 68.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.698 0.285 . . . . 0.0 110.761 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 261' ' ' LEU . 7.5 mp -71.57 -47.63 53.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.65 -21.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.88 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.443 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 60.29 12.58 3.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 102' ' ' GLU . 12.1 tpp180 -71.09 -21.44 62.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 101' ' ' ARG . 94.0 mt-10 -45.65 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.699 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.6 mmt 47.15 67.72 4.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.59 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.51 105.71 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.875 2.383 . . . . 0.0 112.028 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.37 143.99 6.2 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.43 175.67 43.01 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.67 -164.45 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.808 2.339 . . . . 0.0 111.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.6 p -176.23 126.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.543 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.32 124.36 44.36 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -143.52 51.11 1.36 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.612 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -99.43 145.82 27.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.6 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -78.1 -56.04 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.695 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -121.37 143.23 49.32 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.94 129.53 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 p -96.73 141.37 30.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.697 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' CD1' ' CE2' ' A' ' 138' ' ' PHE . 48.1 p90 -128.5 138.23 52.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' A' ' 119' ' ' ASN . 42.9 ttt-85 -135.69 137.17 41.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.153 0.501 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mt -110.76 97.1 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.47 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -93.7 12.79 24.33 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.432 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 163' ' ' PHE . 3.8 t-20 -78.29 -68.97 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.817 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 122' ' ' THR . 20.6 m-85 67.95 16.36 9.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -23.47 88.9 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 123.864 0.728 . . . . 0.0 111.669 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 121' ' ' TYR . 41.6 Cg_exo -54.53 95.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.756 1.637 . . . . 0.0 111.792 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -174.58 -23.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.078 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.5 mmm -142.47 157.71 44.47 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.898 0.38 . . . . 0.0 110.302 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -50.99 110.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -64.04 -23.92 67.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.421 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.19 -38.36 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.274 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.09 -16.67 63.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 85.2 t -85.63 -35.66 9.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.883 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.09 -44.1 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.589 ' CZ ' ' NZ ' ' A' ' 136' ' ' LYS . 87.0 t80 -55.78 -57.06 13.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.245 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.4 mm -75.25 -28.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -78.32 -33.35 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.417 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.589 ' NZ ' ' CZ ' ' A' ' 132' ' ' TYR . 7.1 mmtp -79.0 -15.48 58.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.38 -47.36 15.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 116' ' ' TYR . 37.7 m-85 -59.4 -18.92 43.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.64 -36.5 62.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.286 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.13 -38.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.478 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -83.84 -49.52 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.484 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -61.26 -30.91 70.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -54.9 -39.88 69.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 21.37 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.822 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 79.4 p -153.46 145.73 17.14 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.29 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.63 34.58 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.321 2.014 . . . . 0.0 112.492 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.0 mt -90.91 179.73 5.69 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.61 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -158.65 106.5 1.89 Allowed 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.105 0.478 . . . . 0.0 110.361 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -105.41 120.81 42.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.689 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -130.26 154.98 47.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.83 126.76 55.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.9 pt -85.11 136.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.324 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -53.27 -42.81 66.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.709 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 t -153.33 148.31 26.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 125.61 -159.5 20.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -100.64 131.88 46.32 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.466 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -110.48 152.57 26.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.158 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -44.36 -43.19 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.2 tt -138.34 134.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.221 0.534 . . . . 0.0 110.152 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.78 131.66 47.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.737 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.75 131.38 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.21 127.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.323 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 24.8 m-85 -100.36 144.56 29.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.148 0.499 . . . . 0.0 109.83 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -167.03 177.09 6.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.898 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -129.59 136.18 49.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 75.82 -144.22 31.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.08 109.78 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 55.8 p-80 -94.09 -56.44 2.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.674 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -157.0 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 3.9 p30 -45.27 149.56 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.88 0.372 . . . . 0.0 110.658 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 173' ' ' ALA . 39.3 m-85 -49.77 -38.01 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -63.35 67.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -78.82 156.16 28.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.551 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.518 ' CG ' ' OD1' ' A' ' 198' ' ' ASP . 23.7 m-85 -68.56 136.01 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.47 -6.7 49.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.58 -152.99 17.2 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -73.99 124.14 25.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.749 0.309 . . . . 0.0 110.262 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.511 ' N ' ' OE2' ' A' ' 201' ' ' GLU . . . 111.43 -169.13 13.06 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.78 -109.65 1.17 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.04 150.69 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.863 0.364 . . . . 0.0 110.816 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -114.7 -18.94 11.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.47 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 196' ' ' HIS . 1.7 p80 -145.91 129.79 17.27 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.375 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.36 14.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.3 131.39 44.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.46 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.88 -161.52 4.07 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.91 10.25 3.72 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.498 2.132 . . . . 0.0 112.191 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.68 146.71 8.98 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.3 m -78.89 143.91 35.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.14 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 96.45 93.76 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.9 tt 41.57 18.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.233 0.54 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -78.99 44.07 2.54 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -147.75 -53.81 0.02 OUTLIER Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.526 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -50.79 65.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.336 0.668 . . . . 0.0 111.298 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.705 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -48.67 144.94 3.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 111.881 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 5.7 m80 -126.58 128.68 47.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.179 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.76 140.64 29.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.244 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 174' ' ' PHE . 46.8 t0 -83.48 100.49 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 201' ' ' GLU . 20.3 tt0 -84.4 -7.5 59.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.154 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 1.0 OUTLIER -41.36 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.33 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 199' ' ' GLU . 38.9 mm-40 -101.19 -175.3 2.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -104.35 119.3 38.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 0.0 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 93.7 m95 -91.41 141.02 29.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.099 0.476 . . . . 0.0 110.973 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.8 m -149.22 107.48 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.6 p -52.42 -28.62 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 207' ' ' SER . 19.2 t60 -78.45 168.97 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 206' ' ' HIS . 29.1 p -76.74 80.78 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 58.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.21 -144.84 11.49 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 m -83.75 145.01 28.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 215' ' ' THR . 38.4 m-80 -102.79 111.81 24.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.756 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.25 -31.21 63.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.476 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.16 -61.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.8 mt -52.67 -30.95 34.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.216 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 211' ' ' ASN . 35.3 p -80.71 -32.9 35.69 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.678 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.59 62.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.258 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.02 -34.27 62.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.581 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 45.9 t-80 -67.86 -53.14 29.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.844 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -59.47 -43.56 93.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.789 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.4 -36.87 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.688 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.99 -42.67 95.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -66.19 -23.94 66.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.3 t -43.68 -43.23 5.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.397 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.92 -59.23 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.051 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.51 59.81 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.3 tp -91.73 101.61 14.21 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 111.113 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -49.6 179.03 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -101.72 153.91 19.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.11 -163.17 0.85 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.511 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 231' ' ' ASP . 25.4 p -78.27 -62.79 1.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.179 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.488 ' N ' ' OG ' ' A' ' 230' ' ' SER . 27.3 t70 -175.76 58.27 0.18 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.427 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 231' ' ' ASP . 48.7 Cg_endo -85.54 28.52 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.024 2.483 . . . . 0.0 112.644 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' A' ' 233' ' ' LYS . 9.2 ttmm 40.94 47.96 2.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.107 0.48 . . . . 0.0 110.054 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.86 148.82 25.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.012 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.12 -30.93 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.768 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 218' ' ' HIS . 38.6 tpp -53.09 -61.33 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 238' ' ' PRO . 36.3 t80 -39.69 140.11 0.85 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.123 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 237' ' ' PHE . 14.6 Cg_exo -33.65 -114.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.907 2.405 . . . . 0.0 113.525 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -82.4 72.04 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.534 -0.729 . . . . 0.0 110.233 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 241' ' ' LYS . 5.6 p90 -67.78 -44.37 77.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.301 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.853 ' O ' HG22 ' A' ' 243' ' ' VAL . 69.5 tttt -140.28 58.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.335 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 243' ' ' VAL . 79.2 t80 -40.11 104.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.97 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 241' ' ' LYS . 21.9 m -160.58 172.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.18 -174.74 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.27 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.91 -36.42 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.75 -19.76 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 110.31 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 p -89.83 -0.94 57.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -48.46 110.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -132.35 112.51 12.25 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.05 154.51 41.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -104.45 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.91 64.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.03 -40.51 53.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.379 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -68.72 -24.61 64.49 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 76.3 mt -81.77 -23.23 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.0 -10.74 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.13 -50.23 4.42 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 259' ' ' GLN . 3.5 tp -66.6 -40.85 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.603 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 258' ' ' ILE . 33.2 mm-40 -39.12 -29.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 258' ' ' ILE . 5.0 m -49.86 -21.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.76 0.314 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.88 -13.09 59.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 9.2 t80 78.39 11.34 1.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.773 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.819 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.823 179.769 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.48 ' C37' ' NE2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.513 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 48.2 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.513 ' CG ' ' O ' ' A' ' 99' ' ' MET . 84.7 m-85 -160.13 57.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.395 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' MET . 74.0 mtp180 -79.49 26.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -77.34 41.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.629 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 29.9 mtt -87.61 -27.42 0.35 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 103' ' ' MET . 66.6 Cg_endo -80.93 84.96 1.89 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.311 1.34 . . . . 0.0 112.008 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.56 25.43 0.02 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 170.97 60.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 35.61 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 106' ' ' GLY . 16.3 m -93.03 -155.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.51 ' CG ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -47.91 113.54 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.426 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 24.9 mmt180 -143.85 23.11 1.75 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.057 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 111' ' ' LYS . 21.0 mtmm 54.72 29.97 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 110' ' ' ARG . 67.0 m80 -154.09 -46.12 0.09 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.624 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.59 135.01 54.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.74 124.5 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 4.9 p -96.88 144.13 27.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 111.213 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -127.47 135.08 49.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.572 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -130.47 135.02 47.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 121' ' ' TYR . 32.5 mt -108.61 93.85 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.285 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -83.18 5.0 24.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.546 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -172.04 162.99 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m-85 -138.54 -136.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.214 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -152.25 90.97 3.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.027 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.08 -7.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.03 1.82 . . . . 0.0 112.439 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 122' ' ' THR . 1.4 m-20 -67.76 -21.82 65.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.405 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 86.4 mtp -146.51 165.75 28.5 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.064 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -50.6 110.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -60.81 -27.49 68.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.69 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -36.12 76.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.29 -16.38 63.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.878 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' CZ ' ' A' ' 163' ' ' PHE . 24.5 t -85.94 -35.01 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 121.135 0.493 . . . . 0.0 109.69 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.1 m-20 -82.61 -44.59 15.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.21 -59.9 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.397 . . . . 0.0 110.934 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 213' ' ' PHE . . . -51.68 -33.26 33.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.036 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.47 -27.09 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -77.93 -37.71 47.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.098 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -76.2 -15.41 60.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.66 -53.12 5.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.977 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -55.61 -21.59 18.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -74.26 -37.13 63.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.724 0.297 . . . . 0.0 110.64 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.2 -41.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.251 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -72.33 -50.01 30.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.5 p -59.45 -31.55 69.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.087 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -53.78 -40.39 66.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.838 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 145' ' ' THR . 4.5 m -115.36 23.25 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.849 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 144' ' ' VAL . 80.8 p -150.31 137.57 11.58 Favored Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.483 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.2 36.29 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.136 1.89 . . . . 0.0 112.119 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.8 mt -88.48 -169.29 2.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -158.0 102.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.188 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 3.8 m-85 -98.71 118.8 36.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.724 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.8 m -138.33 155.43 48.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.242 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 151' ' ' LYS . 6.0 ttpm? -106.99 122.33 46.23 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 156' ' ' MET . 5.2 pt -103.95 160.75 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.624 ' N ' HD22 ' A' ' 153' ' ' ASN . 0.7 OUTLIER -110.66 9.32 22.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.8 p -119.13 173.62 6.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 41.36 -102.7 0.03 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -163.81 175.21 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.4 159.88 17.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.894 0.378 . . . . 0.0 110.36 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD1' ' CG ' ' A' ' 109' ' ' TRP . 34.9 m-20 -64.0 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.532 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 159' ' ' ILE . 15.5 tt -138.95 124.91 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.206 0.527 . . . . 0.0 110.414 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 130.99 42.26 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.719 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.53 127.92 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.275 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.9 t -141.42 131.06 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' CZ ' ' CG1' ' A' ' 130' ' ' VAL . 8.5 m-85 -109.39 145.45 36.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -165.9 176.89 7.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -127.4 132.32 50.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 167' ' ' ALA . . . 54.78 106.69 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 166' ' ' GLY . . . 60.04 143.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.611 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 46.7 p-80 -172.89 -52.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.777 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.611 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -89.58 179.79 44.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 172' ' ' HIS . 9.8 t70 -87.02 143.71 27.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.58 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ALA . 43.4 t80 57.46 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.519 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 170' ' ' ASP . 38.9 m80 -66.56 44.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.578 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -83.08 65.93 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.331 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -47.2 163.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.528 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 p30 179.75 49.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.735 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.85 104.51 0.42 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 20.4 pttm -48.57 120.7 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.65 -167.14 12.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.11 -99.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.8 mt -78.7 150.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD2' ' OE2' ' A' ' 201' ' ' GLU . 58.1 mt -124.67 -25.74 3.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.89 32.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 6.2 p80 -124.52 179.35 4.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.431 ' HB3' ' ND1' ' A' ' 222' ' ' HIS . . . -172.46 106.42 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.162 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 186' ' ' GLY . 84.0 t80 -94.77 152.54 18.35 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 185' ' ' PHE . . . -64.12 178.77 7.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 123.37 9.45 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.515 2.143 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -159.32 159.54 30.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.6 m -86.25 166.72 15.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -89.89 1.36 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.7 tt -128.18 1.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' GLY . . . -75.22 74.51 1.44 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . 157.1 -54.17 0.4 Allowed Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.522 ' O ' ' NE2' ' A' ' 196' ' ' HIS . 12.9 m-20 -33.64 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.274 0.632 . . . . 0.0 111.855 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -44.48 131.73 6.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.429 . . . . 0.0 111.679 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 194' ' ' ASP . 10.0 m80 -116.01 161.31 19.05 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.24 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.51 ' CZ ' ' OE2' ' A' ' 219' ' ' GLU . 26.4 m-85 -130.97 133.42 45.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.564 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -94.02 122.69 36.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.44 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 201' ' ' GLU . 22.9 tt0 -102.39 -5.36 24.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.043 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.7 t0 -43.27 -19.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.018 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 199' ' ' GLU . 42.5 mt-10 -100.94 -174.9 2.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.311 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -98.84 105.46 17.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.371 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -83.29 162.18 21.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.9 p -146.87 153.36 40.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.378 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.2 p -98.32 -24.29 15.28 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.919 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 206' ' ' HIS . 18.1 t-80 -91.89 21.37 4.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.844 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' CE1' ' A' ' 242' ' ' TYR . 5.3 t 75.01 -121.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.369 0.418 . . . . 0.0 111.062 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.96 -89.22 0.87 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.87 -112.74 1.24 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -66.21 121.67 15.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.534 ' ND2' ' OG1' ' A' ' 239' ' ' THR . 48.4 m-20 -102.87 113.55 27.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.419 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.45 -31.89 70.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.46 ' CG ' HG21 ' A' ' 245' ' ' ILE . 72.8 m-85 -61.68 -56.96 14.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.384 . . . . 0.0 110.719 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 214' ' ' LEU . 8.7 mp -63.04 -44.94 94.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.428 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 37.9 m -55.54 -45.5 77.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.797 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.07 -59.34 3.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.516 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.45 -32.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.401 ' CE1' ' C5 ' ' A' ' 1' ' ' DSV . 3.4 t-160 -68.54 -57.06 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.412 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' ' CZ ' ' A' ' 197' ' ' PHE . 70.3 mt-10 -45.14 -56.09 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 17.2 mm -58.94 -35.2 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.012 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -46.62 -53.88 9.5 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.431 ' ND1' ' HB3' ' A' ' 184' ' ' ALA . 12.2 m170 -51.12 -45.15 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 225' ' ' GLY . 8.7 p -48.25 -44.83 33.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.16 27.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.85 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 223' ' ' SER . . . 36.43 46.29 1.04 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.728 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 tp -85.98 95.72 9.59 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.943 0.402 . . . . 0.0 111.467 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -69.95 148.04 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.508 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -71.88 160.72 32.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 230' ' ' SER . 48.4 t -123.52 -142.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.745 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 229' ' ' SER . 46.2 m -79.63 -64.71 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -176.37 61.94 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 233' ' ' LYS . 98.2 Cg_endo -81.3 34.05 0.54 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.217 2.612 . . . . 0.0 113.304 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 232' ' ' PRO . 68.2 mttm 36.96 42.1 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.576 0.703 . . . . 0.0 110.261 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.477 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.71 152.54 22.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.241 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 1.4 p -48.86 -13.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.44 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.477 ' N ' ' C ' ' A' ' 234' ' ' ALA . 1.3 tmt? -53.44 -50.59 64.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.6 t80 -39.25 147.81 0.29 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 237' ' ' PHE . 80.4 Cg_exo -46.89 -134.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 122.259 1.972 . . . . 0.0 113.835 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 t -128.18 11.43 6.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -77.2 15.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.528 0.68 . . . . 0.0 109.174 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 239' ' ' THR . 17.9 mmtp -141.47 40.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.981 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.41 ' CE1' ' OG ' ' A' ' 207' ' ' SER . 59.5 t80 -46.27 143.73 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 244' ' ' ASP . 1.3 m -141.27 128.24 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.963 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 243' ' ' VAL . 1.0 OUTLIER -32.87 132.08 0.15 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.063 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CG ' ' A' ' 213' ' ' PHE . 46.7 pt -78.64 -27.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.952 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -75.05 -15.91 60.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.116 0.484 . . . . 0.0 110.399 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.4 p -117.86 20.11 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.251 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.41 133.02 24.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 250' ' ' LEU . 53.6 mtp85 -158.8 98.39 1.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.045 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 249' ' ' ARG . 13.4 mt -42.97 165.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 p -90.35 153.68 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.39 -20.91 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.319 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.0 -40.28 31.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.527 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -69.21 -24.12 63.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.1 -23.4 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.508 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.69 -12.31 60.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.667 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.2 -48.77 3.69 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 259' ' ' GLN . 7.0 tt -67.16 -47.43 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 110.725 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 258' ' ' ILE . 16.5 mm100 -41.27 -20.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.755 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 258' ' ' ILE . 17.8 t -72.77 -28.75 62.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ILE . 32.9 mt -70.69 -47.43 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -176.01 -27.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.999 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.043 -1.42 . . . . 0.0 111.019 -179.923 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.546 HC2B ' O39' ' A' ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.508 ' O ' ' CG ' ' A' ' 100' ' ' PHE . 22.8 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.583 ' H ' HH11 ' A' ' 101' ' ' ARG . 88.7 m-85 -160.48 32.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.583 HH11 ' H ' ' A' ' 100' ' ' PHE . 36.3 mmt-85 -79.26 7.92 6.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.862 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -150.75 179.66 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ttt 48.71 64.07 9.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.64 113.02 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.787 2.325 . . . . 0.0 112.154 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.55 50.12 2.82 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 108' ' ' VAL . . . -71.22 -168.96 9.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.4 Cg_exo -61.69 50.96 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.174 2.583 . . . . 0.0 112.024 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 106' ' ' GLY . 19.6 m -156.0 47.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.289 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' O ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -45.56 118.94 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.253 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.4 mtp-105 -137.44 51.87 1.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 111' ' ' LYS . 7.6 mtpm? -106.09 137.96 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.44 -47.83 18.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.352 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 31.2 p90 -113.46 128.32 56.41 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 114' ' ' ILE . 12.2 mt -120.07 127.14 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' OD2' ' A' ' 158' ' ' ASP . 10.0 p -98.98 142.88 29.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 110.797 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 116' ' ' TYR . 12.1 p90 -128.06 137.93 52.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.123 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.497 ' NE ' ' OD1' ' A' ' 119' ' ' ASN . 41.6 ttt85 -135.68 137.22 41.58 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 4.6 mt -111.16 98.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.519 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' OD1' ' NE ' ' A' ' 117' ' ' ARG . 78.1 m-20 -97.86 12.0 35.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.425 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' THR . 7.1 t30 -101.94 -20.23 14.93 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.507 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 40.8 m-85 25.04 39.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -23.01 107.44 0.12 Allowed Pre-proline 0 N--CA 1.474 0.751 0 O-C-N 123.738 0.649 . . . . 0.0 111.848 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 97.09 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.627 1.552 . . . . 0.0 112.139 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -174.94 -22.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 53.6 mmm -138.57 156.77 47.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -50.6 110.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.41 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -60.96 -23.9 65.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.694 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.28 -38.18 63.48 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.97 -15.99 63.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 134' ' ' ILE . 77.5 t -85.7 -38.62 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.967 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.75 -39.6 21.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -56.71 -60.82 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.23 64.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.506 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 130' ' ' VAL . 49.9 mt -78.05 -29.91 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -77.41 -33.27 55.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.398 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -81.44 -15.08 56.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.425 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.99 -46.57 14.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.525 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 30.0 m-85 -57.49 -19.58 25.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.18 -34.48 68.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.63 -43.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.42 ' O ' ' OG1' ' A' ' 145' ' ' THR . 82.0 m95 -76.89 -51.81 10.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.15 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -58.06 -30.84 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -53.01 -41.53 64.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.28 22.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.58 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 141' ' ' TRP . 65.7 p -155.51 146.47 16.45 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.574 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.21 39.41 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.397 2.064 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 mt -92.7 -178.73 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.645 0.26 . . . . 0.0 110.654 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -158.81 105.44 1.8 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -104.11 120.93 42.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.703 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.7 m -130.99 155.63 46.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.305 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -114.01 126.94 55.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 pt -84.96 136.79 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.137 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -57.94 -39.59 78.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.87 143.39 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.07 -161.45 20.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mtp -101.85 135.04 44.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.166 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.97 157.35 20.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 115' ' ' THR . 43.3 m-20 -45.9 -43.17 13.55 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 159' ' ' ILE . 6.7 tt -135.45 126.39 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.355 0.598 . . . . 0.0 110.239 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 160' ' ' LEU . 15.1 tp -92.68 129.42 38.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.53 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.68 131.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 120' ' ' ASN . 60.8 t -137.29 126.16 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -102.35 146.06 28.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.099 0.476 . . . . 0.0 109.961 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.08 176.47 7.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.178 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -128.37 133.09 48.57 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.427 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.76 -150.31 29.38 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.44 98.04 0.46 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.712 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' A' ' 169' ' ' GLY . 56.2 p-80 -90.99 -138.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.604 ' N ' ' CD2' ' A' ' 168' ' ' HIS . . . -72.73 -132.55 0.17 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 1.1 m-20 -55.94 -162.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 171' ' ' PHE . 34.6 t80 62.63 35.16 14.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 17.3 m80 55.12 -96.9 0.06 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 179.52 152.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.604 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.601 ' CZ ' ' CE1' ' A' ' 168' ' ' HIS . 8.8 m-85 -73.44 143.56 46.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.16 -1.83 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.44 -148.65 16.48 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.43 109.85 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.94 -178.87 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.28 -128.64 8.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.8 mm -83.13 150.89 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 110.915 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -123.65 -22.95 4.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.361 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.472 ' N ' ' O22' ' A' ' 1' ' ' DSV . . . -161.98 162.74 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.077 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.437 ' NE2' ' ND1' ' A' ' 196' ' ' HIS . 10.9 p80 -145.0 175.88 9.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.353 . . . . 0.0 110.941 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.48 106.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.37 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -64.04 140.41 58.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.81 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.64 -66.94 2.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 189' ' ' SER . 57.7 Cg_endo -70.21 93.53 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.657 2.238 . . . . 0.0 111.755 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -56.51 -2.8 0.51 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 187' ' ' PRO . 48.6 m -66.0 122.38 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 111.1 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 192' ' ' GLY . . . 64.77 -169.04 26.75 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 193' ' ' GLY . 18.8 tt -44.41 -15.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.326 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 190' ' ' GLY . . . -66.5 42.38 0.18 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -158.5 -40.35 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.524 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 67.5 m-20 -43.41 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 O-C-N 124.452 0.736 . . . . 0.0 111.81 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -45.71 134.12 7.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.135 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 194' ' ' ASP . 39.8 m80 -116.58 124.14 49.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.212 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.08 139.94 30.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.267 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.426 ' CG ' ' CD2' ' A' ' 174' ' ' PHE . 53.4 t0 -92.11 110.68 22.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 203' ' ' TRP . 12.1 tp10 -92.57 -0.87 57.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.93 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.89 -18.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.05 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 199' ' ' GLU . 57.5 mm-40 -96.95 179.62 4.88 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.309 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -100.83 118.49 36.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.43 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.514 ' CD1' ' OE2' ' A' ' 199' ' ' GLU . 86.2 m95 -93.35 162.11 14.12 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 205' ' ' THR . 53.6 m -158.32 169.12 25.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.23 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.621 ' N ' HG22 ' A' ' 204' ' ' THR . 1.7 p -112.21 49.83 0.89 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.637 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -158.67 -58.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.7 p 175.25 -136.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 209' ' ' GLY . . . 60.7 -91.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 208' ' ' GLY . . . -59.91 -134.25 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 ' CH2' ' A' ' 203' ' ' TRP . 18.3 m -89.5 148.69 23.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' O ' ' OG1' ' A' ' 215' ' ' THR . 22.2 m120 -101.88 112.75 25.47 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -68.67 -34.44 75.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -69.77 -61.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.652 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 214' ' ' LEU . 9.6 mp -56.93 -27.98 61.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.759 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.423 ' OG1' ' CY1' ' A' ' 1' ' ' DSV . 24.1 m -74.72 -39.12 62.08 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.918 0.39 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.08 -60.25 3.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -51.78 -33.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.573 ' HD1' ' C5 ' ' A' ' 1' ' ' DSV . 9.7 t-160 -69.49 -58.21 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.714 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -53.52 -48.75 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.01 -34.2 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.035 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.46 -45.74 66.04 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -65.86 -24.01 66.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.695 0.284 . . . . 0.0 110.469 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.526 ' O ' ' CE3' ' A' ' 109' ' ' TRP . 20.5 p -48.35 -39.38 21.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.429 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.95 -69.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.333 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 161.57 25.3 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tp -78.07 138.3 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.37 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -119.87 169.17 13.79 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.601 ' CD2' ' SD ' ' A' ' 236' ' ' MET . 2.7 m170 -72.51 161.07 31.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.088 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.5 m -125.65 -145.04 0.32 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.8 m -79.62 -52.52 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 64.75 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.11 22.38 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.316 2.677 . . . . 0.0 113.158 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 43.02 40.32 2.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.451 0.643 . . . . 0.0 109.901 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.498 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -84.67 149.59 25.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.491 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.25 -12.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.31 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.601 ' SD ' ' CD2' ' A' ' 228' ' ' HIS . 13.1 ttp -55.1 -56.98 13.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.105 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 238' ' ' PRO . 6.2 t80 -39.74 147.1 0.34 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 237' ' ' PHE . 71.6 Cg_exo -44.82 -141.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.384 2.056 . . . . 0.0 113.57 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -95.23 -87.43 0.28 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.431 -0.793 . . . . 0.0 111.448 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 242' ' ' TYR . 11.3 m-85 38.46 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.498 0.499 . . . . 0.0 110.436 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 239' ' ' THR . 34.1 tttp -68.09 41.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 243' ' ' VAL . 21.5 t80 -55.24 168.23 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.12 0.485 . . . . 0.0 110.329 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.625 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 3.6 p -162.46 140.59 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.676 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -41.89 150.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.55 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 245' ' ' ILE . 15.9 pt -76.37 -28.71 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 -13.27 59.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 0.0 110.617 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -111.45 8.94 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.61 131.72 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.897 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -155.88 131.03 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.05 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 35.0 mt -75.71 159.77 30.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 46.1 m -94.12 156.23 16.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.78 62.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.24 -41.48 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.414 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -70.52 -23.33 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.677 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.4 mt -81.81 -22.69 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.553 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -66.18 -49.55 66.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.623 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.18 -45.72 57.24 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.138 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 261' ' ' LEU . 6.1 tt -67.96 -50.24 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.506 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -42.7 -33.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 28.5 p -71.42 -31.93 67.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 0.0 110.594 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 258' ' ' ILE . 64.8 mt -65.56 -53.76 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.389 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -176.54 -27.36 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.038 -1.423 . . . . 0.0 110.908 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.573 ' C5 ' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' GLU . 94.4 m-85 -73.25 155.88 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 53.48 6.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.155 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' PHE . 32.5 mm-40 47.19 54.18 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.665 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 71.3 mtp -100.8 -16.52 0.19 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 103' ' ' MET . 74.4 Cg_endo -80.32 176.2 9.47 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 CA-C-N 120.606 1.252 . . . . 0.0 112.012 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.58 62.46 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -50.81 175.3 0.07 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 140.61 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.863 2.376 . . . . 0.0 111.703 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -70.81 99.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -75.98 102.09 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.184 0.516 . . . . 0.0 110.419 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 112' ' ' HIS . 21.3 mmt180 -74.78 62.84 1.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.546 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -60.61 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.247 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.611 ' N ' ' O ' ' A' ' 110' ' ' ARG . 12.6 m-70 -79.26 -57.75 3.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 40.6 p90 -113.51 123.82 50.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.91 127.95 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 158' ' ' ASP . 8.6 p -98.65 145.48 26.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.744 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 12.9 p90 -127.17 136.23 51.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.224 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.774 ' HE ' HD21 ' A' ' 119' ' ' ASN . 29.1 ttp180 -135.73 137.96 42.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.12 0.486 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 121' ' ' TYR . 2.7 mt -110.54 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.053 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.774 HD21 ' HE ' ' A' ' 117' ' ' ARG . 27.5 m-80 -97.71 6.1 48.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.807 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -124.14 -18.39 5.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.404 0.145 . . . . 0.0 111.326 -179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' H ' HG22 ' A' ' 118' ' ' ILE . 91.8 m-85 37.51 -157.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -171.14 83.61 0.51 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.05 -3.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.452 2.101 . . . . 0.0 113.083 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 122' ' ' THR . 14.9 m-20 -61.53 -29.84 70.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.182 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 15.9 mtp -135.31 168.92 18.29 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.172 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -58.14 105.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -49.96 -24.32 2.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.497 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 12.2 mp0 -77.81 -40.4 40.62 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.646 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.23 -16.35 64.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.0 t -86.16 -35.71 9.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 109.903 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.7 -41.39 17.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.104 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -55.74 -61.98 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.397 . . . . 0.0 111.359 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.03 -25.84 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.139 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.4 mm -76.61 -29.56 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.59 -34.98 58.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.403 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -79.16 -15.6 57.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.14 -47.39 16.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 35.2 m-85 -59.17 -20.74 56.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.08 -38.15 61.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.494 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 97.0 t -53.42 -39.05 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.16 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' O ' ' OG1' ' A' ' 145' ' ' THR . 89.8 m95 -77.36 -51.64 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -59.08 -28.74 66.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.379 . . . . 0.0 110.151 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.02 -37.8 72.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.794 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 145' ' ' THR . 5.9 m -113.09 19.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 39.3 p -157.38 147.99 16.15 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.599 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.98 33.13 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.412 2.075 . . . . 0.0 112.713 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.55 -179.66 6.95 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -158.37 104.04 1.82 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.982 0.42 . . . . 0.0 110.413 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -105.13 120.61 41.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.723 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 p -133.48 155.73 49.02 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.696 0.284 . . . . 0.0 110.427 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -109.73 126.04 53.31 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.9 pt -85.01 138.94 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -59.79 -38.58 82.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.644 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.9 m -153.61 148.78 26.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.514 ' O ' ' NH1' ' A' ' 117' ' ' ARG . . . 123.28 -153.93 17.18 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.474 ' CE ' ' O ' ' A' ' 157' ' ' ALA . 1.3 tmt? -108.54 132.64 53.64 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' CE ' ' A' ' 156' ' ' MET . . . -109.71 152.06 26.12 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 115' ' ' THR . 2.4 m-20 -44.7 -42.05 7.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.403 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 159' ' ' ILE . 5.7 tt -137.98 130.71 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.209 0.528 . . . . 0.0 110.327 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.25 129.92 43.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.78 131.29 54.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.129 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -134.69 123.43 41.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.72 143.44 32.79 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.153 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.85 178.03 6.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 166' ' ' GLY . 8.9 ptp180 -131.55 137.99 48.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.754 0.312 . . . . 0.0 110.484 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.579 ' H ' ' CG ' ' A' ' 200' ' ' ASP . . . 53.48 109.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 60.02 151.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 111.002 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' A' ' 174' ' ' PHE . 50.3 p-80 -164.24 123.97 2.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.509 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 45.24 -122.71 5.47 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -45.22 152.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.683 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -57.94 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -146.06 86.88 1.72 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.761 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.7 12.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.333 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' A' ' 168' ' ' HIS . 63.1 m-85 -41.64 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.65 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.416 ' O ' ' OE2' ' A' ' 201' ' ' GLU . . . 118.68 -155.69 15.97 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -65.69 117.48 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.57 -168.24 13.16 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.93 1.58 Allowed Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.9 mt -78.25 150.37 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.981 0.419 . . . . 0.0 110.941 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.63 -22.57 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.231 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.13 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.971 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 58.4 t60 -127.24 82.11 2.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.14 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.86 171.72 14.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.262 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 192' ' ' GLY . 1.1 t80 -149.99 144.56 25.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.166 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.5 162.96 51.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 140.97 31.44 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.663 2.242 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' SER . . . 177.79 -171.2 43.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 188' ' ' GLY . 48.0 m -40.64 169.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -27.87 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.467 0.746 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.26 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 191' ' ' ILE . 21.4 tt -74.63 57.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.778 0.799 . . . . 0.0 110.207 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -139.04 -38.55 0.11 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -96.61 -32.02 6.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.28 56.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.815 0.34 . . . . 0.0 111.762 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -51.46 163.54 0.26 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.183 0.516 . . . . 0.0 111.873 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -131.77 133.79 45.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.984 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -99.43 144.4 28.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 198' ' ' ASP . 1.9 p30 -102.78 132.47 48.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 201' ' ' GLU . 16.8 tt0 -111.63 5.86 19.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.828 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 166' ' ' GLY . 4.8 m-20 -44.9 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.045 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 199' ' ' GLU . 14.7 mp0 -100.95 -178.93 3.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.696 0.284 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -104.57 114.85 29.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 110.186 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 210' ' ' THR . 91.5 m95 -83.78 151.04 25.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 83.8 m -158.52 101.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.216 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.5 p -81.46 56.42 2.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.813 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -167.19 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.018 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 p -174.4 -123.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 54.96 -108.66 1.01 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.8 -56.53 0.02 OUTLIER Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.965 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -58.5 108.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.965 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.431 ' ND2' ' CE1' ' A' ' 242' ' ' TYR . 25.4 m120 -102.32 111.88 24.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.1 tp -70.99 -32.36 69.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.4 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.444 ' CB ' HG22 ' A' ' 245' ' ' ILE . 26.1 t80 -69.76 -60.88 2.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.9 mp -55.06 -30.68 60.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 55.3 m -74.3 -38.09 63.46 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -47.83 -53.99 13.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.375 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.36 -31.52 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.594 ' CE1' ' SD ' ' A' ' 236' ' ' MET . 3.6 t60 -66.33 -53.75 32.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.828 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -44.46 -56.75 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 mm -49.25 -33.42 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.89 -42.49 38.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.54 -35.18 34.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.0 t -46.98 -52.99 13.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.315 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.7 mt -67.86 -74.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.5 30.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.552 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -88.26 146.13 25.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.97 0.414 . . . . 0.0 110.135 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.95 -172.2 47.04 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -87.53 147.74 25.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 51.0 p -125.02 139.86 53.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.21 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 69.7 m -149.22 84.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.338 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.57 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.3 m-20 161.11 -39.84 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.067 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 86.3 Cg_endo -86.96 35.85 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.06 1.84 . . . . 0.0 112.432 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 232' ' ' PRO . 41.0 mttm 37.97 50.34 1.3 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.31 0.576 . . . . 0.0 110.079 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -85.05 137.67 32.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.616 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.73 -13.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.592 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.594 ' SD ' ' CE1' ' A' ' 218' ' ' HIS . 39.6 tpp -62.82 -53.56 52.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 238' ' ' PRO . 4.5 t80 -40.39 145.98 0.46 Allowed Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.233 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 237' ' ' PHE . 34.0 Cg_exo -37.6 -129.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.251 2.634 . . . . 0.0 115.364 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.37 14.04 14.62 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.314 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.4 OUTLIER -39.61 -29.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.428 0.633 . . . . 0.0 109.823 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 34.5 ttpt -119.71 67.94 0.82 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.465 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.486 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.5 t80 -70.24 137.05 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 242' ' ' TYR . 16.4 m -157.02 150.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -53.89 170.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.562 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 213' ' ' PHE . 12.4 pt -79.82 -36.06 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -76.13 -16.13 59.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 67.4 p -100.43 2.0 41.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.471 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.476 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 63.9 t80 -51.71 120.87 5.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 248' ' ' PHE . 6.3 mmp_? -142.89 125.23 15.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 31.0 mt -78.77 164.43 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 58.7 p -106.92 161.87 14.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.61 -18.65 65.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.69 -44.03 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.666 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.97 -26.25 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.8 mt -81.66 -23.11 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.801 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -77.2 -10.4 59.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.448 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.6 -50.03 3.92 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 260' ' ' SER . 10.3 tt -65.31 -39.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 110.91 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 258' ' ' ILE . 14.2 mt-30 -38.78 -22.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 258' ' ' ILE . 41.5 t -65.2 -28.31 69.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.911 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 261' ' ' LEU . 10.1 mp -75.73 -48.91 19.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 35.3 t80 -173.1 -23.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.767 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.884 -179.876 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.471 ' CZ2' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 100' ' ' PHE . 43.8 t80 -167.12 -9.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.81 40.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -73.4 -31.34 63.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.608 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.488 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER 54.63 79.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.85 120.51 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.516 2.144 . . . . 0.0 112.113 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.02 104.28 0.26 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.25 56.98 0.06 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.79 87.98 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.625 2.216 . . . . 0.0 111.781 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 109' ' ' TRP . 15.4 m -75.26 -44.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.403 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.542 ' N ' HG23 ' A' ' 108' ' ' VAL . 3.3 t90 -57.92 102.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' C ' ' H ' ' A' ' 112' ' ' HIS . 64.6 mtp180 -160.3 44.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.4 mttp 59.61 -11.7 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.63 ' H ' ' C ' ' A' ' 110' ' ' ARG . 16.7 m80 -95.49 -44.19 7.63 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.602 ' CE1' ' NZ ' ' A' ' 148' ' ' LYS . 9.9 m-85 -120.96 131.55 54.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.5 mt -139.6 134.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.408 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.5 p -97.99 152.98 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -130.38 138.51 50.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -133.21 136.01 45.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 121' ' ' TYR . 58.7 mt -110.25 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.736 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' ND2' HD21 ' A' ' 160' ' ' LEU . 59.2 m-80 -82.09 9.69 8.04 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.05 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -172.61 158.16 4.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.901 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -140.0 119.01 12.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.701 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -41.35 118.15 1.72 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.482 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.33 88.72 1.42 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.705 1.603 . . . . 0.0 111.947 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -166.21 -22.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.7 mtp -142.07 167.72 21.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -50.91 111.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.095 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.9 mtm-85 -60.41 -24.65 65.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.754 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -73.57 -35.37 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.19 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.48 -16.02 63.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.881 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -85.41 -37.29 11.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.991 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 1.3 m-20 -83.81 -41.36 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.118 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -56.09 -61.57 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.477 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.31 54.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.095 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.95 -27.43 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -77.91 -33.2 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -80.1 -16.07 55.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.38 -47.51 19.67 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.54 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 149' ' ' PHE . 34.0 m-85 -57.21 -19.51 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.682 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -80.45 -34.49 35.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.83 0.348 . . . . 0.0 110.393 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.6 t -53.37 -39.32 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.296 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -79.83 -49.3 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.098 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.71 -28.07 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -57.85 -43.66 86.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.124 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.79 16.62 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.6 p -150.65 148.62 23.97 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.39 35.7 0.55 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.255 1.97 . . . . 0.0 112.639 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 148' ' ' LYS . 13.5 mt -88.34 175.84 7.47 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' A' ' 113' ' ' TYR . 26.2 mtmm -159.7 119.82 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.271 0.557 . . . . 0.0 110.003 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -119.88 122.01 40.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.923 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.2 m -138.42 156.62 47.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.091 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -95.65 113.99 25.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 156' ' ' MET . 6.4 pt -94.45 152.86 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 154' ' ' THR . 30.1 m-80 -105.33 44.32 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 156' ' ' MET . 29.5 p -159.0 156.16 28.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 33.14 30.09 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.817 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.537 ' N ' ' O ' ' A' ' 154' ' ' THR . 63.1 mtp 58.48 -160.9 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.17 155.16 27.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.915 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -47.08 -39.1 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.675 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 5.3 tt -135.49 144.28 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.497 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -106.94 135.54 48.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.14 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.58 126.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.784 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.52 133.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 4.2 m-85 -104.43 149.11 25.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.012 0.434 . . . . 0.0 109.93 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.95 173.04 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -131.42 141.25 49.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.841 0.353 . . . . 0.0 110.419 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 175' ' ' ASP . . . 78.77 -152.02 36.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.64 141.67 42.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.664 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.458 ' CG ' ' N ' ' A' ' 169' ' ' GLY . 30.7 p-80 -161.15 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 168' ' ' HIS . . . -52.94 179.28 0.09 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 172' ' ' HIS . 6.4 m-20 -80.75 102.56 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 110.615 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 173' ' ' ALA . 9.6 m-85 64.0 -65.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 174' ' ' PHE . 42.6 m170 -66.17 68.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 171' ' ' PHE . . . -48.36 139.47 8.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.517 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' HIS . 67.8 m-85 -128.45 120.19 26.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.197 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.6 OUTLIER 171.43 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.632 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' ASP . . . 45.04 97.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.527 ' N ' ' OD2' ' A' ' 200' ' ' ASP . 73.6 tttt -44.44 109.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.318 . . . . 0.0 110.295 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 120.62 -179.27 16.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.52 -90.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 178' ' ' GLY . 79.8 mt -81.73 150.74 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.12 -20.58 5.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.584 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.15 163.14 31.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.535 ' CE1' ' O ' ' A' ' 196' ' ' HIS . 14.9 p-80 -145.6 145.01 30.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -156.74 140.74 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.63 139.45 30.54 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.32 -77.21 1.2 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 189' ' ' SER . 81.4 Cg_exo -44.15 113.2 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.36 2.04 . . . . 0.0 112.17 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -63.74 67.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 187' ' ' PRO . 6.0 m -89.96 168.09 12.3 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -35.61 -48.37 0.94 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 193' ' ' GLY . 17.6 tt -107.42 -18.84 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 109.973 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.23 48.83 0.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.13 -59.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.494 ' O ' ' CE1' ' A' ' 196' ' ' HIS . 63.0 t0 -60.81 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.815 0.341 . . . . 0.0 110.951 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -60.06 -176.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.509 . . . . 0.0 111.573 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' O ' ' CE1' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -152.42 150.5 29.73 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.418 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' OE2' ' A' ' 219' ' ' GLU . 10.4 m-85 -98.64 146.1 26.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.36 118.77 31.25 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.022 0.439 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 201' ' ' GLU . 27.5 tt0 -95.63 -6.94 38.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 177' ' ' LYS . 31.9 t0 -41.01 -22.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 199' ' ' GLU . 55.0 mm-40 -96.69 179.56 4.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -98.27 113.86 25.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.705 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 98.2 m95 -96.42 156.64 16.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 16.6 p -150.63 172.67 15.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.218 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -117.23 -40.99 3.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.478 ' O ' ' CB ' ' A' ' 207' ' ' SER . 4.4 t60 -67.37 -3.01 7.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.559 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 0.7 OUTLIER 83.81 115.05 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.52 -90.91 0.08 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.45 -104.7 0.01 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.8 m -92.79 151.13 20.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 215' ' ' THR . 57.7 m-80 -102.78 113.29 26.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.346 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 53.7 tp -69.63 -31.36 69.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.236 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -70.03 -59.89 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.425 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.97 -31.14 64.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 211' ' ' ASN . 61.3 m -72.86 -39.71 66.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.548 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.69 -60.33 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 47.0 t -45.2 -39.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CD2' ' C6 ' ' A' ' 1' ' ' DSV . 65.7 t60 -69.65 -57.58 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.204 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' A' ' 197' ' ' PHE . 35.0 mt-10 -52.7 -48.5 66.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.33 -31.77 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.483 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.39 -46.66 11.59 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.579 ' CE1' ' HE2' ' A' ' 228' ' ' HIS . 24.6 m-70 -49.45 -41.57 40.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.9 m -45.35 -48.81 13.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 226' ' ' LEU . 11.9 mt -79.41 40.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 38.72 24.75 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 224' ' ' LEU . 5.0 tp -78.15 135.33 37.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.624 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.27 -167.59 41.8 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 222' ' ' HIS . 49.3 m170 -98.78 152.67 19.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.097 0.449 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.2 p -106.29 -156.26 0.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 52.1 m -136.21 -123.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.752 ' O ' ' N ' ' A' ' 233' ' ' LYS . 12.0 m-20 -68.25 -56.07 11.41 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.451 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 234' ' ' ALA . 59.6 Cg_exo -17.54 61.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.729 3.619 . . . . 0.0 115.282 -178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' A' ' 231' ' ' ASP . 63.0 mttm 22.77 42.89 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.57 0.748 . . . . 0.0 112.03 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 232' ' ' PRO . . . -88.19 129.57 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.278 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 235' ' ' VAL . 4.7 p -49.48 -13.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.025 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 1.2 tmt? -57.09 -57.08 14.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.025 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.596 ' O ' ' O ' ' A' ' 238' ' ' PRO . 3.8 t80 -41.73 142.94 0.99 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.487 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 237' ' ' PHE . 45.6 Cg_exo -36.82 -124.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 123.154 2.569 . . . . 0.0 114.536 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.427 ' C ' ' N ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -124.42 18.7 8.92 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.004 -0.435 . . . . 0.0 110.613 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -45.36 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.281 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 76.6 tttt -140.55 64.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 243' ' ' VAL . 4.5 t80 -61.38 149.39 38.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.614 ' N ' ' CD1' ' A' ' 242' ' ' TYR . 1.1 m -146.24 135.54 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -41.36 149.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 12.7 pt -75.73 -21.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.07 -18.93 32.78 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 32.5 p -108.85 9.62 26.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.38 126.59 17.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -154.72 114.97 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.237 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 44.1 mt -60.22 163.85 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.098 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 33.2 t -102.95 160.33 14.71 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.28 51.56 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.93 -43.86 28.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.044 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.32 -28.73 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.53 -23.78 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.678 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -67.28 -50.16 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.963 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -59.28 -45.65 95.08 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.685 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.596 HG23 ' H ' ' A' ' 259' ' ' GLN . 4.4 tp -66.92 -56.32 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.203 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.596 ' H ' HG23 ' A' ' 258' ' ' ILE . 19.6 mm100 -43.64 -26.9 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.963 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.0 t -63.49 -22.6 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.952 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 258' ' ' ILE . 9.2 mt -78.32 -46.82 19.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 0.0 110.565 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -174.51 -25.06 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.543 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.761 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.916 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.498 ' C6 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 101' ' ' ARG . 20.8 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 102' ' ' GLU . 17.7 m-85 -73.2 39.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.482 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 99' ' ' MET . 13.9 mmm180 -68.65 46.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 100' ' ' PHE . 14.7 pt-20 -46.35 143.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.687 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 7.9 ttt -173.13 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.845 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.687 ' CD ' ' H ' ' A' ' 103' ' ' MET . 81.5 Cg_endo -92.88 38.33 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.343 2.028 . . . . 0.0 112.145 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.27 -126.26 0.77 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 107' ' ' PRO . . . 75.5 75.6 0.83 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' GLY . 54.4 Cg_exo -50.94 -167.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.856 2.371 . . . . 0.0 112.2 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -138.15 89.26 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.385 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -79.63 101.55 8.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -72.35 58.08 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 9.1 pttm -57.44 99.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 87.5 m-70 -160.07 -64.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 43.0 p90 -118.29 120.13 36.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.722 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.82 133.77 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.009 0.433 . . . . 0.0 110.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 p -99.86 152.85 19.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.58 144.29 47.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.305 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.688 ' NE ' HD21 ' A' ' 119' ' ' ASN . 58.8 ttt180 -137.95 138.95 39.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.475 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 45.3 mt -111.34 95.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.643 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.688 HD21 ' NE ' ' A' ' 117' ' ' ARG . 10.9 m120 -94.31 14.11 21.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.594 ' CG ' ' H ' ' A' ' 163' ' ' PHE . 3.0 t30 -79.49 -71.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 118' ' ' ILE . 13.9 m-85 64.9 24.23 12.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.606 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -32.03 115.85 0.39 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.89 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 84.4 Cg_endo -79.71 92.9 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.667 1.578 . . . . 0.0 112.138 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 11.2 m-20 -168.84 -26.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 58.3 mtp -142.45 161.19 38.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.244 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -50.66 109.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.6 mtm-85 -63.08 -25.05 68.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.593 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.01 -34.37 61.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.34 -16.79 64.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 61.8 t -86.14 -37.34 11.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.908 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 0.9 OUTLIER -80.23 -41.94 24.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -59.09 -55.83 29.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.17 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.61 70.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 4.2 mm -73.39 -28.74 26.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -77.55 -33.38 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.364 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -78.19 -15.37 58.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.14 -52.25 7.58 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.497 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.05 -19.34 30.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -74.8 -38.2 62.15 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.586 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.05 -36.71 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.281 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.441 ' O ' ' OG1' ' A' ' 145' ' ' THR . 94.7 m95 -80.55 -51.8 8.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.9 m -61.26 -30.26 70.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.143 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.8 -44.53 73.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 145' ' ' THR . 5.5 m -108.53 20.59 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.842 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 144' ' ' VAL . 66.1 p -151.31 147.68 20.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.49 37.75 0.62 Allowed 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.248 1.966 . . . . 0.0 112.751 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.28 -177.33 6.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.024 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -159.14 101.28 1.58 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.016 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -105.84 118.24 36.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 m -141.46 156.8 45.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.32 116.88 32.52 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 156' ' ' MET . 4.9 pt -94.9 153.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 154' ' ' THR . 28.4 m120 -102.09 49.16 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.351 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 156' ' ' MET . 80.4 m -169.3 161.67 10.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.469 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 154' ' ' THR . . . 33.69 26.1 0.01 OUTLIER Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.068 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 154' ' ' THR . 59.5 mtp 58.77 -161.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.4 153.78 26.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.939 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -45.42 -39.81 7.43 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.858 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 193' ' ' GLY . 6.0 tt -134.85 142.26 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.14 0.495 . . . . 0.0 109.978 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.29 135.38 49.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.91 132.5 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.38 130.77 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.594 ' H ' ' CG ' ' A' ' 120' ' ' ASN . 16.2 m-85 -106.32 149.09 27.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.049 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -166.56 177.42 6.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.053 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -128.69 136.82 51.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 200' ' ' ASP . . . 84.48 -148.7 24.11 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.09 157.64 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 0.0 110.802 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 168' ' ' HIS . 5.5 p-80 -166.35 156.77 12.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.701 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 39.77 -103.34 0.03 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -45.51 156.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 110.552 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 172' ' ' HIS . 18.5 p90 -84.13 -23.87 30.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 90.8 m-70 -63.04 -17.19 61.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 172' ' ' HIS . . . 58.34 146.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.84 130.42 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.76 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.462 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 11.5 t0 -178.53 -96.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.835 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . 49.58 79.68 0.07 OUTLIER Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.115 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -39.38 116.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 180' ' ' ILE . . . 123.3 178.4 15.45 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.24 -83.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 178' ' ' GLY . 89.0 mt -83.98 151.07 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.8 mt -125.81 -16.11 5.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.485 ' O ' HC1A ' A' ' 1' ' ' DSV . . . -150.08 151.85 33.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 183' ' ' HIS . 60.0 t60 -117.3 81.97 1.74 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.86 123.34 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 185' ' ' PHE . 5.4 p90 -73.52 124.26 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 188' ' ' GLY . . . -84.98 -159.64 31.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.14 55.52 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.799 2.333 . . . . 0.0 111.885 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 186' ' ' GLY . . . -78.06 -154.58 7.19 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 192' ' ' GLY . 51.7 m -89.04 168.63 12.19 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 189' ' ' SER . . . -34.33 -57.36 0.71 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 192' ' ' GLY . 8.0 tt -45.77 -43.01 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -38.13 -39.21 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -44.5 -49.92 8.36 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 196' ' ' HIS . 9.0 m-20 -56.2 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.175 0.573 . . . . 0.0 111.261 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 193' ' ' GLY . . . -38.93 133.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.047 0.451 . . . . 0.0 111.936 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 194' ' ' ASP . 4.5 m80 -111.95 121.87 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.616 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.63 115.3 27.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 201' ' ' GLU . 13.0 tt0 -94.95 -3.4 48.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.955 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 166' ' ' GLY . 7.9 m-20 -42.3 -20.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.438 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 199' ' ' GLU . 8.8 mm-40 -100.32 -176.44 3.22 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -103.09 115.79 31.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 199' ' ' GLU . 97.6 m95 -92.51 143.9 25.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 111.245 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.9 t -136.14 167.87 20.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.455 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -123.03 -14.84 7.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 207' ' ' SER . 3.8 t60 -84.89 -6.03 59.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.732 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 4.2 p 86.75 108.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.33 97.33 0.12 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.21 -133.07 11.36 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -71.8 131.17 42.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.86 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.551 ' O ' HG23 ' A' ' 215' ' ' THR . 5.8 m120 -102.89 113.76 27.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.862 0.363 . . . . 0.0 110.362 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.14 -32.54 69.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.637 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -71.84 -60.17 2.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.74 -32.0 40.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 211' ' ' ASN . 29.0 p -78.61 -34.08 46.93 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.878 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -49.43 -55.31 13.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 217' ' ' VAL . 4.1 t -50.49 -33.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.731 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -70.58 -57.3 4.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 0.8 OUTLIER -45.26 -54.82 6.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.755 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.59 -32.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.082 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.97 -36.51 56.14 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.547 ' CE1' ' NE2' ' A' ' 228' ' ' HIS . 44.3 m-70 -81.34 -30.62 33.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.3 m -53.2 -39.71 63.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.273 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.94 -75.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 167.94 18.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.52 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.7 mp -84.25 148.46 26.69 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -87.84 -165.21 41.05 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.547 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 28.2 m170 -90.27 148.86 22.63 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.486 ' O ' ' SD ' ' A' ' 236' ' ' MET . 26.2 t -120.26 144.86 47.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.129 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 231' ' ' ASP . 66.8 m -154.06 83.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.836 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.562 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 1.2 m-20 161.86 -40.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.088 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 231' ' ' ASP . 83.9 Cg_endo -88.78 35.94 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.325 2.016 . . . . 0.0 112.434 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' NZ ' ' OD1' ' A' ' 253' ' ' ASP . 22.3 mtmm 39.71 51.14 2.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 110.055 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' MET . . . -82.27 137.68 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.496 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 p -50.45 -16.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.718 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 237' ' ' PHE . 0.5 OUTLIER -57.94 -59.39 5.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.592 ' N ' ' SD ' ' A' ' 236' ' ' MET . 4.4 t80 -41.3 144.27 0.72 Allowed Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.436 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 237' ' ' PHE . 30.7 Cg_exo -36.52 -121.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 123.154 2.569 . . . . 0.0 114.16 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 239' ' ' THR . 1.5 p -75.85 58.59 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.744 -0.598 . . . . 0.0 110.455 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -54.71 -34.63 62.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.138 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 243' ' ' VAL . 9.0 tptm -148.83 71.14 1.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -55.39 107.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.566 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 241' ' ' LYS . 33.8 m -154.55 -142.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 244' ' ' ASP . 1.3 m-20 -111.22 177.17 4.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.478 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.1 pt -84.31 -29.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.725 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -84.71 -16.02 43.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.89 0.376 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 81.3 p -99.09 0.51 43.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.742 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -54.57 123.65 13.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.292 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -144.22 116.09 8.29 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.36 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.33 163.36 18.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 80.8 p -105.4 162.38 13.5 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.73 -20.52 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.478 ' OD1' ' NZ ' ' A' ' 233' ' ' LYS . 6.2 m-20 -77.0 -42.11 40.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.748 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.47 -25.19 63.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.64 -23.82 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -78.34 -10.48 59.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.409 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.62 -50.46 3.77 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 259' ' ' GLN . 9.1 tp -69.5 -45.19 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 110.765 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 258' ' ' ILE . 16.5 mt-30 -40.93 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 258' ' ' ILE . 38.5 t -47.74 -12.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 259' ' ' GLN . 25.6 mt -89.0 -25.02 22.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.06 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 259' ' ' GLN . 6.7 t80 82.74 18.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.565 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 CA-C-O 118.023 -1.431 . . . . 0.0 110.994 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' DSV . . . . . 0.581 HC2B ' O40' ' A' ' 1' ' ' DSV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_